tegafur has been researched along with Lymph Node Metastasis in 572 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 9.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 9.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "The primary aim of this study was to compare the effectiveness of oral uracil-tegafur (UFT) with that of classical cyclophosphamide, methotrexate, and fluorouracil (CMF) given as postoperative adjuvant treatment to women with node-negative, high-risk breast cancer." | 9.14 | Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial. ( Iwata, H; Kitaya, T; Kohno, N; Nakagami, K; Ohashi, Y; Sakamoto, G; Sano, M; Shimozuma, K; Sonoo, H; Takashima, S; Tokuda, Y; Tsuda, H; Watanabe, T; Yoshimoto, M, 2009) |
| " Therefore, we compared UFT with a combination therapy of cyclophosphamide, methotrexate, and fluorouracil (CMF) in patients who had undergone curative surgery for axillary lymph node-positive breast cancer." | 9.14 | Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study. ( Asaga, T; Higaki, K; Inaji, H; Ito, T; Koh, J; Kohno, N; Komichi, H; Koyama, H; Kyono, S; Mitsuyama, S; Nishikawa, H; Ogita, M; Okamura, K; Osaki, A; Park, Y; Saito, T; Suzuki, T; Tanaka, F; Yamazaki, K, 2009) |
| "We performed a controlled study to compare the response to cyclophosphamide (CPA), adriamycin (ADM), and fluorouracil (5-FU) (CAF therapy) with that to uracil-tegafur (UFT) plus tamoxifen (TAM) (UFT+TAM therapy), when given as postoperative adjuvant therapy to women with breast cancer." | 9.12 | [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set ( Inaji, H; Koyama, H; Mori, T; Nakao, K; Oka, T; Oshima, A; Ozawa, K; Saito, Y; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T, 2006) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 9.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| "Between February 1985 and October 1989, 26 patients previously treated for metastatic breast cancer received oral tegafur, at a median daily dose of 1200 mg." | 9.07 | Oral tegafur in the treatment of metastatic breast cancer: a phase II study. ( Kajanti, MJ; Maiche, AG; Pyrhönen, SO, 1993) |
| "A prospective randomized study was performed in 22 institutions from July 1978, to evaluate the efficiency of long-term adjuvant chemotherapy with tegafur alone for primary breast cancer." | 9.06 | [Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy]. ( Iwasa, Z; Kawahara, T; Kousaki, G; Okajima, K; Okamoto, E; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T; Utsunomiya, J, 1988) |
| "The aim of this study was to investigate the prognostic significance of HuR in cholangiocarcinoma patients who received adjuvant gemcitabine-based chemotherapy (AGC) after surgical resection." | 7.88 | Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy. ( Kondo, N; Murakami, Y; Nakagawa, N; Sueda, T; Takahashi, S; Toyota, K; Uemura, K, 2018) |
| "We report the case of a patient in which S-1 plus anastrozole was administered as first-line chemotherapy for Stage IV breast cancer with skin invasion, multiple lymph node metastasis, and lymphangitis carcinomatosis." | 7.85 | [A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy]. ( Akami, T; Hatakeyama, T; Matsumura, A; Mugitani, T; Ogino, S; Okano, S; Sakai, T, 2017) |
| "We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 7.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
| "A 70-year-old woman with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases due to gastric cancer, was treated by combination chemotherapy of S-1 and irinotecan (CPT-11)." | 7.74 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)]. ( Adachi, K; Arimoto, Y; Nishio, K; Ohba, H; Ohtani, H; Shintani, M; Yui, S, 2008) |
| " He had nausea, vomiting and anorexia due to pyloric stenosis, and was treated with 600 mg of UFT E granules/day orally for 5 consecutive days followed by 2 drug-free days (weekly-5 method), and 2 mg of lentinan intravenously twice a week." | 7.70 | [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. ( Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T, 2000) |
| " Because the replacement of 2-day-infusional 5-fluorouracil (5-FU) of FOLFIRI with oral tegafur-uracil/leucovorin (UFT/LV) would be highly beneficial for clinical management, we performed a phase I trial using oral UFT/LV and a pharmacokinetic evaluation." | 6.74 | Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. ( Azuma, T; Chayahara, N; Hirai, M; Inoue, Y; Kadowaki, Y; Kasuga, M; Maeda, T; Miki, I; Nishisaki, H; Okumura, K; Okuno, T; Sakaeda, T; Tamura, T; Tsuda, M; Yamamori, M, 2009) |
| "Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 5.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
| "We report a case of advanced gastric cancer successfully treated with preoperative S-1/Lentinan (LTN)chemotherapy followed by curative gastrectomy." | 5.39 | [A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy]. ( Aono, T; Deguchi, K; Deguchi, T; Endo, S; Fujitani, K; Fukui, A; Fushimi, H; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Noguchi, Y; Nomura, M; Okumura, Y; Takagi, M; Tamagawa, H; Tanaka, Y; Yoshida, H, 2013) |
| "A 70-year-old male presented with gastric cancer with para-aortic lymph node metastasis." | 5.36 | [A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy]. ( Matsunaga, N; Nakagawa, Y; Noda, S; Yanagawa, K, 2010) |
| "We recently established a metastasis model in nude mice using the MKL-4 cell line, a contransfectant of the MCF-7 human breast cancer cell line with fgf-4 and lacZ in which micrometastases in several organs can be quantitatively observed." | 5.30 | Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. ( Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N, 1997) |
| "This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 5.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 5.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "The primary aim of this study was to compare the effectiveness of oral uracil-tegafur (UFT) with that of classical cyclophosphamide, methotrexate, and fluorouracil (CMF) given as postoperative adjuvant treatment to women with node-negative, high-risk breast cancer." | 5.14 | Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial. ( Iwata, H; Kitaya, T; Kohno, N; Nakagami, K; Ohashi, Y; Sakamoto, G; Sano, M; Shimozuma, K; Sonoo, H; Takashima, S; Tokuda, Y; Tsuda, H; Watanabe, T; Yoshimoto, M, 2009) |
| " Therefore, we compared UFT with a combination therapy of cyclophosphamide, methotrexate, and fluorouracil (CMF) in patients who had undergone curative surgery for axillary lymph node-positive breast cancer." | 5.14 | Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study. ( Asaga, T; Higaki, K; Inaji, H; Ito, T; Koh, J; Kohno, N; Komichi, H; Koyama, H; Kyono, S; Mitsuyama, S; Nishikawa, H; Ogita, M; Okamura, K; Osaki, A; Park, Y; Saito, T; Suzuki, T; Tanaka, F; Yamazaki, K, 2009) |
| "We performed a controlled study to compare the response to cyclophosphamide (CPA), adriamycin (ADM), and fluorouracil (5-FU) (CAF therapy) with that to uracil-tegafur (UFT) plus tamoxifen (TAM) (UFT+TAM therapy), when given as postoperative adjuvant therapy to women with breast cancer." | 5.12 | [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set ( Inaji, H; Koyama, H; Mori, T; Nakao, K; Oka, T; Oshima, A; Ozawa, K; Saito, Y; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T, 2006) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 5.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| " This phase II study assessed the response rate and toxicity profile of the combination of epirubicin, cisplatin and UFT in patients with metastatic adenocarcinoma of the stomach." | 5.11 | A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma. ( Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS, 2005) |
| "Between February 1985 and October 1989, 26 patients previously treated for metastatic breast cancer received oral tegafur, at a median daily dose of 1200 mg." | 5.07 | Oral tegafur in the treatment of metastatic breast cancer: a phase II study. ( Kajanti, MJ; Maiche, AG; Pyrhönen, SO, 1993) |
| "A prospective randomized study was performed in 22 institutions from July 1978, to evaluate the efficiency of long-term adjuvant chemotherapy with tegafur alone for primary breast cancer." | 5.06 | [Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy]. ( Iwasa, Z; Kawahara, T; Kousaki, G; Okajima, K; Okamoto, E; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T; Utsunomiya, J, 1988) |
| "The aim of this study was to investigate the prognostic significance of HuR in cholangiocarcinoma patients who received adjuvant gemcitabine-based chemotherapy (AGC) after surgical resection." | 3.88 | Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy. ( Kondo, N; Murakami, Y; Nakagawa, N; Sueda, T; Takahashi, S; Toyota, K; Uemura, K, 2018) |
| "We report the case of a patient in which S-1 plus anastrozole was administered as first-line chemotherapy for Stage IV breast cancer with skin invasion, multiple lymph node metastasis, and lymphangitis carcinomatosis." | 3.85 | [A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy]. ( Akami, T; Hatakeyama, T; Matsumura, A; Mugitani, T; Ogino, S; Okano, S; Sakai, T, 2017) |
| "We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 3.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
| "This study enrolled 100 patients with Union for International Cancer Control (UICC) stages I-IV biliary tract cancer who underwent surgical resection, including 16 who received sequential adjuvant chemotherapy with gemcitabine or S-1." | 3.79 | Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients. ( Harada, N; Ikeda, T; Ikegami, T; Kawanaka, H; Maehara, Y; Matsuura, H; Morita, M; Okadome, K; Oki, E; Saeki, H; Shirabe, K; Soejima, Y; Uchiyama, H; Yamashita, Y; Yoshizumi, T, 2013) |
| "A 70-year-old woman with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases due to gastric cancer, was treated by combination chemotherapy of S-1 and irinotecan (CPT-11)." | 3.74 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)]. ( Adachi, K; Arimoto, Y; Nishio, K; Ohba, H; Ohtani, H; Shintani, M; Yui, S, 2008) |
| "High-dose toremifene therapy (120 mg/day) is useful for the recurrence of receptor-positive breast cancer." | 3.74 | [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. ( Murakami, S; Yamamoto, Y, 2007) |
| "We describe our experience with a patient who had undifferentiated gastric carcinoma with extensive lymph node metastasis, including para-aortic lymph-node metastasis, and had a complete response to induction therapy with methotrexate plus 5-fluorouracil (sequential therapy with MTX, 5-FU, and Leucovorin) and secondary treatment with oral TS-1." | 3.73 | [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1]. ( Hiramatsu, K; Mizukami, Y; Momiyama, M; Nagashima, T; Niimi, K; Suzuki, M, 2005) |
| "We report a patient with hepatocellular carcinoma (HCC) with intraperitoneal lymph node metastases in whom UFT (uracil + tegafur) was markedly effective." | 3.71 | [A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective]. ( Baba, Y; Imamura, Y; Kubozono, O; Maenohara, S; Moriya, H; Ogura, Y; Tahara, K, 2002) |
| "One patient with pulmonary metastasis from colon cancer and one with para-aortic lymph node metastasis were treated with a combination of irinotecan and UFT." | 3.71 | [Two patients with recurrent colon cancer who underwent surgery following a combination of irinotecan and UFT]. ( Ishikawa, K; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Saguchi, T; Suzuki, T; Yamamoto, T; Yasuda, S, 2002) |
| "A patient with stage IVb advanced gastric cancer, who was Group 4 lymph node metastasis positive, underwent two postoperative courses of low-dose CDDP-tegafur therapy (800 mg/body/day of tegafur + 5 mg/body/5 administrations, 2 days of rest, of cisplatin)." | 3.70 | [Case of stage IVb gastric cancer in which favorable anti-tumor effect and good QOL were observed due to UFTP therapy after low-dose CDDP-tegafur therapy]. ( Fujino, R; Hayashi, N; Hirose, Y; Matsumura, M; Nagano, T; Oshita, M; Otsuka, T; Sumitomo, M; Takai, S; Taki, S, 1999) |
| " He had nausea, vomiting and anorexia due to pyloric stenosis, and was treated with 600 mg of UFT E granules/day orally for 5 consecutive days followed by 2 drug-free days (weekly-5 method), and 2 mg of lentinan intravenously twice a week." | 3.70 | [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. ( Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T, 2000) |
| " Grade 3 or worse adverse events were less frequent in the elderly group receiving SOX than in the elderly group receiving CS except for the low incidence of sensory neuropathy (5." | 2.82 | Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. ( Amagai, K; Bando, H; Chin, K; Fujii, H; Gotoh, M; Hamada, C; Hironaka, S; Hyodo, I; Imamura, H; Miwa, H; Nishikawa, K; Nishina, T; Niwa, Y; Shimada, K; Sugimoto, N; Tanabe, S; Tsuda, M; Tsuji, A; Yamada, Y; Yamaguchi, K; Yasui, H, 2016) |
| "Patients with resected pancreatic cancer were randomly assigned (in a 1:1 ratio) to receive gemcitabine (1000 mg/m(2), intravenously administered on days 1, 8, and 15, every 4 weeks [one cycle], for up to six cycles) or S-1 (40 mg, 50 mg, or 60 mg according to body-surface area, orally administered twice a day for 28 days followed by a 14 day rest, every 6 weeks [one cycle], for up to four cycles) at the data centre by a modified minimisation method, balancing residual tumour status, nodal status, and institutions." | 2.82 | Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). ( Boku, N; Fukutomi, A; Hirano, S; Hishinuma, S; Imai, K; Kainuma, O; Kaneoka, Y; Konishi, M; Matsumoto, I; Morinaga, S; Nakamori, S; Ohashi, Y; Ojima, H; Okamura, Y; Sakamoto, H; Sata, N; Shimizu, Y; Sudo, T; Uesaka, K; Yamaguchi, R, 2016) |
| "The purpose of this phase I study of the dose escalation of oxaliplatin in combination with oral S-1 and pelvic radiation preoperatively for poor-risk lower rectal cancer was to determine the dose-limiting toxicity (DLT) and recommended dose of oxaliplatin." | 2.80 | A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis. ( Fujita, S; Hamaguchi, T; Ito, Y; Kinugasa, Y; Moriya, Y; Noura, S; Ohue, M; Saito, N; Sakai, D; Shimada, Y, 2015) |
| "In patients with highly advanced gastric cancer, the recurrence rate remains high and the prognosis disappointing." | 2.79 | Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-. ( Fukada, J; Fukuda, K; Kawaguchi, O; Kawakubo, H; Kitagawa, Y; Matsuda, S; Saikawa, Y; Shigematsu, N; Takahashi, T; Takeuchi, H, 2014) |
| "Locally advanced gastric cancer with extensive regional and/or para-aortic lymph node (PAN) metastases is typically unresectable and associated with poor outcomes." | 2.79 | Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. ( Fukushima, N; Mizusawa, J; Nashimoto, A; Sasako, M; Tanaka, Y; Tsuburaya, A, 2014) |
| "Postoperative complications were identified in 18 patients and the overall morbidity rate was 26." | 2.79 | Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy. ( Aoyama, T; Cho, H; Hayashi, T; Ito, Y; Miyashita, Y; Morita, S; Nishikawa, K; Ogata, T; Sakamoto, J; Tanabe, K; Tsuburaya, A; Yoshikawa, T, 2014) |
| " After six chemotherapy cycles, the short-term efficacy was evaluated according to the Response Evaluation Criteria in Solid Tumors guidelines and adverse reactions were recorded according to National Cancer Institute Common Toxicity Criteria 2." | 2.79 | Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer. ( Chang, ZW; Dong, L; Han, ZF; Li, J; Lou, XP; Lu, P; Miao, JH, 2014) |
| "S-1 in patients with advanced gastric cancer (AGC)." | 2.78 | Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer. ( Lu, XY; Wang, ML; Wang, X; Yang, JF; Yu, HG; Zhou, LY, 2013) |
| "Paclitaxel (160 mg/m²) was administered by infusion for 3 h on the first day." | 2.76 | A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. ( Goto, H; Haruta, J; Ina, K; Iwase, H; Kumada, T; Shimada, M; Shinoda, M; Sugihara, M; Tsuzuki, T, 2011) |
| "CEA mRNA (+) patients with gastric cancer were treated postoperatively with S-1 monotherapy." | 2.75 | Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR. ( Ito, S; Kodera, Y; Kojima, T; Mochizuki, Y; Nakanishi, H; Yamamura, Y, 2010) |
| "Patients with advanced gastric cancer, naive to chemotherapy or not refractory to fluoropyrimidine, were enrolled." | 2.75 | Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. ( Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T, 2010) |
| "Patients with histological proof of prostate cancer refractory to hormonal therapies were eligible." | 2.75 | Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study. ( Akaza, H; Fujimoto, H; Ikemoto, I; Kobayashi, M; Naito, S; Namiki, M; Tsukamoto, T; Usami, M, 2010) |
| " Because the replacement of 2-day-infusional 5-fluorouracil (5-FU) of FOLFIRI with oral tegafur-uracil/leucovorin (UFT/LV) would be highly beneficial for clinical management, we performed a phase I trial using oral UFT/LV and a pharmacokinetic evaluation." | 2.74 | Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. ( Azuma, T; Chayahara, N; Hirai, M; Inoue, Y; Kadowaki, Y; Kasuga, M; Maeda, T; Miki, I; Nishisaki, H; Okumura, K; Okuno, T; Sakaeda, T; Tamura, T; Tsuda, M; Yamamori, M, 2009) |
| " A pharmacokinetic study of PTX was also performed." | 2.74 | Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. ( Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H, 2009) |
| "More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited." | 2.73 | Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. ( Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB, 2007) |
| "We report a patient with gallbladder cancer and multiple liver and lymph node metastases which completely responded to S-1, an oral fluoropyrimidine anticancer drug." | 2.73 | [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]. ( Furuse, J; Ishii, H; Nakachi, K; Shimizu, S; Suzuki, E; Yoshino, M, 2007) |
| "We treated 12 patients with advanced gastric cancer with 80 mg/m2 of S-1 for 21 days and 60 mg/m2 of cisplatin (CDDP) on day 8 every 5 weeks." | 2.71 | Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. ( Baba, H; Endo, K; Ikeda, Y; Kohnoe, S; Okamura, T; Toh, Y; Yamamoto, M, 2003) |
| "93 patients with laryngo-pharyngeal squamous cell carcinoma in stage III or IV were prospectively entered into a protocol to receive four cycles of UFTVP." | 2.71 | [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study]. ( Gallo Terán, J; Mesuro Domínguez, N; Rubio Suárez, A; Señaris González, B; Teigeiro Núñez, V, 2003) |
| "Uracil-tegafur (UFT) has been reported to have a broad anti-tumor activity in a variety of malignancies including colorectal cancer and breast cancer." | 2.70 | Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer. ( Ikeda, M; Kuriyama, H; Okada, S; Okusaka, T; Ueno, H, 2002) |
| "Forty-two patients with head and neck cancer were treated with tegafur suppository for 7 days preoperatively and clinical value of this treatment was assessed." | 2.68 | [High tissue concentration of 5-FU reduced local recurrence after administration of tegafur suppositories]. ( Itokazu, T; Kochi, A; Koja, S; Maeda, H; Maeshiro, N; Matsumura, J; Noda, Y; Yasuda, S, 1995) |
| "For the local recurrence of rectal cancer, it was observed in Dukes C and cases of relative curative resection." | 2.68 | [Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan]. ( Kikuchi, K; Kunii, Y, 1995) |
| "Forty-eight patients with unresectable gastric cancer were enrolled for a randomized trial of FP (n = 24) vs FEP (n = 24) combination chemotherapy with respect to their effects on survival period." | 2.68 | [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy]. ( Horiuchi, Y; Ina, K; Iwase, H; Kaneko, H; Kuroiwa, A; Kusugami, K; Morise, K; Oka, Y; Shinoda, M; Suga, S, 1995) |
| "The subjects were 39 patients with gastric cancer and 44 patients with colorectal cancer divided into a group administered 400 mg/day of UFT orally for 2 weeks preoperatively (UFT group) and a group administered 400 mg/day of UFT as well as 40 mg/m2 (i." | 2.68 | [Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat]. ( Fuchino, Y; Ikeda, S; Kimura, H; Mitsuishi, K; Tanaka, S; Tomita, A; Umeno, T, 1997) |
| "Thirty-four patients with advanced gastric cancer were treated with combination chemotherapy employing Tegafur-Uracil (UFT), etoposide, Adriamycin, and Cisplatinum (CDDP) (UFT-EAP therapy)." | 2.67 | Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer. ( Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M, 1994) |
| " No severe side effects appeared in either of the groups, and a long-term administration was safe." | 2.67 | [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy]. ( Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Taira, A; Yamamoto, H; Yamanouchi, A, 1991) |
| "After curative surgery for gastric cancers judged macroscopically to be at stage 2 or 3, patients were divided into 4 groups by randomization." | 2.66 | [Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy]. ( Awane, Y; Ishibiki, H; Kamei, H; Nakajima, T; Nomoto, K; Sekiguchi, M; Tamada, R; Toge, T; Tsuru, S, 1986) |
| "The group of research for colorectal cancer treatments-Kajitani-group (chief T." | 2.66 | [Adjuvant chemotherapy of colorectal cancer--results of prospective randomized trials]. ( Hojo, K; Kajitani, T, 1986) |
| "In the colon cancer patients, 5-year survival rates were 88." | 2.66 | [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku]. ( Kinami, Y; Miyazaki, I; Takashima, S, 1988) |
| "According to the Japan Mammary Cancer Society's criteria of response, more than partial response was observed in 11 out of 32 cases (34." | 2.65 | [Clinical trial of UFT against disseminated breast cancer]. ( Harauchi, D; Itoh, S; Konishi, Y; Shinoto, M, 1984) |
| "A group of 243 patients with gastric cancer was subjected to a prospective randomized trial of adjuvant chemotherapy after curative gastrectomy." | 2.65 | Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. ( Kajitani, T; Kuno, K; Nakajima, T; Takagi, K; Takahashi, T, 1984) |
| "However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
| "We report a case of advanced gastric cancer that responded completely to S-1 neoadjuvant chemotherapy." | 2.53 | [A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient]. ( Akashi, Y; Inagaki, Y; Inagawa, S; Kemmochi, A; Ohkohchi, N; Satomi, K, 2016) |
| "An 80-year-old man with a local recurrence of gastric cancer was treated with S-1 monotherapy leading to a complete response(CR)." | 2.53 | [An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy]. ( Hasegawa, M; Ichikawa, K; Kokado, Y; Koshiba, T; Kusama, T; Sone, N; Yamagami, K, 2016) |
| "Without any sign of infection, leukocytosis developed around the 30th POD." | 2.46 | Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor. ( Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T, 2010) |
| "Moreover, pancreatic cancer in most patients is surgically unresectable at the time of diagnosis." | 2.43 | [Recent important insights into treatment of pancreatic cancer]. ( Abe, N; Atomi, Y; Sugiyama, M, 2005) |
| "Case 2: A 74-year-old female with anal squamous cell carcinoma Stage II was treated by chemoradiotherapy with tegafur/uracil, external irradiation (30 Gy) and interstitial irradiation (24 Gy)." | 2.42 | [Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma]. ( Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Sawamura, T; Takeda, Y; Takeno, A; Tsujinaka, T, 2004) |
| "Although the prognosis of gastric cancer with a high level of lymph node metastasis is poor, TS-1 therapy may have a potent efficacy in gastric cancer patients with a high level of lymph node metastasis such as the current case." | 2.41 | [A complete response persisting for twelve months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer]. ( Hongo, S; Kusumoto, Y; Nakagawa, M; Sado, S; Tamaki, H; Watanabe, A; Yamada, T; Yoriki, R, 2001) |
| "The main therapy for primary breast cancer is not surgery, but a systemic therapy involving administration of cytotoxic chemotherapy or the use of ablative or additive endocrine therapy to control disseminated micrometastasis." | 2.40 | [Benefits of adjuvant chemotherapy for breast cancer]. ( Inaji, H; Koyama, H; Motomura, K; Noguchi, S, 1997) |
| "Computed tomographic scan revealed the bladder tumors and swelling of the internal iliac lymph nodes." | 2.40 | [A case of urothelial carcinoma associated with penile metastasis]. ( Horinaga, M; Ikeuchi, K; Kosugi, M, 1999) |
| "We report a case of gastric cancer in which pCR was obtained in the primary lesion, although stenosis appeared after the neoadjuvant chemotherapy." | 1.62 | [A Case of Gastric Cancer with Extensive Lymph Node Metastasis Causing Stenosis Symptoms in the Primary pCR after Preoperative Chemotherapy]. ( Hiramoto, H; Ishimoto, T; Kosuga, T; Masuyama, M; Matsui, T; Mochizuki, S; Nakamichi, N; Nakashima, S; Tsujiura, M, 2021) |
| "Lymph node metastasis was an independent risk factor for both locoregional (P < 0." | 1.62 | Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma. ( Hayami, S; Hirono, S; Kawai, M; Kitahata, Y; Kobayashi, R; Miyazawa, M; Okada, KI; Ueno, M; Yamaue, H, 2021) |
| " Although weekly paclitaxel followed by reduced S-1 dosage was introduced after surgery, the recurrent mass was observed in the para-aortic region after 2 years." | 1.56 | [A Case of Long-Term Survival with Far Advanced Gastric Cancer after Multidisciplinary Treatments, including Conversion Surgery]. ( Akiyama, T; Fujiwara, Y; Higashida, M; Iwamoto, R; Kinoshita, S; Kitagawa, S; Kubota, H; Mineta, S; Okada, T; Okamoto, Y; Tsuruta, A; Ueno, M; Ueno, T; Watanabe, Y, 2020) |
| "We report a case of advanced gastric cancer with right gastroepiploic vein tumor thrombus treated using preoperative S-1 plus cisplatin(CDDP)in which pathological complete response was achieved." | 1.51 | [A Case of Advanced Gastric Cancer with Right Gastroepiploic Vein Tumor Thrombus Treated by Preoperative S-1 plus CDDP That Resulted in Pathological Complete Response]. ( Arai, S; Goseki, N; Koike, M; Kuwabara, H; Nakamura, N; Sanada, T; Sato, T; Tomi, Y; Yoshida, T, 2019) |
| "We diagnosed gastric cancer, UM, Less, Type 3, gastric neuroendocrine carcinoma, cT4aN3M0P0CY0, Stage ⅢC." | 1.51 | [Gastric Neuroendocrine Carcinoma(NEC)Treated with CDDP plus CPT-11 Chemotherapy]. ( Kawai, S; Nagase, M; Ono, K; Takehana, T; Yamamoto, K, 2019) |
| "Lymph node metastasis was observed microscopically in the #6 lymph nodes." | 1.51 | [A Case of Gastric Small Cell Carcinoma with Rapid Regrowth after Surgery]. ( Aoyama, K; Hayashi, D; Kajiwara, Y; Mikane, Y; Miyake, T; Nishikawa, H; Nogami, T; Nonaka, Y; Shigemitsu, K; Shinoura, S; Syoji, R; Watanabe, M, 2019) |
| "Fifty-four patients with resected pancreatic cancer were enrolled." | 1.51 | Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer. ( Furuhashi, S; Hiraide, T; Kikuchi, H; Kitajima, R; Kiuchi, R; Konno, H; Morita, Y; Sakaguchi, T; Shibasaki, Y; Takeda, M; Takeuchi, H, 2019) |
| "Although, gastric cancer is one of the most common cancers worldwide, alpha-fetoprotein (AFP) producing human epidermal growth factor receptor 2 (HER2) positive gastric cancers are rare." | 1.48 | Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2. ( Arakawa, Y; Hayashi, K; Nagasaki, E; Nakada, K; Tamura, M; Uwagawa, T; Yano, S, 2018) |
| "Tegafur-uracil treatment is a useful, effective, and well-tolerated anticancer treatment for advanced oral cancer." | 1.48 | The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer. ( Chang, DC; Chen, G; Chen, MK; Chien, SY; Hsieh, MY, 2018) |
| "This study suggests that platelets in gastric cancer stroma may create a favorable microenvironment for chemoresistance." | 1.46 | Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study. ( Fushida, S; Kinoshita, J; Miyashita, T; Ninomiya, I; Ohta, T; Oyama, K; Saito, H; Tajima, H; Tsukada, T; Yamaguchi, T, 2017) |
| "On the other hand, the 2014 Japanese gastric cancer treatment guidelines(ver." | 1.46 | [A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy]. ( Choda, Y; Harano, M; Idani, H; Ishida, M; Kubota, T; Matsukawa, H; Miyake, S; Morito, T; Nakano, K; Ojima, Y; Okajima, M; Sato, D; Shiozaki, S; Sumitani, D, 2017) |
| "Virchow's lymph node metastasis was confirmed 2 months after surgery." | 1.43 | [A Case of Virchow's Lymph Node Recurrence of Gastric Cancer Who Had Underwent Gastrectomy, and Treated with S-1 Monotherapy Leading to Complete Response (CR)]. ( Kabashima, A; Maekawa, S; Sanefuji, K; Tanaka, S, 2016) |
| "He was diagnosed with gastric cancer with para-aortic lymph node metastases." | 1.43 | [Long-Term Complete Response by S-1 Chemotherapy for Gastric Cancer with Para-Aortic Lymph Node Metastases]. ( Akai, T; Higashi, Y; Kojima, T; Maruo, H; Nakamura, K; Nishiyama, R; Shoji, T; Taniguchi, M; Yamazaki, M, 2016) |
| "We report a case of advanced gastric cancer with a pathological complete response after neoadjuvant chemotherapy." | 1.43 | [A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin)]. ( Fukabori, M; Itoh, Y; Morita, A; Nakayama, M; Saito, H; Suematsu, Y; Takahashi, M; Wakabayashi, K; Yamagishi, S, 2016) |
| "The standard of care for stage II/III gastric cancer in Japan is D2 dissection followed by adjuvant S-1 monotherapy." | 1.42 | A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106). ( Ishigure, K; Ishiyama, A; Ito, S; Kobayashi, D; Kodera, Y; Kurimoto, K; Matsui, T; Mochizuki, Y; Nakao, A; Nakayama, H; Sakamoto, J; Tanaka, N, 2015) |
| "The indications for this were advanced gastric cancer with bulky N2 or N3 lymph nodes, or stage above T4a." | 1.42 | [A Study of Preoperative Chemotherapy with S-1 plus Cisplatin for Advanced Gastric Cancer]. ( Hiratsuka, M; Ishibashi, Y; Ito, Y; Mazaki, J; Omori, K; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K, 2015) |
| "We report a rare case of recurrence with bone metastasis from early gastric cancer." | 1.42 | [A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy]. ( Hamakawa, T; Hoshino, H; Ikeda, N; Kamigaki, S; Kawase, T; Kimura, Y; Makari, Y; Mikami, J; Munakata, S; Nakata, K; Ohzato, H; Tsujie, M; Yamamoto, T; Yamamura, J, 2015) |
| "A 62-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy, and D1+b lymph node dissection." | 1.42 | [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)]. ( Hosoda, Y; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Okano, M; Okuyama, M; Tsujinaka, T; Yamasaki, M; Yasui, M, 2015) |
| "The patient was diagnosed with gastric cancer with liver metastasis, Stage Ⅳ, and treated with chemotherapy (S-1 plus CDDP)." | 1.42 | [A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis]. ( Ishigami, E; Kawamoto, J; Miyazaki, M; Nakada, S; Shinoda, K; Teranaka, R; Yoichi, T, 2015) |
| "He was diagnosed with advanced gastric cancer with multiple liver metastases." | 1.42 | [Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases]. ( Ako, E; Hirakawa, T; Kametani, N; Kanehara, I; Kato, Y; Komoto, M; Nakazawa, K; Nishimura, S; Taenaka, N; Tanaka, R; Yamada, N; Yamagata, S, 2015) |
| "Abdominal computed tomography showed gastric cancer invasion to the left liver lobe." | 1.42 | [A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy]. ( Kawamoto, S; Maeno, H; Munechika, T; Nagao, S; Nomi, M; Okamoto, T; Sasaguri, T; Sueishi, K; Tanaka, K; Yonemitsu, K, 2015) |
| "A 71-year-old man was diagnosed with gastric cancer (LM, Less, type 2, T4aN2M0, cStageⅢb)." | 1.42 | [A Case of Resected Advanced Gastric Cancer Exhibiting Pathological Complete Response after Neoadjuvant Che-motherapy(DTX/CDDP/S-1:DCS)]. ( Kunisaki, C; Masuda, M; Ohshima, T; Rino, Y; Suzuki, Y; Tsuburaya, A; Yukawa, N, 2015) |
| "A diagnosis of advanced gastric cancer MLU, Circ, Type 3, 160 mm, tub2, cT4b (SI: panc), cN1, cM0, cH0, cP0, cCY0, cStage ⅢB was made." | 1.42 | [A Case of Advanced Gastric Cancer Responding to Neoadjuvant Docetaxel/CDDP/S-1 Therapy with Metallic Stent Placement, Leading to Curative Surgery]. ( Akiyama, H; Endo, I; Kimura, J; Kunisaki, C; Makino, H; Minami, Y; Suzuki, Y; Takagawa, R; Tsuburaya, A; Yazawa, K, 2015) |
| "We report a case of ascending colon cancer with right extra iliac lymph node metastases." | 1.42 | [A Case of Ascending Colon Cancer with Extra Iliac Lymph Node Metastases]. ( Amaya, K; Kaji, M; Kawahara, Y; Maeda, K; Shimizu, K; Terada, I; Terai, S; Watanabe, T; Yamamoto, S, 2015) |
| "Patients with stage III gastric cancer who underwent D2 gastrectomy were enrolled." | 1.40 | Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. ( Fuse, N; Goto, M; Hamaguchi, T; Ito, S; Katai, H; Konishi, M; Sano, T; Sasako, M; Shirao, K; Takahari, D; Tanigawa, N; Terashima, M; Yasui, H; Yoshimura, K, 2014) |
| "Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 1.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
| "We recruited 93 rectal cancer patients who underwent neoadjuvant CRT and radical resection." | 1.40 | CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. ( Hase, K; Hashiguchi, Y; Ishiguro, M; Kajiwara, Y; Kobayashi, H; Sekizawa, A; Shikina, A; Shinto, E; Ueno, H; Yamamoto, J, 2014) |
| " The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
| "The histologically diffuse type of gastric cancer accounted for 85% of cases." | 1.40 | Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa. ( Boku, N; Endo, M; Fukutomi, A; Funakoshi, T; Kenmotsu, H; Machida, N; Onozawa, Y; Todaka, A; Tsushima, T; Yamazaki, K; Yasui, H; Yokota, T, 2014) |
| "We report a rare case in which primary squamous cell carcinoma of the nipple skin was successfully treated with S-1 alone." | 1.40 | [A case of squamous cell carcinoma of the nipple skin successfully treated with S-1 alone]. ( Ishikawa, M; Miyoshi, K; Murakami, S; Nakano, R; Ohuchi, K; Sozaki, M; Uchiyama, A; Umeda, S, 2014) |
| "The study included 405 gastric cancer patients who underwent curative gastrectomy with D2 lymph node dissection and received adjuvant therapy between January 2008 and July 2009." | 1.40 | Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. ( Bae, JM; Choi, MG; Kang, WK; Kim, S; Lee, J; Lee, JH; Lee, SJ; Lim, DH; Lim, HY; Park, JO; Park, SH; Park, YS; Sohn, TS, 2014) |
| "The standard treatment for stage IV gastric cancer is chemotherapy, but outcomes remain poor." | 1.40 | Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients. ( Kiyozaki, H; Rikiyama, T; Saito, M; Suzuki, K; Takata, O, 2014) |
| "A 69 -year-old female with advanced gallbladder cancer underwent cholecystectomy, S4a/S5 segmentectomy of the liver, and resection of the extra-hepatic bile duct in October 2005." | 1.40 | [A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy]. ( Karasawa, H; Katagiri, M; Katayose, Y; Morikawa, T; Motoi, F; Naito, T; Sato, J; Unno, M; Yabuuchi, S, 2014) |
| "We report a case of advanced gastric cancer that was successfully treated with second-line chemotherapy followed by curative conversion gastrectomy." | 1.40 | [A case of advanced gastric cancer successfully treated with second-line chemotherapy followed by curative conversion gastrectomy]. ( Asaoka, T; Endo, S; Fujitani, K; Fukuda, Y; Fukui, A; Fushimi, H; Harada, Y; Haraguchi, N; Hirao, M; Ikeda, M; Iwase, K; Kawada, J; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takagi, M; Yamamoto, K, 2014) |
| "A gastric cancer recurrence with paraaortic lymph node (PALN) metastasis was diagnosed fifteen months after the operation." | 1.40 | [A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy]. ( Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H, 2014) |
| "Six months after surgery, recurrence was detected in the para-aortic lymph node." | 1.40 | [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy]. ( Egawa, T; Ito, Y; Kemmochi, T; Mihara, K; Nagashima, A; Nishiya, S; Yamashiro, N, 2014) |
| "The number of lymph nodes in rectal cancer was correlated with the response of primary rectal lesions to chemoradiotherapy, and was not associated with patient survival." | 1.40 | Number of Lymph Nodes in Rectal Cancer is Correlated with Response to Preoperative Chemoradiotherapy but is not Associated with Patient Survival. ( Akahane, T; Aoyagi, Y; Fukushima, Y; Hashiguchi, Y; Hayama, T; Horiuchi, A; Ishihara, S; Matsuda, K; Nakamura, K; Nozawa, K; Shimada, R; Watanabe, T; Yamada, H, 2014) |
| "Medical records of 133 patients with extrahepatic cholangiocarcinoma who underwent curative resection were reviewed retrospectively." | 1.39 | Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. ( Hashimoto, Y; Kondo, N; Murakami, Y; Muto, T; Nakagawa, N; Sasaki, H; Sudo, T; Sueda, T; Uemura, K; Urabe, K, 2013) |
| "Here, we present a case of recurrent gastric cancer during S-1 adjuvant therapy that showed partial response to CDDP + capecitabine therapy." | 1.39 | [A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy]. ( Ebata, T; Fukaya, M; Hirata, A; Igami, T; Itatsu, K; Nagino, M; Sugawara, G; Tsunoda, N; Uehara, K; Usui, H; Yokoyama, Y; Yoshioka, Y, 2013) |
| "S-1/CDDP as a NAC regimen for advanced gastric cancer appears to be an effective treatment." | 1.39 | [A case of advanced gastric cancer with bulky lymph node metastases responding to S-1/CDDP neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response]. ( Eshita, Y; Ogawa, F, 2013) |
| "A case of recurrent pancreatic cancer effectively responded to S-1 and irinotecan combined with third-line chemotherapy (IRIS) with PSK." | 1.39 | [A case of recurrent pancreatic cancer effectively responding to S-1 combined irinotecan third-line chemotherapy with PSK]. ( Asano, T; Ishii, M; Iwata, K; Kobayashi, H; Kobayashi, S; Koizumi, S; Okamura, R; Otsubo, T; Saji, O; Sumiyoshi, K, 2013) |
| "Colorectal cancer associated with Crohn's disease (CD) is increasing in proportion to the number of patients with CD in Japan." | 1.39 | Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report. ( Doki, Y; Haraguchi, N; Hata, T; Mizushima, T; Mori, M; Nakajima, K; Nishimura, J; Takemasa, I; Takeyama, H; Uemura, M; Yamamoto, H, 2013) |
| "We report a case of advanced gastric cancer successfully treated with preoperative S-1/Lentinan (LTN)chemotherapy followed by curative gastrectomy." | 1.39 | [A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy]. ( Aono, T; Deguchi, K; Deguchi, T; Endo, S; Fujitani, K; Fukui, A; Fushimi, H; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Noguchi, Y; Nomura, M; Okumura, Y; Takagi, M; Tamagawa, H; Tanaka, Y; Yoshida, H, 2013) |
| "The postoperative diagnosis was gastric cancer fStage IA (T1a, N0, and M0)." | 1.39 | [A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis]. ( Aoki, T; Chono, A; Hyuga, N; Kobayashi, K; Matsumoto, T; Nishioka, K; Takachi, K; Takemoto, H; Uemura, Y; Watanabe, R; Yoshida, K, 2013) |
| "The final diagnosis was stage II gastric cancer, designated T1N2M0 according to the Japanese classification of gastric carcinoma." | 1.38 | Intramucosal gastric cancer with fifteen metastatic lymph nodes: report of a case. ( Bando, E; Kawamura, T; Sasaki, K; Tanizawa, Y; Terashima, M; Tokunaga, M, 2012) |
| " Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy." | 1.38 | Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. ( Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M, 2012) |
| "The prognosis of gastric cancer with para-aortic lymph node (PAN) metastasis is poor." | 1.38 | Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes. ( Fujimura, T; Fujita, H; Fushida, S; Hayashi, H; Kinoshita, J; Kitagawa, H; Makino, I; Nakagawara, H; Nakamura, K; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Tani, T, 2012) |
| "We obtained total RNA from residual cancer cells using microdissection from a total of 52 rectal cancer specimens from patients who underwent preoperative CRT." | 1.38 | Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy. ( Fujikawa, H; Inoue, Y; Kusunoki, M; Matsushita, K; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Uchida, K, 2012) |
| "The patient was diagnosed with advanced gastric cancer accompanied by multiple bone metastases, with compression fractures in the thoracolumbar vertebrae as well as distant lymph node metastases." | 1.38 | [A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy]. ( Chiba, T; Fujiwara, H; Koeda, K; Mitomo, S; Sugai, T; Takahashi, M; Uesugi, N; Wakabayashi, G, 2012) |
| " After recovery from the adverse event, another 4 courses at a 20% lower dosage for safety were administered." | 1.38 | [A case of S-1-resistant resected advanced gastric cancer with para-aortic lymph node recurrence responding to bi-weekly CPT-11 and CDDP]. ( Ikeda, T; Minamoto, K; Yuasa, I, 2012) |
| "Patients who had Japanese Gastric Cancer Association (JGCA) cStage IIIB gastric cancer were enrolled onto this study and received oral S-1 (65 mg/m(2)/day) administration and 50-Gy radiotherapy followed by radical surgery." | 1.38 | Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases. ( Hagiike, M; Inoue, T; Kimura, T; Okano, K; Suzuki, Y; Usuki, H; Yachida, S, 2012) |
| "We experienced two cases of Stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy." | 1.38 | [Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy]. ( Azuma, T; Inoue, T; Mori, Y; Ohtani, H; Tamamori, Y, 2012) |
| "He was diagnosed as advanced gastric cancer." | 1.38 | [A case of advanced gastric cancer with recurrence-free long survival showing disappearance of distant lymph node metastases by S-1/docetaxel therapy followed by curative resection]. ( Hirata, Y; Itagaki, T; Kameda, A; Miyahara, E; Okamura, K; Sasaki, T; Teramoto, S; Ukon, K, 2012) |
| "We report a case of recurrent gastric cancer with paraaortic lymph nodes (No." | 1.38 | [A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy]. ( Danno, K; Fujita, S; Imaoka, S; Kagawa, K; Kanoh, T; Kim, C; Kimura, Y; Monden, T; Ohnishi, T; Taniguchi, H; Tono, T; Yamada, Y; Yoshida, T, 2012) |
| " The main adverse events were hematological toxicity, mucositis and dermatitis." | 1.37 | Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer. ( Murai, M; Ohashi, T; Ohnishi, M; Tanahashi, S, 2011) |
| "In patients with stage II/III gastric cancer, tumors often recur even after curative D2 gastrectomy followed by adjuvant S-1 chemotherapy." | 1.37 | Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. ( Aoyama, T; Cho, H; Hayashi, T; Ogata, T; Tsuburaya, A; Watanabe, T; Yoshikawa, T, 2011) |
| " To the best of our knowledge, cases of EGC combined with metachronous osteosclerotic multiple bone and bone marrow metastases that respond to chemoradiotherapy are very rare." | 1.37 | Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy. ( Chiba, F; Kiyozaki, H; Konishi, F; Saito, M; Shuto, C; Takata, O; Yamada, S; Yoshida, T, 2011) |
| "Herein, we report a bladder cancer case with multiple metastases which were controlled by low-dose UFT." | 1.37 | [A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. ( Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M, 2011) |
| "Gemcitabine was administered intravenously at a dose of 1000 mg/m(2) on days 1 and 15, and repeated every 4 weeks." | 1.37 | [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy]. ( Handa, K; Hatogai, K; Hibi, T; Higuchi, H; Iwasaki, E; Izumiya, M; Kishino, R; Maeda, N; Mizuki, A; Mukai, K; Nakazawa, A; Seki, E; Shimoyama, Y; Takaishi, H; Takita, M; Tsukada, N, 2011) |
| "No distant recurrence was noted during this time." | 1.37 | [A case of breast cancer with postoperative metastasis to the supraclavicular lymph nodes-recurrence-free survival achieved by surgical excision following chemotherapy]. ( Dan, N; Hori, T; Nishino, H; Tendo, M; Tezuka, K, 2011) |
| "We report a case of anal cancer in a 58-year-old woman who complained of narrow, bloody stools and anal pain." | 1.37 | Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer. ( Deguchi, T; Fujisaki, M; Kadomura, T; Kato, A; Kato, Y; Kitajima, M; Kojima, M; Kubota, K; Kuroda, J; Nitori, N; Okada, A; Origuchi, N, 2011) |
| "The patient was diagnosed as having squamous cell carcinoma of the anal cana (l cStage III)." | 1.37 | [A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal]. ( Baba, H; Goseki, N; Kuwabara, H; Nakajima, K; Nakamura, H; Sanada, T; Wakabayashi, M, 2011) |
| "Patients with T4 esophageal cancer generally have poor prognosis." | 1.37 | [A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1]. ( Fujiwara, H; Ichikawa, D; Ikoma, H; Kokuba, Y; Komatsu, S; Kuriu, Y; Murayama, Y; Nakanishi, M; Ochiai, T; Okamoto, K; Otsuji, E; Shiozaki, A; Yoneda, M, 2011) |
| "Computed tomography showed nodal recurrence 6 months after surgery." | 1.37 | [A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2011) |
| "We report two cases of advanced gastric cancer successfully treated with combination S-1 and docetaxel (DOC) therapy." | 1.36 | [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. ( Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K, 2010) |
| "The rectal cancer was in stage III, and the patient selected no adjuvant chemotherapy." | 1.36 | [A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1]. ( Aiki, F; Hattori, A; Kakisaka, T; Kazui, K; Matsuhisa, T, 2010) |
| " When chemotherapy with S-1 or UFT/LV started from the micrometastasis stage, not the advanced macroscopic metastasis stage, anti-LNM efficacy of S-1 was significantly higher than that of UFT/LV at the dosage in which antitumor activity of the two drugs against primary subcutaneous tumor was comparable." | 1.36 | Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV. ( Hirai, T; Ito, Y; Kato, T; Kodera, Y; Nakanishi, H; Nakao, A, 2010) |
| "The human scirrhous gastric cancer cell line OCUM-2MLN and the human gastric fibroblasts NF-33 were used." | 1.36 | Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice. ( Hirakawa, K; Kawajiri, H; Miwa, A; Shimizu, K; Shimizu, T; Shinto, O; Yashiro, M, 2010) |
| "We report a case of advanced gastric cancer, with cervical, axillary, and abdominal paraaortic lymph node metastases, that was successfully treated with chemotherapy and surgery." | 1.36 | Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery. ( Chin, K; Hatake, K; Hijioka, S; Seto, Y; Yamamoto, N, 2010) |
| "Due to advanced gastric cancer with abdominal para-aortic lymph node metastases, we performed a curative operation in three cases in which S-1/CDDP combination therapy proved effective." | 1.36 | [Three cases of gastric cancer with para-aortic lymph node metastases succesfully treated by S-1/CDDP combination therapy followed by curative resection]. ( Imai, T; Kanematsu, M; Kawai, M; Kunieda, K; Matsuhashi, N; Nagao, N; Nishina, T; Sakuratani, T; Sasaki, Y; Tajima, JY; Tanaka, C; Yamada, A, 2010) |
| "A 70-year-old male presented with gastric cancer with para-aortic lymph node metastasis." | 1.36 | [A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy]. ( Matsunaga, N; Nakagawa, Y; Noda, S; Yanagawa, K, 2010) |
| "Primary cutaneous squamous cell carcinoma (SCC) is a malignant tumor that arises from keratinizing cells of the epidermis or its appendages." | 1.36 | Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy. ( Ibusuki, A; Kanekura, T; Kawai, K; Kubo, H; Matsushita, S; Mera, K; Tada, K; Yoshii, N, 2010) |
| "In patients with advanced rectal cancer, preoperative chemoradiotherapy is superior to postoperative chemoradiotherapy because of causing less toxicity and achieving higher rates of sphincter preservation and curative resection." | 1.36 | A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1. ( Hama, T; Horiuchi, T; Ishida, K; Miyagawa, Y; Sakaguchi, S; Shono, Y; Tabuse, K; Tamagawa, K; Tanishima, H; Tsubakihara, H; Tsujimoto, T; Uemura, R, 2010) |
| " The regimen of pre-op CCRT was a radiation dosage of 45 Gy in 20 fractions and oral tegafur-uracil (UFUR) and leucovorin." | 1.36 | The impact of preoperative chemoradiotherapy on advanced low rectal cancer. ( Chang, SC; Chen, WS; Jiang, JK; Kao, PS; Lee, RC; Liang, WY; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH, 2010) |
| "In the case of pancreatic cancer that CRT is effective to the remission of primary lesion, CRT is potentially useful to perform for the control of metastatic lesion or palliative therapy." | 1.36 | [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy]. ( Aoki, H; Choda, Y; Fujiwara, Y; Harano, M; Matsukawa, H; Ninomiya, M; Nishizaki, M; Ohno, S; Ojima, Y; Shiozaki, S; Takakura, N, 2010) |
| "Lymph node metastasis was confirmed." | 1.36 | [A clinical case of lymph node recurrence after resection of gastric cancer successfully treated by combination chemotherapy with irinotecan and cisplatin]. ( Endo, W; Fujie, Y; Fukunaga, H; Hojou, S; Maeura, Y; Ota, H; Shimizu, K; Toyoda, Y; Yoshioka, A; Yoshioka, S, 2010) |
| "Sigmoidectomy was performed for sigmoid colon cancer in January 2002." | 1.36 | [A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy]. ( Doki, Y; Hirose, H; Ikeda, M; Kim, HM; Miyoshi, N; Mizushima, T; Mori, M; Okano, M; Sekimoto, M; Takemasa, I; Yamamoto, H; Yamashita, S, 2010) |
| "A 42-year-old man with advanced rectal cancer underwent a low anterior resection with TME and pelvic lateral lymph-node and paraaortic lymph-node dissections." | 1.36 | [A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes]. ( Gotoh, K; Ishikawa, O; Kano, S; Kishi, K; Miyashiro, I; Motoori, M; Noura, S; Ohigashi, H; Ohue, M; Shingai, T; Takahashi, H; Yamada, T; Yano, M, 2010) |
| "The patient was recurrence-free and her clinical course was satisfactory." | 1.35 | [Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy]. ( Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T, 2008) |
| "We present a case of esophageal cancer with multiple lymph node metastases successfully performed early response evaluation for preoperative chemotherapy by FDG-PET." | 1.35 | [Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET]. ( Arakaki, K; Isa, T; Kaneshiro, T; Nakachi, A; Nishimaki, T; Shiroma, H; Teruya, T; Yamamoto, H, 2008) |
| "Cholangiocarcinoma is a therapeutically challenging malignancy." | 1.35 | Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases. ( Akaike, M; Morinaga, S; Shiozawa, M; Sugano, N; Sugimasa, Y; Wada, H; Yamamoto, Y, 2008) |
| "Chemotherapy is rarely used in treating adenosquamous carcinoma, and it has been difficult to establish treatment guidelines due to the paucity of cases." | 1.35 | Adenosquamous carcinoma of maxillary sinus: case showing complete response to S-1. ( Hanata, K; Ishikawa, K; Nanjo, H; Suzuki, S, 2009) |
| "A 82-year-old man with advanced gastric cancer underwent distal gastrectomy in January 2006." | 1.35 | [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer]. ( Kitajima, Y; Miyazaki, K; Nakafusa, Y; Ohtsuka, T; Sato, S; Tanaka, M; Yakabe, T, 2009) |
| "We report a case of gastric cancer with simultaneous multiple liver metastasis that was successfully treated by paclitaxel and UFT-E." | 1.35 | [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E]. ( Fujiwara, H; Ichikawa, D; Ikoma, H; Kikuchi, S; Kokuba, Y; Kubota, T; Nakanishi, M; Ochiai, T; Okamoto, K; Okamura, H; Otsuji, E; Sakakura, C; Sonoyama, T; Taniguchi, H, 2009) |
| "Thirty-three patients with rectal cancer underwent preoperative CRT." | 1.35 | Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. ( Ioue, Y; Kusunoki, M; Miki, C; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Yokoe, T, 2009) |
| "Approximately 50% of oral squamous cell carcinomas (OSCC) exhibit cervical lymph node metastasis." | 1.35 | S-1 mediates the inhibition of lymph node metastasis in oral cancer cells. ( Ando, Y; Hatori, M; Kurihara, Y; Sato, H; Shintani, S; Shirota, T; Tachikawa, T; Takayama, S, 2009) |
| "The prognosis of gastric cancer patients with peritoneal dissemination is poor." | 1.35 | Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. ( Hosogi, H; Obama, K; Okabe, H; Sakai, Y; Ueda, S, 2009) |
| "Lymph node metastasis was not found by CT scan 20 months after beginning chemotherapy." | 1.35 | [A case of effective treatment with UFT/LV chemotherapy for para-aortic lymph node metastasis from colonic cancer 8 years after colectomy]. ( Kimura, H; Takamura, H; Watanabe, K, 2009) |
| "A 45-year-old male patient with right colonic cancer, of which clinical finding was SIM1 (No." | 1.35 | [A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy]. ( Inoue, S; Nasu, K; Noda, K; Umekita, N, 2009) |
| " He was treated with single agent S-1 in 10 courses on a 4-week dosing regimen with a 2-week interval." | 1.35 | [A case of advanced gastric cancer with paraaortic lymph node recurrence reaching a long-term survival by S-1 chemotherapy]. ( Iwanaga, T; Iwasaki, Y; Matsumoto, H; Matsumura, H; Nakano, D; Ohashi, M; Takahashi, K; Yamaguchi, T, 2009) |
| "Recently, chemotherapy against gastric cancer has been diversified with an appearance of new agents such as S-1, capecitabine, CPT-11, oxaliplatin, paclitaxel and docetaxel." | 1.35 | [A case of recurrence gastric cancer patient who was post operated and multi drug chemotherapy was effective for administration of S-1 and docetaxel combination therapy]. ( Ami, K; Andou, M; Arai, K; Fukuda, A; Ganno, H; Hataji, K; Kurokawa, T; Nagahama, T; Ohara, T; Tei, S, 2009) |
| "Primary liver cancer with lymph node metastasis was recognized as poor prognosis." | 1.35 | [A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT]. ( Akagi, K; Dono, K; Fujita, J; Hata, T; Hayashi, S; Ikeda, K; Kagawa, Y; Kawanishi, K; Kitada, M; Munakata, K; Shimano, T; Shimizu, J; Takamoto, K; Watanabe, N; Yasumoto, T; Zenitani, M, 2009) |
| "The diagnosis was the esophageal cancer (type 2, 11 cm) with big lymph node metastasis on cardia (8 cm), and also pathologically poorly differentiated squamous cell carcinoma from two legions." | 1.35 | [A 14-month surviving patient on advanced esophageal cancer with big lymph node metastasis to cardia responding to S-1 plus cisplatin (CDDP) therapy at home]. ( Doi, T; Handa, R; Hoshi, M; Iijimal, S; Kato, T; Kikkawa, N; Kurokawa, E; Makari, Y; Miyake, Y; Ooshima, S, 2008) |
| " As for the dosing method of combination chemotherapy,the patient was treated with a course of TS-1 80 mg daily divided into two doses over 21 days continuously, followed by a 14-day cessation of the drug,together with a dose of CDDP 70 mg on day 8." | 1.34 | [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases]. ( Hayakawa, Y; Hioki, J; Irinoda, T; Kimura, T; Kobayashi, M; Matsumoto, Y; Meguro, E; Noda, Y; Takagane, A, 2007) |
| "He was diagnosed as having esophageal cancer of stage IVa (T2N4M0) in October, 2002, and he received chemoradiotherapy (nedaplatin (CDGP)/5-fluorouracil (5-FU) total 6 course+60 Gy)." | 1.34 | [Recurrent esophageal cancer with complete response to TS-1 chemotherapy]. ( Chinen, T; Fujita, J; Hirata, T; Hokama, A; Kinjo, F; Kinjo, N; Nakachi, N; Nakamoto, M; Uchima, N; Watanabe, T, 2007) |
| "A 37-year-old female with advanced gastric cancer and liver metastases was treated with S-1." | 1.34 | A case of suspected S-1 induced interstitial pneumonia. ( Koizumi, W; Munakata, M; Sakata, Y; Shitara, K, 2007) |
| "A 62-year-old woman with Barrett's esophageal cancer was hospitalized." | 1.34 | Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer. ( Azuma, M; Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S, 2007) |
| "We report a case with gastric cancer and lung metastasis,who responded remarkably to combination chemotherapy using S-1 and weekly CDDP." | 1.34 | [A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP]. ( Akamatsu, M; Karimata, H; Nagahama, M; Nishimaki, T; Takaesu, H; Teruya, J, 2007) |
| "We report a case of recurrent gastric cancer with peritoneal dissemination and paraaortic lymph node metastases, successfully treated with weekly administration of paclitaxel." | 1.34 | [A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel]. ( Hirata, K; Ito, T; Sato, T; Takashima, T, 2007) |
| "She was diagnosed as primary gastric cancer with peritoneal dissemination and received systemic chemotherapy after distal gastrectomy for a primary lesion." | 1.34 | [A case of breast metastasis of gastric cancer]. ( Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T, 2007) |
| "A 65-year-old man who had AFP producing gastric cancer with massive lymph-node metastasis was admitted to our institution." | 1.34 | [A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP]. ( Amano, S; Aramaki, O; Kano, H; Kawasaki, A; Kuboi, Y; Mimatsu, K; Ogura, M; Oida, T, 2007) |
| "Adjuvant chemotherapy for advanced gastric cancer has not yet been established." | 1.34 | [A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1]. ( Gotoh, M; Hashimoto, Y; Hoshino, Y; Kashimura, S; Kogure, M; Odashima, Y; Osuka, F; Otani, S; Saito, T; Saze, Z; Soeta, N; Terashima, M; Watanabe, K, 2007) |
| "A 75-year-old male patient had advanced gastric cancer with severe lymph node metastasis." | 1.34 | [A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy]. ( Itoh, J; Kawasaki, H; Kijima, H; Matsuya, H; Miyamoto, K; Sasaki, M; Shibata, S, 2007) |
| "We report a recurrent case of gastric cancer with para-aortic lymph node metastasis that showed a marked response to systemic chemotherapy consisting of S-1 alone." | 1.34 | [Marked response to S-1 chemotherapy for para-aortic lymph node metastasis arising from gastric cancer]. ( Chikuba, A; Chikuba, H; Nakamoto, M; Nezu, M; Shimamura, H; Suzuki, T; Takiue, T; Teraishi, F, 2007) |
| "We reported a case of unresectable gastric cancer presenting pylorus stenosis treated orally by S-1 therapy in a 72-year-old man who underwent gastrojejunostomy." | 1.34 | [A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy]. ( Matsui, K; Morita, S; Shinbo, M; Tazawa, K; Tsukada, K; Yamada, A; Yamagishi, F; Yoshida, T, 2007) |
| " The patient was treated with S-1 combined with CPT-11." | 1.34 | [An elderly patient with recurrent rectal cancer successfully responded to S-1 combined with CPT-11]. ( Doi, M; Egawa, T; Hayashi, S; Ito, Y; Kitano, M; Nagashima, A; Sekine, K; Shimizu, M; Yoshii, H, 2007) |
| "Case 1: 66-year-old male with advanced gastric cancer invading the pancreas with metastasis to the liver and left neck lymph nodes." | 1.33 | [Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Ohta, K; Suzuki, T; Tanabe, K; Taomoto, J; Toge, T; Yoshida, K, 2005) |
| "The data on 307 patients with colorectal cancer at stage II or III, who underwent potentially curative resection with lymphadenectomy, were reviewed." | 1.33 | The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. ( Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K, 2006) |
| "For this gastric cancer, clinical Stage IIIA (cT3N1HOPOMO), neoadjuvant chemotherapy with TS-1/CDDP was planned." | 1.33 | [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy]. ( Inoue, S; Kawahara, Y; Kitamura, M; Kusano, T; Shioiri, T; Umekita, N; Warabi, M, 2005) |
| " After that TS-1 was administered on a 4-week dosing regimen with a 2-week interval between sessions." | 1.33 | [A case of advanced gastric cancer with paraaortic lymph node metastasis reaching long-term survival by TS-1 treatment]. ( Ishii, Y; Suzuki, K; Takahashi, M; Yoshida, S, 2005) |
| "In advanced gastric cancer, the frequency of relapses such as metastasis to the peritoneum is high." | 1.33 | [Prediction and treatment of peritoneal dissemination in gastric cancer]. ( Aratake, K; Itabashi, M; Kameoka, S; Mitsuhashi, M; Ogawa, S; Seshimo, A; Shirotani, N, 2005) |
| "We reported 2 cases with advanced gastric cancer, successfully treated with TS-1 and CDDP." | 1.33 | [Two cases of advanced gastric cancer, successfully treated with TS-1/CDDP combination chemotherapy--case report]. ( Ando, K; Ishihara, C; Ishiwa, N; Morinaga, S; Noguchi, Y; Ogoshi, T; Shotsu, M; Takeda, A; Yamamoto, Y; Yoshida, S; Yoshikawa, T, 2005) |
| "We report herein a case with stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy." | 1.33 | [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy]. ( Jingu, K; Kagaya, A; Ochiai, T; Sasagawa, K, 2005) |
| " Because salvage therapy with S-1 alone showed good antitumor efficacy and beneficial tolerability when the standard dosage was maintained, it was considered that this home therapy was effective for advanced/recurrent breast cancer that was resistant to anthracycline and taxane antitumor drugs." | 1.33 | [Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer]. ( Itoh, K; Minami, H, 2005) |
| "Three cases with unresectable advanced gastric cancer with liver metastases were successfully treated by the combination therapy of TS-1 and cisplatin( CDDP)." | 1.33 | [Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy]. ( Goto, H; Ina, K; Inagaki, J; Ito, A; Ito, N; Kataoka, T; Matsui, W; Nagao, S, 2006) |
| "We administered UFT to patients with gastric cancer preoperatively to prevent cancers from advancing while they await surgery or down staging." | 1.33 | [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients]. ( Endo, Y; Mitsuya, T; Sanada, Y; Tajiri, T; Uyama, R; Yoshizawa, Y, 2006) |
| "This chemotherapy made it possible to treat liver and lymph node metastasis in an ambulatory setting." | 1.33 | [A case of recurrent esophageal cancer responding to second-line chemotherapy of TS-1/docetaxel combination]. ( Hashimoto, Y; Hayashidani, Y; Morifuji, M; Murakami, Y; Sudo, A; Sueda, T; Sugiyama, Y; Uemura, K, 2006) |
| "The patient diagnosed as recurrent pancreatic cancer was treated with UFT combined gemcitabine (GEM) chemotherapy." | 1.33 | [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. ( Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T, 2006) |
| " We carried out 4-week administration of 80-120 mg/day of TS-1 according to body surface area, followed by a 2-week discontinuation, then repeated administration which adjusting the dosage according to the incidence of side effects, and discussed the antitumor effects and adverse events." | 1.33 | [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer]. ( Hatori, S; Imada, T; Kunisaki, C; Makino, T; Ohshima, T; Rino, Y; Suda, T; Takanashi, Y; Yamada, R; Yamazaki, Y, 2006) |
| "At laparotomy to improve anemia and pyloric stenosis in September 2001, lymphnode metastases invaded the stomach and the pancreatic body." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
| " Thus, TS-1 and CPT-11 combination therapy has been effective for 17 months, suggesting that it is promising for long-term administration and survival to continue it perseveringly." | 1.33 | [A case of non-curatively resected gastric cancer successfully treated over 17 months with TS-1 and irinotecan combination therapy]. ( Kawamura, S; Okumura, S; Shimada, E; Sumi, Y; Tei, M; Yamagishi, D, 2006) |
| "We report a case of N 3 gastric cancer successfully treated by TS-1 followed by curative resection." | 1.33 | [A case of N3 gastric cancer successfully treated by TS-1 followed by curative resection]. ( Hara, S; Hashizume, S; Ishikawa, H; Iwasaki, K; Kamohara, R; Kondou, M; Minami, H; Sumida, Y; Tokunaga, T; Yoshida, K, 2006) |
| "In two patients with advanced pancreatic cancer with cervical lymph node or liver metastasis and no indication of pancreatic resection and radiotherapy, oral treatment with S-1 (an anti-cancer agent of fluoropyrimidine derivative) exerted high anti-tumor activity on the metastatic lesions." | 1.33 | [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy]. ( Funakoshi, A; Senju, T; Sumii, T, 2006) |
| "We have experienced three gastric cancer cases successfully treated by the combination therapy of CDDP and TS-1." | 1.33 | [Three cases of successfully resectable advanced gastric cancer responding to TS-1 plus CDDP]. ( Hatakeyama, G; Hosoi, Y; Koeda, K; Obuchi, T; Sugimura, Y, 2006) |
| "Further examination showed an advanced gastric cancer with peritoneal dissemination." | 1.33 | [A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy]. ( Asagoe, K; Azechi, H; Inoue, F; Ishii, K; Katsurada, A; Kondo, M; Nishikawa, K; Nishiura, H; Nonami, M; Otani, Y; Saiga, T; Shigemori, M; Suwa, H; Tojo, M, 2006) |
| "Gastrofiberscopy revealed an advanced gastric cancer located on the anterior wall of the antrum." | 1.33 | [A partial response to combined TS-1 and docetaxel chemotherapy enabling a curative resection after the failure of combined TS-1 and CDDP chemotherapy in a patient with unresectable gastric cancer]. ( Doi, M; Egawa, T; Hayashi, S; Ito, Y; Kitano, M; Nagashima, A; Shimizu, M; Yoshii, H, 2006) |
| "We report a recent case of squamous cell carcinoma originating in the right tonsil, with metastasis to the right superior cervical lymph nodes (T3N2bM0: stage IVA)." | 1.32 | [A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1]. ( Hashimoto, K; Iguchi, H; Nakamura, A; Sunami, K; Takayama, M; Yamane, H, 2003) |
| "Paclitaxel 90 mg was infused once a week, and TS-1 100 mg was administered daily." | 1.32 | [A case of advanced gastric cancer treated with paclitaxel and TS-1]. ( Kokai, H; Nikkuni, K; Saito, M; Tsukahara, A, 2003) |
| "Paclitaxel was administered to 4 patients at a weekly dose of 80 mg/m2/day for three weeks followed by a one week interval." | 1.32 | [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1]. ( Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H, 2003) |
| "We report a case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1." | 1.32 | [A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1]. ( Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Tamura, M; Tsuge, T; Watabe, S, 2003) |
| "A 67-year-old man with gallbladder cancer was treated by cholecystectomy and extrahepatic bile duct resection with regional lymph node dissection." | 1.32 | [A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy]. ( Kido, S; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Motoyama, K; Takei, M, 2003) |
| "S-1 appears to be safe and highly active, with favorable longterm survival in patients with metastatic gastric cancer, particularly in those with diffuse-type histology and peritoneal metastasis." | 1.32 | Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey. ( Boku, N; Doi, T; Hamamoto, Y; Kawai, H; Mera, K; Muto, M; Nagashima, F; Ohtsu, A; Sano, Y; Yano, T; Yoshida, S, 2003) |
| "was started for the residual cancer lesions, with CDDP i." | 1.32 | [Sustained NC status for a long period after combined chemotherapy of TS-1 and CDDP for residual lesions following gastrectomy for gastric cancer]. ( Hasegawa, S; Imazu, H; Matsubara, T; Nakamura, Y; Nozoe, Y; Ochiai, M; Sakai, W; Sakurai, Y; Tonomura, S; Yoshida, I, 2003) |
| "Preoperative diagnosis was stage IV gastric cancer (T3 (SE) H0 P0 N3), and we considered a curative operation impossible." | 1.32 | [A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin]. ( Kanehiro, T; Morifuji, M; Murakami, Y; Sasaki, M; Sueda, T; Uemura, K; Yokoyama, T; Yokoyama, Y, 2003) |
| "Biliary stenosis was remarkably improved." | 1.32 | [A case of advanced gallbladder cancer with biliary tract stenosis which responded to TS-1 chemotherapy]. ( Kuramochi, H; Ohashi, M; Tenma, N, 2003) |
| " Furthermore, he was administered tegafur/uracil (400 mg/day) 5 days weekly as pharmacokinetic modulating chemotherapy (PMC)." | 1.32 | [A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Baba, Y; Hayashi, S; Ishikawa, T; Kamimura, T; Nomura, K; Oota, H; Yoshida, T, 2003) |
| "A 62-year-old advanced gastric cancer patient with bulky N2 lymph node metastases was treated by neoadjuvant chemotherapy with TS-1 and CDDP." | 1.32 | [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP therapy]. ( Kameyama, H; Nashimoto, A; Ohta, T; Takii, Y; Tanaka, O; Tsuchiya, Y; Yabusaki, H, 2003) |
| "The upper endoscopy revealed advanced gastric cancer." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP]. ( Akaiwa, J; Kondo, Y; Makuuchi, H; Morita, M; Nabeshima, K; Nakamura, K; Nishi, T; Ogoshi, K; Okamoto, Y; Soeda, J; Tajima, T, 2003) |
| "A patient with advanced recurrent laryngeal cancer complicated with cervical lymph node metastasis was successfully treated with chemoradiotherapy with an oral anticancer drug, TS-1." | 1.32 | [A case of lymph node metastasis after total laryngectomy successfully treated with chemoradiotherapy with TS-1]. ( Suzuki, S; Yoshihara, T, 2003) |
| "This was diagnosed as inoperable gastric cancer, and gastro-jejunostomy was performed." | 1.32 | [A case of effective response to TS-1 of inoperable gastric cancer, in the course of chemotherapy for malignant lymphoma]. ( Fujita, T; Fukuda, K; Komatsubara, S; Mano, M; Nishi, H; Ohmura, Y; Takao, T; Yano, T, 2003) |
| " Pharmacokinetic modulating chemotherapy (PMC), a combination of infused 5-fluorouracil and oral uracil-tegafur, has been proven to be highly effective for the treatment of colorectal carcinoma." | 1.32 | Modified pharmacokinetic modulating chemotherapy using 5-fluorouracil, UFT, and taxotere (docetaxel) for advanced gastric cancer. ( Kobayashi, M; Konishi, N; Kusunoki, M; Mohri, Y; Ohmori, Y; Tanaka, K; Tonouchi, H, 2003) |
| "At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3)." | 1.32 | Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. ( Akiba, Y; Hibi, T; Kitajima, M; Kubota, T; Kumai, K; Otani, Y; Saikawa, Y; Shigematsu, N; Takahashi, T; Yoshida, M, 2003) |
| "A 51-year-old male patient with esophageal cancer and cervical, thoracic and celiac artery lymph node metastases was treated by combination chemotherapy of TS-1 and cisplatin." | 1.32 | [A case of metastatic esophageal cancer responding remarkably to combination chemotherapy of TS-1 and cisplatin]. ( Doi, R; Iwase, H; Kaida, S; Nakarai, K; Okeya, M; Shimada, M; Tsuzuki, T, 2004) |
| "We report a case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with novel oral anticancer drug TS-1 as a neoadjuvant chemotherapy (NAC)." | 1.32 | [A case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with TS-1]. ( Hirata, K; Inoue, D; Kashiwagi, K; Maeda, H; Sasaki, K; Shibuya, H; Takashima, T, 2004) |
| "The prognosis of gastric cancer with liver metastasis is very poor." | 1.32 | [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Shirouzu, K; Takeda, J; Yano, S, 2004) |
| "Since gastric cancer was detected, he was referred to our department." | 1.32 | [A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP combination therapy]. ( Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Murayama, M; Naritaka, Y; Obu, M; Ogawa, K; Shimakawa, T; Yagawa, Y, 2004) |
| "A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with TS-1 and CDDP: Akihiro Tsukahara, Kazuhiro Kaneko and Syuji Tanaka (Dept." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP]. ( Kaneko, K; Tanaka, S; Tsukahara, A, 2004) |
| "Computed tomography (CT) showed gastric cancer with extensive paraaortic lymph node metastasis." | 1.31 | [A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP as neoadjuvant chemotherapy]. ( Furukawa, J; Katsumoto, Y; Maruyama, K; Maruyama, N; Nakaguchi, K; Nakamura, M; Sue, F; Tanaka, J; Yokouchi, H; Yoshihara, W, 2002) |
| "Five patients with inoperable advanced gastric cancer were treated with combination chemotherapy of TS-1 and cisplatin (CDDP)." | 1.31 | [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy]. ( Furukawa, J; Katsumoto, Y; Maruyama, K; Maruyama, N; Nakaguchi, K; Nakamura, M; Sue, F; Tanaka, J; Yokouchi, H; Yoshihara, W, 2002) |
| "Diarrhea was the major adverse effect of UFT/LV that made patients reduce dosage." | 1.31 | Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer. ( Chen, JS; Hsu, KC; Tang, R; Wang, JY; Yang, TS, 2002) |
| "In stage 3 gastric cancer, the overall survival rates following surgery was significantly (p < 0." | 1.31 | Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study. ( Kitaoka, A; Ohsumi, K; Tokuka, A; Tokunaga, Y; Yagi, T, 2000) |
| "A patient with recurrent gastric cancer which infiltrated the pelvic muscle after the treatment of paraaortic lymph node and ovarian metastases was successfully managed by a novel oral anticancer drug, TS-1." | 1.31 | [A case of recurrent gastric cancer successfully treated with TS-1]. ( Higaki, K; Ikeda, T; Kobayashi, N; Ninomiya, M; Ohno, S; Okamura, S; Onoda, T; Shiozaki, S; Takakura, N, 2001) |
| "Human colon cancer cells (KM12SM) were injected into the cecal wall of the nude rats." | 1.31 | [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats]. ( Akagi, Y; Kobayashi, H; Matono, K; Miyagi, Y; Nakagawa, M; Nozoe, Y; Ogata, Y; Sasatomi, T; Shirouzu, K, 2001) |
| "A 67-year-old male patient with gastric cancer of Borrmann type 2 and liver and intra-abdominal lymph node metastases was treated by combined chemotherapy of TS-1 and CDDP TS-1 (100 mg/day) was administered for 14 days followed by 14 days rest as one course." | 1.31 | [Complete response in a case of advanced gastric cancer with liver and intra-abdominal lymph node metastases treated by combined chemotherapy of TS-1 and CDDP]. ( Hiraiwa, A; Indo, T; Iwase, H; Iyo, T; Kaida, S; Mizuno, T; Nakamura, M; Nakarai, K, 2001) |
| "Computed tomography showed advanced gastric cancer with huge lymph node metastases." | 1.31 | [A case of postoperative gastric cancer responding to adjuvant chemotherapy with TS-1--a novel oral formation of 5-fluorouracil]. ( Harada, T; Kinoshita, S; Kitagawa, S; Morishita, M; Morita, K; Nakagawa, M; Nakamura, M; Yagi, S; Yamada, T; Yokoi, K; Yoshida, K, 2001) |
| "The extent of lymphatic metastasis is the most important factor in the prognosis for non-small cell lung cancer (NSCLC)." | 1.31 | Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line. ( Fujino, H; Ishikura, H; Kinoshita, H; Kondo, K; Miyoshi, T; Monden, Y; Takahashi, Y, 2001) |
| "A patient with advanced gastric cancer complicated with liver and lymph node metastases was successfully treated with a novel oral anticancer drug, TS-1, TS-1 was administered at a dose of 100 mg/day." | 1.31 | [A case of advanced gastric cancer successfully treated with TS-1]. ( Funakoshi, A; Iguchi, H; Matsuo, S; Miyagi, Y; Ouchi, J; Sumii, T; Uchimura, K; Yokota, M, 2002) |
| "We experienced a case of recurrent gastric cancer with a long-term survival." | 1.31 | [Dormant chemotherapy by low-dose FP and low-dose UFT-E in recurrent gastric cancer with long-term survival--a case report]. ( Koyama, S; Shimoda, S; Takeda, N; Tanaka, N; Tsukahara, A; Yajima, K, 2002) |
| "We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin." | 1.31 | [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002) |
| "We report one case of advanced gastric cancer with lung and lymph node metastases that completely responded to TS-1." | 1.31 | [A case report of advanced gastric cancer responding to TS-1, a novel oral fluorouracil derivative]. ( Isomoto, H; Kohno, S; Mizuta, Y; Morikawa, S; Murase, K; Murata, I; Nakamura, T; Ohnita, K; Taura, K; Yamasaki, K, 2002) |
| "A patient with advanced gastric cancer responded remarkably to UFT combined with CDDP." | 1.30 | [A case of advanced gastric cancer successfully treated by UFT and CDDP followed by surgical resection proving cancer cell disappearance in the stomach]. ( Akao, M; Azuma, M; Inukai, A; Manabe, T; Matsugaki, K; Muramoto, M; Nakai, T; Ogino, K, 1998) |
| "We recently established a metastasis model in nude mice using the MKL-4 cell line, a contransfectant of the MCF-7 human breast cancer cell line with fgf-4 and lacZ in which micrometastases in several organs can be quantitatively observed." | 1.30 | Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. ( Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N, 1997) |
| "We recently established a spontaneous metastasis model of MKL-4 human breast cancer cells transplanted into nude mice." | 1.29 | [Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice]. ( Kurebayashi, J; Sonoo, H, 1995) |
| "Peritoneal metastasis of breast cancer was one of the worst reactions with any therapy." | 1.29 | [A case of peritoneal metastasis of breast cancer successfully treated by multidisciplinary therapy with hyperthermia therapy]. ( Arima, M; Ebihara, Y; Kimura, K; Koyanagi, Y; Kusama, M; Matsunaga, T; Murata, A; Nakamura, Y; Shimizu, T, 1994) |
| "The tegafur suppository was useful because of the high concentration in cancer tissue and metastatic lymph nodes without any obvious side effects in the head and neck region." | 1.29 | [Tissue concentration of tegafur suppository in patients with head and neck cancer--concentration of 5-FU in cancer tissue]. ( Esu, H; Itokazu, T; Kamiya, S; Kanazawa, T; Koja, S; Maeshiro, N; Noda, Y; Simoji, Y; Yamauchi, M, 1994) |
| "A 64-year-old women with gallbladder cancer was treated by extended cholecystectomy and regional lymph node dissection." | 1.29 | [A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy]. ( Arima, S; Futami, K; Kotoh, T, 1994) |
| "We report a case of early gastric cancer with Virchow's node metastasis." | 1.29 | [A case of early gastric cancer with Virchow's node metastasis, effectively treated by high dose of UFT]. ( Eguchi, A; Fukano, M; Furuta, T; Haraguchi, M; Iwao, Y; Tsuboi, S, 1993) |
| "Generally, patients with unresectable gastric cancer have a poor prognosis." | 1.29 | [A case report of adenosquamous cell carcinoma of the stomach responding well to combination chemotherapy]. ( Kano, T; Masaoka, T; Nakamura, T; Ohashi, Y; Sato, K; Suzuki, T; Tenma, K, 1993) |
| " Pharmacokinetic examination after intravenous injection of low-dose MMC (0." | 1.29 | A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics. ( Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S, 1996) |
| "A case of gastric cancer with liver metastasis who responded well to low-dose PMUE (CDDP, MMC, UFT, etoposide) therapy is reported." | 1.29 | [A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy]. ( Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y, 1996) |
| "Influencing factors of recurrence in rectal cancer, such as depth of invasion, ew, vessel invasion (ly, v) and lymph node involvements were improved in the irradiated group, especially in effective cases, as compared with the non-irradiated group." | 1.28 | [Histopathological findings in rectal carcinomas undergoing preoperative irradiation combined with chemotherapy]. ( Takiguchi, N, 1992) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
| "A 59-year-old man with a gastric cancer underwent a laparotomy and was found to have an unresectable tumor that formed a large mass with metastatic lymph nodes around the aorta." | 1.28 | [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. ( Adachi, M; Kobori, O; Nomura, K; Sano, T, 1990) |
| "A Case of local recurrent breast cancer in a 45-year-old female with complete response to Combination of chemotherapy and topical administration of Adriamycin is reported." | 1.28 | [A case of local recurrent breast cancer with complete response to combination of systemic chemotherapy and topical use of adriamycin ointment]. ( Deguchi, S; Hokama, A; Kurihara, K; Muto, Y; Nomura, K; Toda, T, 1990) |
| "In 14 gastric cancer and 15 colonic cancer cases, to which UFT 400 mg/day and OK-432 2KE 2/W were administered orally and intra-muscularly for 2 weeks preoperatively until surgical treatment, intratumor 5-fluorouracil (5-FU) concentration was measured and compared with that of patients who given UFT 400 mg/day orally for 2 weeks (15 gastric cancer and 15 colonic cancer cases)." | 1.28 | [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT]. ( Hosoi, H; Kitagawa, M; Sinmyo, K; Susaki, H; Suwa, H; Yamaguchi, K, 1989) |
| "We report a case of advanced gastric cancer with Virchow's node metastasis which responded to concomitant plasma exchange and immunochemotherapy." | 1.28 | [A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy]. ( Iga, C; Kawashima, Y; Nishimura, J; Okajima, K; Sakuramoto, K; Toyoda, M, 1989) |
| "Lymph node metastasis was not related to the concentration of 5-FU in the lymph nodes." | 1.27 | [Serum and tissue concentrations of UFT in patients with lung cancer]. ( Aota, M; Daitoh, N; Jinno, K; Nakayama, S; Yokomise, H, 1986) |
| "A case of relapsed gastric cancer postoperatively presenting obstructive jaundice due to metastases in the hepatic portal and periaortic lymph nodes and multiple lung metastases was given OK-432 continuously i." | 1.27 | [A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system]. ( Kawahara, M; Matsuo, T; Nagamatsu, Y; Nakarai, I; Shinoda, A, 1986) |
| "One hundred forty-three patients with pancreatic cancer were treated with a number of chemotherapeutic agents, while ninety-eight patients did not receive any chemotherapy." | 1.27 | [Clinical study on the effect of chemotherapy in the treatment of pancreatic cancer]. ( Fujimoto, T; Ishida, T; Kurogoh, F; Ohyanagi, H; Okumura, S; Saitoh, Y; Shimada, Y; Tagashira, Y; Uchida, K; Yamamoto, M, 1988) |
| "A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported." | 1.27 | [Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow]. ( Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (6.82) | 18.7374 |
| 1990's | 52 (9.09) | 18.2507 |
| 2000's | 236 (41.26) | 29.6817 |
| 2010's | 232 (40.56) | 24.3611 |
| 2020's | 13 (2.27) | 2.80 |
| Authors | Studies |
|---|---|
| Demura, K | 1 |
| Murakami, K | 2 |
| Yoshida, M | 4 |
| Yoneda, K | 1 |
| Ohashi, T | 2 |
| Osawa, H | 1 |
| Ide, Y | 2 |
| Morimoto, O | 2 |
| Hatanaka, N | 1 |
| Nishida, T | 3 |
| Miyashita, S | 1 |
| Shimizu, T | 6 |
| Ishizuka, M | 1 |
| Niki, M | 2 |
| Nishi, Y | 1 |
| Shibuya, N | 1 |
| Hachiya, H | 1 |
| Matsumoto, T | 4 |
| Sakuraoka, Y | 1 |
| Shiraki, T | 1 |
| Mori, S | 2 |
| Iso, Y | 1 |
| Irisawa, A | 1 |
| Aoki, T | 8 |
| Shin, K | 1 |
| Park, SJ | 1 |
| Lee, J | 3 |
| Park, CH | 1 |
| Song, KY | 1 |
| Lee, HH | 1 |
| Seo, HS | 1 |
| Jung, YJ | 1 |
| Park, JM | 1 |
| Lee, SH | 1 |
| Roh, SY | 1 |
| Kim, IH | 1 |
| Sato, Y | 6 |
| Kurokawa, Y | 2 |
| Doki, Y | 5 |
| Mizusawa, J | 5 |
| Tanaka, K | 8 |
| Katayama, H | 4 |
| Boku, N | 10 |
| Yoshikawa, T | 11 |
| Terashima, M | 7 |
| Urahigashi, A | 1 |
| Fukunaga, H | 3 |
| Sawami, H | 1 |
| Hiraki, M | 2 |
| Sawada, G | 1 |
| Murakami, M | 2 |
| Chihara, Y | 1 |
| Yamamoto, M | 5 |
| Kimura, H | 3 |
| Morita, S | 7 |
| Sato, T | 7 |
| Nakamura, N | 1 |
| Arai, S | 1 |
| Tomi, Y | 1 |
| Sanada, T | 2 |
| Kuwabara, H | 5 |
| Yoshida, T | 12 |
| Goseki, N | 2 |
| Koike, M | 1 |
| Seita, K | 1 |
| Ebata, T | 3 |
| Mizuno, T | 3 |
| Maeda, A | 5 |
| Yamaguchi, R | 3 |
| Kurumiya, Y | 1 |
| Sakamoto, E | 3 |
| Hiramatsu, K | 4 |
| Ando, M | 2 |
| Nagino, M | 5 |
| Kinoshita, S | 5 |
| Higashida, M | 1 |
| Kubota, H | 2 |
| Kitagawa, S | 2 |
| Iwamoto, R | 1 |
| Ueno, M | 3 |
| Mineta, S | 1 |
| Okamoto, Y | 2 |
| Watanabe, Y | 4 |
| Okada, T | 2 |
| Tsuruta, A | 1 |
| Akiyama, T | 1 |
| Fujiwara, Y | 5 |
| Ueno, T | 1 |
| Wada, R | 2 |
| Akamaru, Y | 1 |
| Wada, N | 2 |
| Hokkoku, D | 1 |
| Ikeshima, R | 1 |
| Munakata, K | 2 |
| Takiuchi, D | 2 |
| Ota, H | 2 |
| Shibata, K | 1 |
| Kobayashi, T | 5 |
| Mizuno, S | 2 |
| Matsuba, H | 1 |
| Kanamori, M | 1 |
| Maruyama, S | 1 |
| Tamauchi, T | 1 |
| Tohyama, T | 1 |
| Sakamoto, K | 3 |
| Tamura, K | 2 |
| Nakamura, T | 8 |
| Watanabe, J | 1 |
| Wakisaka, H | 1 |
| Takada, Y | 1 |
| Yamamoto, A | 1 |
| Suda, T | 3 |
| Yamauchi, Y | 1 |
| Kondo, S | 1 |
| Okazaki, N | 1 |
| Takahashi, K | 7 |
| Watanabe, T | 9 |
| Makuuchi, Y | 2 |
| Ota, Y | 1 |
| Nagakawa, Y | 1 |
| Seshimo, A | 2 |
| Katsumata, K | 2 |
| Itoi, T | 1 |
| Tsuchida, A | 3 |
| Yamakoshi, Y | 1 |
| Ohtani, H | 3 |
| Nagamori, M | 1 |
| Nomura, S | 4 |
| Nakagawa, H | 1 |
| Yoshii, M | 1 |
| Tamura, T | 3 |
| Toyokawa, T | 1 |
| Tanaka, H | 2 |
| Muguruma, K | 1 |
| Ohira, M | 2 |
| Mochizuki, S | 1 |
| Matsui, T | 3 |
| Nakamichi, N | 1 |
| Hiramoto, H | 1 |
| Ishimoto, T | 1 |
| Kosuga, T | 2 |
| Tsujiura, M | 1 |
| Nakashima, S | 1 |
| Masuyama, M | 1 |
| Hirono, S | 1 |
| Kawai, M | 4 |
| Okada, KI | 1 |
| Miyazawa, M | 1 |
| Kitahata, Y | 1 |
| Kobayashi, R | 1 |
| Hayami, S | 1 |
| Yamaue, H | 1 |
| Wada, T | 2 |
| Sekine, S | 1 |
| Kamiya, A | 1 |
| Hayashi, T | 6 |
| Otsuki, S | 1 |
| Yamagata, Y | 1 |
| Katai, H | 3 |
| Saito, H | 6 |
| Fushida, S | 6 |
| Miyashita, T | 1 |
| Oyama, K | 4 |
| Yamaguchi, T | 7 |
| Tsukada, T | 1 |
| Kinoshita, J | 4 |
| Tajima, H | 2 |
| Ninomiya, I | 3 |
| Ohta, T | 6 |
| Kano, K | 2 |
| Aoyama, T | 6 |
| Maezawa, Y | 2 |
| Nakajima, T | 6 |
| Ikeda, K | 4 |
| Yamada, T | 13 |
| Oshima, T | 3 |
| Rino, Y | 6 |
| Masuda, M | 5 |
| Ogata, T | 6 |
| Cho, H | 8 |
| Yoshizawa, J | 1 |
| Ishizone, S | 2 |
| Ikeyama, M | 1 |
| Nakayama, J | 2 |
| Hosokawa, A | 1 |
| Ando, T | 2 |
| Ogawa, K | 4 |
| Ueda, A | 1 |
| Yoshita, H | 1 |
| Mihara, H | 1 |
| Fujinami, H | 1 |
| Kajiura, S | 1 |
| Yabushita, K | 1 |
| Horikawa, N | 1 |
| Kobayashi, Y | 1 |
| Yoshioka, A | 2 |
| Origasa, H | 1 |
| Sugiyama, T | 1 |
| Hayashi, K | 4 |
| Nagasaki, E | 1 |
| Nakada, K | 1 |
| Tamura, M | 2 |
| Arakawa, Y | 1 |
| Uwagawa, T | 1 |
| Yano, S | 3 |
| Wang, X | 2 |
| Zhao, DB | 1 |
| Yang, L | 1 |
| Chi, Y | 1 |
| Tang, Y | 1 |
| Li, N | 1 |
| Wang, SL | 1 |
| Song, YW | 1 |
| Liu, YP | 1 |
| Liu, WY | 1 |
| Ren, H | 1 |
| Zhang, T | 1 |
| Wang, JY | 2 |
| Chen, XS | 1 |
| Fang, H | 1 |
| Wang, WH | 1 |
| Li, YX | 1 |
| Jin, J | 1 |
| Kamei, K | 1 |
| Matsumoto, I | 3 |
| Makutani, Y | 1 |
| Kawaguchi, K | 3 |
| Matsumoto, M | 2 |
| Murase, T | 1 |
| Satoi, S | 2 |
| Nakai, T | 2 |
| Kamata, K | 2 |
| Imai, H | 1 |
| Chikugo, T | 1 |
| Takeyama, Y | 1 |
| Shimaoka, H | 1 |
| Shibata, R | 2 |
| Hosoda, Y | 3 |
| Hirano, Y | 2 |
| Munechika, T | 2 |
| Yonemitsu, K | 2 |
| Ishii, Y | 3 |
| Okamoto, T | 2 |
| Maeno, H | 2 |
| Noritomi, T | 1 |
| Sueishi, K | 2 |
| Shinkai, M | 2 |
| Imano, M | 3 |
| Hiraki, Y | 2 |
| Kato, H | 3 |
| Iwama, M | 2 |
| Shiraishi, O | 1 |
| Yasuda, A | 3 |
| Kimura, Y | 7 |
| Imamoto, H | 2 |
| Furukawa, H | 4 |
| Yasuda, T | 2 |
| Miura, T | 1 |
| Tsunenari, T | 1 |
| Sasaki, T | 5 |
| Yokoyama, T | 3 |
| Fukuhara, K | 1 |
| Kubota, T | 5 |
| Choda, Y | 3 |
| Morito, T | 1 |
| Miyake, S | 2 |
| Ishida, M | 3 |
| Sato, D | 1 |
| Sumitani, D | 1 |
| Nakano, K | 2 |
| Harano, M | 2 |
| Matsukawa, H | 3 |
| Ojima, Y | 3 |
| Idani, H | 2 |
| Shiozaki, S | 4 |
| Okajima, M | 3 |
| Mugitani, T | 1 |
| Hatakeyama, T | 1 |
| Sakai, T | 2 |
| Matsumura, A | 1 |
| Ogino, S | 1 |
| Akami, T | 1 |
| Okano, S | 1 |
| Terashima, T | 1 |
| Kawamoto, S | 4 |
| Maekawa, K | 1 |
| Kuroki, N | 1 |
| Toyota, K | 1 |
| Murakami, Y | 9 |
| Kondo, N | 5 |
| Uemura, K | 7 |
| Nakagawa, N | 4 |
| Takahashi, S | 6 |
| Sueda, T | 7 |
| Kim, SM | 1 |
| An, JY | 1 |
| Sohn, TS | 2 |
| Kim, S | 2 |
| Matsuda, C | 2 |
| Ishiguro, M | 3 |
| Teramukai, S | 1 |
| Kajiwara, Y | 3 |
| Fujii, S | 1 |
| Kinugasa, Y | 2 |
| Nakamoto, Y | 1 |
| Kotake, M | 2 |
| Sakamoto, Y | 2 |
| Kurachi, K | 1 |
| Komori, K | 1 |
| Tomita, N | 2 |
| Shimada, Y | 3 |
| Kotake, K | 1 |
| Watanabe, M | 6 |
| Mochizuki, H | 2 |
| Nakagawa, Y | 2 |
| Sugihara, K | 1 |
| Hsieh, MY | 1 |
| Chen, G | 1 |
| Chang, DC | 1 |
| Chien, SY | 1 |
| Chen, MK | 1 |
| Chiba, Y | 1 |
| Shiraisi, O | 1 |
| Tsubaki, M | 1 |
| Nishida, S | 1 |
| Oki, E | 2 |
| Shimokawa, M | 1 |
| Ando, K | 2 |
| Murata, A | 3 |
| Takahashi, T | 8 |
| Maeda, K | 2 |
| Kusumoto, T | 1 |
| Munemoto, Y | 2 |
| Nakanishi, R | 1 |
| Nakashima, Y | 2 |
| Saeki, H | 4 |
| Maehara, Y | 4 |
| Morita, J | 1 |
| Amano, S | 2 |
| Sawazaki, S | 1 |
| Numata, M | 1 |
| Ozawa, Y | 1 |
| Yukawa, N | 2 |
| Tsuchiya, T | 2 |
| Matsumoto, K | 3 |
| Miyazaki, T | 1 |
| Yamaguchi, H | 3 |
| Yamazaki, T | 1 |
| Sano, I | 1 |
| Fukuoka, J | 1 |
| Nakamura, Y | 7 |
| Yamasaki, N | 1 |
| Nagayasu, T | 1 |
| Misumi, T | 1 |
| Suzuki, T | 7 |
| Tazawa, H | 1 |
| Kojima, M | 3 |
| Akabane, S | 1 |
| Hadano, N | 1 |
| Shimizu, W | 2 |
| Ishiyama, K | 1 |
| Onoe, T | 2 |
| Sudo, T | 6 |
| Shimizu, Y | 2 |
| Hinoi, T | 1 |
| Tashiro, H | 2 |
| Okamoto, K | 4 |
| Shoda, K | 1 |
| Konishi, H | 1 |
| Shiozaki, A | 2 |
| Fujiwara, H | 5 |
| Arita, T | 1 |
| Morimura, R | 1 |
| Murayama, Y | 2 |
| Kuriu, Y | 2 |
| Ikoma, H | 3 |
| Nakanishi, M | 4 |
| Otsuji, E | 4 |
| Ono, K | 3 |
| Takehana, T | 1 |
| Yamamoto, K | 6 |
| Kawai, S | 1 |
| Nagase, M | 1 |
| Miyake, T | 1 |
| Mikane, Y | 1 |
| Syoji, R | 1 |
| Aoyama, K | 1 |
| Nogami, T | 1 |
| Nishikawa, H | 2 |
| Shinoura, S | 1 |
| Shigemitsu, K | 1 |
| Nonaka, Y | 1 |
| Hayashi, D | 1 |
| Akiyama, N | 2 |
| Karayama, M | 1 |
| Inui, N | 1 |
| Yasui, H | 6 |
| Hozumi, H | 1 |
| Suzuki, Y | 5 |
| Furuhashi, K | 1 |
| Fujisawa, T | 1 |
| Enomoto, N | 1 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 1 |
| Uto, T | 1 |
| Asada, K | 1 |
| Matsuda, H | 1 |
| Fujii, M | 4 |
| Toyoshima, M | 1 |
| Takahashi, R | 1 |
| Ohashi, M | 5 |
| Kano, Y | 2 |
| Ida, S | 1 |
| Kumagai, K | 1 |
| Nunobe, S | 1 |
| Chin, K | 4 |
| Yamaguchi, K | 4 |
| Sano, T | 6 |
| Hiki, N | 1 |
| Morita, Y | 2 |
| Sakaguchi, T | 1 |
| Kitajima, R | 1 |
| Furuhashi, S | 1 |
| Kiuchi, R | 1 |
| Takeda, M | 1 |
| Hiraide, T | 1 |
| Shibasaki, Y | 1 |
| Kikuchi, H | 2 |
| Konno, H | 1 |
| Takeuchi, H | 2 |
| Tsuburaya, A | 14 |
| Nakamura, K | 9 |
| Imamura, H | 8 |
| Nashimoto, A | 7 |
| Fukushima, N | 3 |
| Sasako, M | 6 |
| Hanaka, J | 1 |
| Kobayashi, A | 2 |
| Goya, T | 1 |
| Tanizawa, Y | 1 |
| Bando, E | 2 |
| Kawamura, T | 2 |
| Tokunaga, M | 2 |
| Sasaki, K | 3 |
| Migita, K | 2 |
| Takayama, T | 4 |
| Saeki, K | 1 |
| Matsumoto, S | 1 |
| Wakatsuki, K | 1 |
| Enomoto, K | 1 |
| Tanaka, T | 3 |
| Ito, M | 1 |
| Kurumatani, N | 1 |
| Nakajima, Y | 1 |
| Kunisaki, C | 5 |
| Hasegawa, S | 3 |
| Takagawa, R | 3 |
| Momiyama, M | 2 |
| Kosaka, T | 3 |
| Makino, H | 4 |
| Ono, HA | 2 |
| Akiyama, H | 3 |
| Endo, I | 3 |
| Takahari, D | 2 |
| Hamaguchi, T | 2 |
| Yoshimura, K | 3 |
| Ito, S | 4 |
| Fuse, N | 2 |
| Konishi, M | 3 |
| Goto, M | 2 |
| Tanigawa, N | 2 |
| Shirao, K | 1 |
| Hashimoto, Y | 8 |
| Muto, T | 1 |
| Sasaki, H | 2 |
| Urabe, K | 1 |
| Ema, A | 1 |
| Yamashita, K | 1 |
| Sakuramoto, S | 1 |
| Wang, G | 1 |
| Mieno, H | 1 |
| Nemoto, M | 1 |
| Shibata, T | 1 |
| Katada, N | 1 |
| Kikuchi, S | 4 |
| Hirata, A | 1 |
| Itatsu, K | 1 |
| Fukaya, M | 1 |
| Yokoyama, Y | 2 |
| Tsunoda, N | 1 |
| Igami, T | 1 |
| Sugawara, G | 1 |
| Uehara, K | 3 |
| Yoshioka, Y | 1 |
| Usui, H | 1 |
| Eshita, Y | 1 |
| Ogawa, F | 1 |
| Shioyama, Y | 1 |
| Atsumi, K | 1 |
| Nonoshita, T | 1 |
| Ooga, S | 1 |
| Yoshitake, T | 1 |
| Uehara, S | 2 |
| Hirata, H | 1 |
| Honda, H | 2 |
| Kitayama, J | 3 |
| Ishigami, H | 3 |
| Yamashita, H | 3 |
| Emoto, S | 1 |
| Kaisaki, S | 2 |
| Takahara, N | 1 |
| Isayama, H | 1 |
| Nakai, Y | 1 |
| Hamada, T | 2 |
| Uchino, R | 1 |
| Miyabayashi, K | 1 |
| Kogure, H | 1 |
| Yamamoto, N | 2 |
| Sasahira, N | 1 |
| Hirano, K | 1 |
| Ijichi, H | 1 |
| Tateishi, K | 1 |
| Tada, M | 1 |
| Koike, K | 1 |
| Kanagawa, T | 1 |
| Ookawa, T | 1 |
| Nogami, H | 1 |
| Kobatake, T | 1 |
| Saji, O | 1 |
| Ishii, M | 1 |
| Kobayashi, H | 6 |
| Sumiyoshi, K | 1 |
| Asano, T | 1 |
| Iwata, K | 1 |
| Okamura, R | 1 |
| Kobayashi, S | 3 |
| Koizumi, S | 1 |
| Otsubo, T | 1 |
| Fukai, Y | 1 |
| Ojima, H | 2 |
| Sano, A | 1 |
| Akao, T | 1 |
| Sohda, M | 1 |
| Tanabe, A | 1 |
| Fukuda, T | 1 |
| Takeyama, H | 1 |
| Mizushima, T | 4 |
| Nakajima, K | 4 |
| Uemura, M | 3 |
| Haraguchi, N | 2 |
| Nishimura, J | 3 |
| Hata, T | 4 |
| Takemasa, I | 4 |
| Yamamoto, H | 7 |
| Mori, M | 4 |
| Shinmura, K | 2 |
| Kaiho, T | 1 |
| Yanagisawa, S | 1 |
| Okamoto, R | 1 |
| Nishimura, M | 1 |
| Okaniwa, A | 1 |
| Tsuchiya, S | 2 |
| Shirai, J | 1 |
| Fujikawa, H | 2 |
| Iwasaki, K | 2 |
| Sujishi, K | 1 |
| Osaragi, T | 2 |
| Yoneyama, K | 2 |
| Kasahara, A | 1 |
| Yamamoto, Y | 4 |
| Nishikawa, K | 6 |
| Iwase, K | 2 |
| Aono, T | 1 |
| Yoshida, H | 4 |
| Nomura, M | 4 |
| Tamagawa, H | 1 |
| Deguchi, T | 2 |
| Kawada, J | 3 |
| Higashi, S | 1 |
| Deguchi, K | 1 |
| Noguchi, Y | 2 |
| Okumura, Y | 1 |
| Fushimi, H | 2 |
| Takagi, M | 2 |
| Fukui, A | 2 |
| Fujitani, K | 4 |
| Endo, S | 3 |
| Tanaka, Y | 2 |
| Kondo, J | 1 |
| Nisimura, T | 1 |
| Nagashima, Y | 1 |
| Nakamura, M | 7 |
| Setoguchi, M | 1 |
| Yoshino, S | 1 |
| Sakata, K | 1 |
| Hashimoto, T | 2 |
| Takeno, A | 3 |
| Taniguchi, H | 4 |
| Morimoto, Y | 1 |
| Kusama, H | 1 |
| Matsushita, K | 2 |
| Kawashima, H | 1 |
| Kimura, K | 2 |
| Mukai, Y | 1 |
| Katsura, Y | 2 |
| Kagawa, Y | 3 |
| Okishiro, M | 1 |
| Sakisaka, H | 1 |
| Nakahira, S | 1 |
| Egawa, C | 2 |
| Takeda, Y | 4 |
| Kato, T | 7 |
| Tamura, S | 4 |
| Yasui, T | 1 |
| Mukubo, H | 1 |
| Sato, N | 1 |
| Kita, I | 1 |
| Hyuga, N | 1 |
| Kobayashi, K | 4 |
| Watanabe, R | 2 |
| Chono, A | 1 |
| Takemoto, H | 2 |
| Takachi, K | 2 |
| Nishioka, K | 2 |
| Uemura, Y | 3 |
| Yoshida, K | 5 |
| Matsuoka, T | 1 |
| Hosaka, S | 1 |
| Inada, K | 1 |
| Tsukao, Y | 1 |
| Moon, JH | 1 |
| Hyuga, S | 1 |
| Chono, T | 1 |
| Matsuda, S | 1 |
| Fukada, J | 1 |
| Fukuda, K | 3 |
| Kawakubo, H | 1 |
| Saikawa, Y | 3 |
| Kawaguchi, O | 1 |
| Shigematsu, N | 2 |
| Kitagawa, Y | 2 |
| Okabe, Y | 1 |
| Yajima, K | 4 |
| Ishikawa, T | 6 |
| Kosugi, S | 2 |
| Kanda, T | 2 |
| Wakai, T | 5 |
| Nagano, I | 1 |
| Yamada, I | 1 |
| Niwa, M | 1 |
| Kanazawa, H | 1 |
| Matsumoto, N | 2 |
| Yoshinaka, H | 1 |
| Shinto, E | 2 |
| Hase, K | 2 |
| Hashiguchi, Y | 3 |
| Sekizawa, A | 1 |
| Ueno, H | 5 |
| Shikina, A | 1 |
| Yamamoto, J | 3 |
| Kochi, M | 2 |
| Kanamori, N | 2 |
| Mihara, Y | 1 |
| Funada, T | 1 |
| Tamegai, H | 1 |
| Takayama, Y | 1 |
| Suda, H | 4 |
| Harada, N | 2 |
| Shirabe, K | 1 |
| Yoshizumi, T | 1 |
| Ikegami, T | 1 |
| Uchiyama, H | 2 |
| Soejima, Y | 1 |
| Yamashita, Y | 3 |
| Kawanaka, H | 2 |
| Morita, M | 4 |
| Ikeda, T | 5 |
| Matsuura, H | 1 |
| Okadome, K | 1 |
| Maeda, T | 4 |
| Hashimoto, K | 5 |
| Ishida, T | 4 |
| Tsujitani, S | 2 |
| Tanabe, K | 2 |
| Ito, Y | 11 |
| Miyashita, Y | 2 |
| Sakamoto, J | 6 |
| Dong, L | 1 |
| Li, J | 1 |
| Lou, XP | 1 |
| Miao, JH | 1 |
| Lu, P | 1 |
| Chang, ZW | 1 |
| Han, ZF | 1 |
| Hori, Y | 1 |
| Itagaki, R | 1 |
| Iwata, H | 2 |
| Maekawa, S | 2 |
| Ueki, K | 2 |
| Tada, T | 2 |
| Ishizuka, D | 2 |
| Murase, H | 1 |
| Oono, R | 1 |
| Ueda, Y | 1 |
| Enjoji, M | 1 |
| Ishimaru, S | 1 |
| Obara, M | 1 |
| Tsuchiya, N | 1 |
| Yamagishi, S | 2 |
| Ishibe, A | 1 |
| Matsuo, K | 1 |
| Misuta, K | 1 |
| Nakano, A | 2 |
| Fushimi, K | 1 |
| Tanabe, N | 1 |
| Takami, M | 1 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Ha, SW | 1 |
| Zhang, ZD | 1 |
| Kong, Y | 1 |
| Yang, W | 1 |
| Zhang, B | 1 |
| Zhang, YL | 1 |
| Ma, EM | 1 |
| Liu, HX | 1 |
| Chen, XB | 1 |
| Hua, YW | 1 |
| Toyoda, M | 2 |
| Kaira, K | 1 |
| Ohshima, Y | 1 |
| Ishioka, NS | 1 |
| Shino, M | 1 |
| Sakakura, K | 1 |
| Takayasu, Y | 1 |
| Tominaga, H | 1 |
| Oriuchi, N | 1 |
| Nagamori, S | 1 |
| Kanai, Y | 1 |
| Oyama, T | 3 |
| Chikamatsu, K | 1 |
| Kurimoto, K | 1 |
| Ishigure, K | 1 |
| Mochizuki, Y | 2 |
| Ishiyama, A | 1 |
| Nakayama, H | 2 |
| Tanaka, N | 5 |
| Kobayashi, D | 2 |
| Nakao, A | 2 |
| Kodera, Y | 4 |
| Ohue, M | 4 |
| Sakai, D | 1 |
| Noura, S | 3 |
| Fujita, S | 4 |
| Saito, N | 2 |
| Moriya, Y | 1 |
| Tashiro, J | 1 |
| Yamaguchi, S | 2 |
| Ishii, T | 2 |
| Suzuki, A | 2 |
| Kondo, H | 2 |
| Hara, K | 1 |
| Koyama, I | 1 |
| Endo, M | 2 |
| Hirayama, N | 1 |
| Akai, T | 2 |
| Matsubara, H | 1 |
| Funakoshi, T | 1 |
| Fukutomi, A | 2 |
| Yamazaki, K | 4 |
| Machida, N | 3 |
| Todaka, A | 2 |
| Tsushima, T | 2 |
| Yokota, T | 3 |
| Onozawa, Y | 2 |
| Kenmotsu, H | 1 |
| Okabayashi, T | 1 |
| Shima, Y | 1 |
| Iwata, J | 1 |
| Sumiyoshi, T | 2 |
| Kozuki, A | 1 |
| Tokumaru, T | 1 |
| Iiyama, T | 1 |
| Kosaki, T | 1 |
| Kobayashi, M | 6 |
| Hanazaki, K | 1 |
| Yamamura, A | 1 |
| Ono, F | 1 |
| Hiraga, M | 1 |
| Omura, N | 1 |
| Takano, N | 1 |
| Sato, H | 2 |
| Toyama, S | 1 |
| Onochi, S | 1 |
| Murakami, S | 2 |
| Umeda, S | 1 |
| Sozaki, M | 1 |
| Miyoshi, K | 1 |
| Ishikawa, M | 1 |
| Uchiyama, A | 1 |
| Ohuchi, K | 1 |
| Nakano, R | 1 |
| Omori, K | 3 |
| Wakabayashi, K | 6 |
| Ishibashi, Y | 3 |
| Fukuda, N | 1 |
| Sano, M | 2 |
| Ogura, R | 1 |
| Wada, J | 1 |
| Tanaka, C | 3 |
| Fujiwara, M | 1 |
| Lee, SJ | 1 |
| Park, SH | 1 |
| Park, JO | 1 |
| Lim, DH | 1 |
| Park, YS | 1 |
| Lim, HY | 1 |
| Choi, MG | 2 |
| Lee, JH | 1 |
| Bae, JM | 1 |
| Kang, WK | 3 |
| Itoyama, R | 1 |
| Hashimoto, D | 1 |
| Chikamoto, A | 1 |
| Hayashi, H | 2 |
| Beppu, T | 1 |
| Baba, H | 5 |
| Saito, M | 4 |
| Kiyozaki, H | 2 |
| Takata, O | 2 |
| Suzuki, K | 4 |
| Rikiyama, T | 1 |
| Kimura, J | 2 |
| Kanazawa, A | 2 |
| Ota, M | 1 |
| Kitayama, K | 1 |
| Kanehara, I | 2 |
| Teraoka, H | 1 |
| Noda, E | 1 |
| Nishino, H | 3 |
| Hirakawa, K | 5 |
| Maeda, H | 4 |
| Usui, T | 1 |
| Kawamura, A | 1 |
| Takeshita, A | 1 |
| Konishi, K | 2 |
| Okuyama, M | 2 |
| Hiraoka, K | 2 |
| Nakagawa, T | 1 |
| Kim, C | 4 |
| Nishijima, J | 1 |
| Katagiri, M | 1 |
| Katayose, Y | 3 |
| Yabuuchi, S | 1 |
| Karasawa, H | 3 |
| Sato, J | 1 |
| Morikawa, T | 3 |
| Motoi, F | 3 |
| Naito, T | 2 |
| Unno, M | 3 |
| Kimura, S | 3 |
| Ohnuma, S | 2 |
| Kudoh, K | 1 |
| Watanabe, K | 5 |
| Nagao, M | 2 |
| Abe, T | 3 |
| Musha, H | 2 |
| Naitoh, T | 1 |
| Kono, E | 1 |
| Kudo, K | 1 |
| Miyachi, T | 1 |
| Kajiwara, T | 1 |
| Nakagawa, K | 4 |
| Hokonohara, K | 1 |
| Takata, A | 1 |
| Hirota, M | 2 |
| Oshima, K | 2 |
| Tanida, T | 1 |
| Hatano, H | 1 |
| Noda, T | 1 |
| Komori, T | 1 |
| Iwazawa, T | 1 |
| Akagi, K | 2 |
| Adachi, S | 1 |
| Dono, K | 2 |
| Hirao, M | 3 |
| Harada, Y | 2 |
| Fukuda, Y | 1 |
| Miyake, M | 1 |
| Asaoka, T | 1 |
| Miyamoto, A | 2 |
| Miyazaki, M | 4 |
| Ikeda, M | 8 |
| Nakamori, S | 3 |
| Sekimoto, M | 5 |
| Nishiuchi, A | 1 |
| Kato, S | 1 |
| Kadokawa, Y | 1 |
| Machimoto, T | 1 |
| Asao, Y | 1 |
| Furuyama, H | 1 |
| Yoshimura, T | 2 |
| Okada, K | 3 |
| Ebisui, C | 1 |
| Nushijima, Y | 1 |
| Yanagisawa, T | 1 |
| Okamura, S | 4 |
| Fukuchi, N | 1 |
| Murata, K | 2 |
| Yokouchi, H | 3 |
| Kinuta, M | 1 |
| Mihara, K | 2 |
| Yamashiro, N | 1 |
| Nishiya, S | 1 |
| Kemmochi, T | 1 |
| Egawa, T | 4 |
| Nagashima, A | 4 |
| Ogasawara, T | 1 |
| Ootsuka, Y | 1 |
| Nakano, S | 1 |
| Shida, T | 2 |
| Kin, M | 1 |
| Takahashi, M | 10 |
| Komatsu, T | 1 |
| Zhou, J | 1 |
| Zhao, R | 1 |
| Wen, F | 1 |
| Zhang, P | 1 |
| Tang, R | 2 |
| Du, Z | 1 |
| He, X | 1 |
| Zhang, J | 1 |
| Li, Q | 1 |
| Shimizu, K | 4 |
| Yukawa, T | 1 |
| Okita, R | 1 |
| Saisho, S | 1 |
| Nojima, Y | 1 |
| Nakata, M | 2 |
| Takeuchi, E | 2 |
| Goto, H | 4 |
| Tojima, Y | 2 |
| Yatsuya, H | 1 |
| Ishihara, S | 1 |
| Fukushima, Y | 1 |
| Akahane, T | 1 |
| Horiuchi, A | 2 |
| Shimada, R | 1 |
| Aoyagi, Y | 1 |
| Hayama, T | 1 |
| Yamada, H | 2 |
| Nozawa, K | 1 |
| Matsuda, K | 1 |
| Shigematsu, T | 2 |
| Murai, K | 1 |
| Furuta, M | 1 |
| Matsumoto, H | 6 |
| Katayama, M | 2 |
| Okajima, T | 2 |
| Tanaka, M | 4 |
| Baba, M | 1 |
| Ryu, MH | 2 |
| Baba, E | 1 |
| Lee, KH | 2 |
| Park, YI | 1 |
| Hyodo, I | 2 |
| Nam, BH | 1 |
| Esaki, T | 1 |
| Yoo, C | 1 |
| Ryoo, BY | 2 |
| Song, EK | 1 |
| Cho, SH | 1 |
| Yang, SH | 2 |
| Zang, DY | 2 |
| Shin, DB | 2 |
| Park, SR | 2 |
| Shinozaki, K | 1 |
| Takano, T | 1 |
| Kang, YK | 2 |
| Ogata, D | 1 |
| Hokama, Y | 1 |
| Tsuchida, T | 1 |
| Kataoka, K | 1 |
| Shitara, K | 6 |
| Tomita, T | 1 |
| Bando, H | 1 |
| Yamada, Y | 6 |
| Tanabe, S | 3 |
| Gotoh, M | 3 |
| Sugimoto, N | 1 |
| Nishina, T | 3 |
| Amagai, K | 1 |
| Niwa, Y | 1 |
| Tsuji, A | 2 |
| Tsuda, M | 2 |
| Fujii, H | 1 |
| Hironaka, S | 2 |
| Shimada, K | 1 |
| Miwa, H | 3 |
| Hamada, C | 1 |
| Cao, C | 1 |
| Kuang, M | 1 |
| Xu, W | 1 |
| Zhang, X | 1 |
| Chen, J | 1 |
| Tang, C | 1 |
| Okabe, H | 2 |
| Hata, H | 1 |
| Ueda, S | 3 |
| Zaima, M | 1 |
| Tokuka, A | 2 |
| Ota, S | 1 |
| Kinjo, Y | 1 |
| Sakai, Y | 2 |
| Mazaki, J | 1 |
| Suematsu, Y | 3 |
| Hiratsuka, M | 2 |
| Makari, Y | 3 |
| Mikami, J | 1 |
| Kawase, T | 2 |
| Hamakawa, T | 1 |
| Hoshino, H | 1 |
| Nakata, K | 2 |
| Yamamoto, T | 3 |
| Yamamura, J | 1 |
| Kamigaki, S | 2 |
| Ikeda, N | 1 |
| Tsujie, M | 3 |
| Munakata, S | 1 |
| Ohzato, H | 3 |
| Kim, Y | 2 |
| Nishino, M | 2 |
| Okano, M | 4 |
| Yamasaki, M | 2 |
| Nagai, K | 2 |
| Yasui, M | 3 |
| Tsujinaka, T | 3 |
| Nomi, M | 2 |
| Mase, T | 2 |
| Nagao, S | 4 |
| Nakada, S | 1 |
| Kawamoto, J | 1 |
| Yoichi, T | 1 |
| Shinoda, K | 1 |
| Ishigami, E | 1 |
| Teranaka, R | 1 |
| Nakazawa, K | 1 |
| Tanaka, R | 1 |
| Kametani, N | 1 |
| Hirakawa, T | 1 |
| Kato, Y | 6 |
| Komoto, M | 2 |
| Yamagata, S | 2 |
| Ako, E | 1 |
| Yamada, N | 1 |
| Nishimura, S | 1 |
| Taenaka, N | 1 |
| Sasaguri, T | 1 |
| Ohshima, T | 2 |
| Yazawa, K | 1 |
| Minami, Y | 1 |
| Morita, A | 2 |
| Terada, I | 1 |
| Terai, S | 1 |
| Kawahara, Y | 2 |
| Amaya, K | 1 |
| Yamamoto, S | 1 |
| Kaji, M | 2 |
| Eto, R | 1 |
| Nakatsu, H | 1 |
| Ozasa, H | 2 |
| Shimizu, R | 1 |
| Kemmochi, A | 1 |
| Inagawa, S | 1 |
| Akashi, Y | 1 |
| Inagaki, Y | 1 |
| Satomi, K | 1 |
| Ohkohchi, N | 1 |
| Torigoe, H | 1 |
| Toyooka, S | 1 |
| Katsui, K | 1 |
| Soh, J | 1 |
| Maki, Y | 1 |
| Kiura, K | 1 |
| Miyoshi, S | 1 |
| Kim, SG | 1 |
| Hwang, SH | 1 |
| Kusama, T | 1 |
| Yamagami, K | 1 |
| Hasegawa, M | 1 |
| Sone, N | 1 |
| Kokado, Y | 1 |
| Koshiba, T | 1 |
| Ichikawa, K | 1 |
| Tanaka, S | 4 |
| Sanefuji, K | 1 |
| Kabashima, A | 1 |
| Uesaka, K | 1 |
| Okamura, Y | 1 |
| Kaneoka, Y | 1 |
| Sakamoto, H | 1 |
| Morinaga, S | 3 |
| Kainuma, O | 1 |
| Imai, K | 1 |
| Sata, N | 1 |
| Hishinuma, S | 1 |
| Hirano, S | 1 |
| Ohashi, Y | 5 |
| Iida, Y | 2 |
| Ogawa, H | 3 |
| Kamijo, T | 1 |
| Hamauchi, S | 1 |
| Nakagawa, M | 5 |
| Yurikusa, T | 1 |
| Tanuma, A | 1 |
| Yamashita, A | 1 |
| Nishimura, T | 1 |
| Onitsuka, T | 1 |
| Kuga, Y | 2 |
| Moriya, T | 4 |
| Fukuda, S | 1 |
| Kiyota, S | 1 |
| Matsuda, Y | 2 |
| Hanada, S | 1 |
| Kinoshita, M | 1 |
| Nishizawa, S | 1 |
| Kanazawa, G | 1 |
| Nishiguchi, R | 1 |
| Kim, DH | 1 |
| Honda, M | 2 |
| Sakamoto, T | 2 |
| Asakage, M | 1 |
| Kuwahara, R | 1 |
| Akiyama, Y | 1 |
| Inatome, J | 1 |
| Naito, A | 1 |
| Ohmura, Y | 2 |
| Ogawa, T | 2 |
| Ninomiya, M | 3 |
| Nagai, Y | 1 |
| Mimura, N | 1 |
| Osakabe, H | 1 |
| Katayanagi, S | 1 |
| Shigoka, M | 1 |
| Sumi, T | 1 |
| Kawachi, S | 1 |
| Kojima, T | 3 |
| Higashi, Y | 2 |
| Shoji, T | 1 |
| Yamazaki, M | 1 |
| Taniguchi, M | 2 |
| Nishiyama, R | 1 |
| Maruo, H | 1 |
| Nakayama, M | 1 |
| Fukabori, M | 1 |
| Itoh, Y | 1 |
| Mori, K | 1 |
| Kishi, K | 3 |
| Masuzawa, T | 1 |
| Tsukada, R | 1 |
| Tanemura, M | 1 |
| Tei, M | 2 |
| Otsuka, M | 1 |
| Furukawa, K | 1 |
| Akamatsu, H | 3 |
| Ichikawa, H | 1 |
| Hanyu, T | 1 |
| Usui, K | 1 |
| Muneoka, Y | 1 |
| Otani, T | 1 |
| Hishiki, M | 1 |
| Nagahashi, M | 1 |
| Sakata, J | 2 |
| Kameyama, H | 2 |
| Hama, N | 2 |
| Maeda, S | 1 |
| Miyake, K | 1 |
| Matsusaki, K | 1 |
| Hirose, N | 1 |
| Okamoto, F | 1 |
| Kawano, T | 1 |
| Miura, O | 1 |
| Okazaki, Y | 1 |
| Toda, T | 2 |
| Minamisono, Y | 1 |
| Nagasaki, S | 1 |
| Ina, K | 5 |
| Kataoka, T | 2 |
| Takeuchi, Y | 1 |
| Fukuoka, T | 1 |
| Miwa, T | 1 |
| Nishio, T | 1 |
| Furuta, R | 1 |
| Masaki, A | 1 |
| Mori, F | 1 |
| Kayukawa, S | 1 |
| Lee, JL | 1 |
| Kang, HJ | 1 |
| Kim, JG | 1 |
| Chang, HM | 1 |
| Kim, TW | 1 |
| Baek, JH | 1 |
| Min, YJ | 1 |
| Isa, T | 1 |
| Kaneshiro, T | 1 |
| Nakachi, A | 1 |
| Teruya, T | 1 |
| Shiroma, H | 1 |
| Arakaki, K | 1 |
| Nishimaki, T | 2 |
| Otsuki, K | 1 |
| Saigo, K | 1 |
| Kenmochi, T | 2 |
| Maruyama, M | 3 |
| Akutsu, N | 1 |
| Iwashita, C | 1 |
| Sugano, N | 2 |
| Wada, H | 1 |
| Shiozawa, M | 1 |
| Akaike, M | 1 |
| Sugimasa, Y | 1 |
| Arimoto, Y | 1 |
| Nishio, K | 2 |
| Adachi, K | 1 |
| Ohba, H | 1 |
| Shintani, M | 1 |
| Yui, S | 1 |
| Matono, S | 1 |
| Horiuchi, H | 1 |
| Kishimoto, Y | 1 |
| Sasahara, H | 1 |
| Ureshino, M | 1 |
| Kashihara, M | 1 |
| Sueyoshi, S | 1 |
| Shirouzu, K | 4 |
| Kishimoto, K | 1 |
| Yoshida, S | 5 |
| Ono, T | 1 |
| Yoshihama, Y | 1 |
| Nishiyama, A | 1 |
| Sasaki, A | 1 |
| Ishiguro, H | 1 |
| Kuwabara, Y | 1 |
| Kimura, M | 1 |
| Mitsui, A | 1 |
| Ogawa, R | 1 |
| Fujii, Y | 1 |
| Iguchi, H | 3 |
| Uyama, T | 1 |
| Amatsu, H | 1 |
| Yamane, H | 2 |
| Kusuki, M | 1 |
| Nakamura, A | 2 |
| Tomimaru, Y | 1 |
| Suzuki, S | 5 |
| Hanata, K | 1 |
| Nanjo, H | 1 |
| Ishikawa, K | 2 |
| Chayahara, N | 1 |
| Yamamori, M | 1 |
| Kadowaki, Y | 1 |
| Okuno, T | 1 |
| Miki, I | 1 |
| Nishisaki, H | 2 |
| Inoue, Y | 5 |
| Okumura, K | 1 |
| Azuma, T | 2 |
| Kasuga, M | 1 |
| Sakaeda, T | 1 |
| Hirai, M | 1 |
| Takashima, S | 4 |
| Kitaya, T | 1 |
| Tokuda, Y | 1 |
| Yoshimoto, M | 1 |
| Kohno, N | 4 |
| Nakagami, K | 1 |
| Shimozuma, K | 1 |
| Sonoo, H | 3 |
| Tsuda, H | 1 |
| Sakamoto, G | 1 |
| Otani, K | 1 |
| Kamei, T | 1 |
| Soma, D | 1 |
| Miyato, H | 1 |
| Hidemura, A | 1 |
| Nagawa, H | 1 |
| Sakurai, T | 2 |
| Umemura, T | 1 |
| Jinta, E | 1 |
| Suzuma, T | 1 |
| Yoshimura, G | 1 |
| Shimizu, S | 2 |
| Kitajima, Y | 1 |
| Yakabe, T | 1 |
| Ohtsuka, T | 1 |
| Sato, S | 1 |
| Nakafusa, Y | 1 |
| Miyazaki, K | 3 |
| Sugawara, H | 1 |
| Ichiki, M | 1 |
| Sai, K | 1 |
| Ansai, M | 1 |
| Nakano, Y | 2 |
| Kawamura, M | 1 |
| Ichinose, A | 1 |
| Miyazaki, S | 2 |
| Okamura, H | 1 |
| Ichikawa, D | 2 |
| Ochiai, T | 4 |
| Sakakura, C | 1 |
| Kokuba, Y | 2 |
| Sonoyama, T | 1 |
| Fujimura, T | 3 |
| Yagi, Y | 1 |
| Niwa, T | 1 |
| Ohkawa, S | 1 |
| Amano, A | 1 |
| Masaki, T | 1 |
| Miyakawa, K | 1 |
| Qiu, MZ | 1 |
| Teng, KY | 1 |
| Ruan, DY | 1 |
| Li, YH | 1 |
| Chen, XQ | 1 |
| Pan, ZZ | 1 |
| He, YJ | 1 |
| Wan, DS | 1 |
| Xu, RH | 1 |
| Park, Y | 1 |
| Okamura, K | 2 |
| Mitsuyama, S | 1 |
| Saito, T | 2 |
| Koh, J | 1 |
| Kyono, S | 2 |
| Higaki, K | 2 |
| Ogita, M | 1 |
| Asaga, T | 1 |
| Inaji, H | 3 |
| Komichi, H | 1 |
| Tanaka, F | 1 |
| Ito, T | 2 |
| Osaki, A | 1 |
| Koyama, H | 5 |
| Saigusa, S | 2 |
| Toiyama, Y | 2 |
| Yokoe, T | 1 |
| Okugawa, Y | 2 |
| Ioue, Y | 1 |
| Miki, C | 1 |
| Kusunoki, M | 3 |
| Fujita, M | 3 |
| Sato, R | 1 |
| Iwaya, A | 1 |
| Takii, Y | 3 |
| Hatori, M | 1 |
| Ando, Y | 1 |
| Kurihara, Y | 1 |
| Takayama, S | 2 |
| Shirota, T | 1 |
| Tachikawa, T | 1 |
| Shintani, S | 2 |
| Naito, M | 1 |
| Shinohara, T | 2 |
| Ishii, F | 1 |
| Maki, K | 2 |
| Hoshino, S | 1 |
| Kang, SM | 1 |
| Tendou, M | 1 |
| Tezuka, K | 2 |
| Nishino, Y | 1 |
| Obama, K | 2 |
| Hosogi, H | 1 |
| Koizumi, W | 3 |
| Takiuchi, H | 2 |
| Muro, K | 3 |
| Komatsu, Y | 1 |
| Oya, H | 1 |
| Honda, I | 2 |
| Hirabayashi, S | 1 |
| Onishi, E | 1 |
| Nakanishi, K | 1 |
| Fukumoto, R | 1 |
| Nishi, T | 2 |
| Morioka, Y | 1 |
| Hashimoto, M | 1 |
| Nagata, J | 1 |
| Egi, H | 1 |
| Takakura, Y | 1 |
| Nakahara, H | 1 |
| Matsugu, Y | 1 |
| Kohashi, T | 1 |
| Kadoya, T | 1 |
| Ohmori, I | 1 |
| Urushihara, T | 1 |
| Itamoto, T | 1 |
| Takamura, H | 2 |
| Arita, M | 1 |
| Usui, Y | 1 |
| Okanobu, H | 1 |
| Numata, Y | 1 |
| Miwata, T | 1 |
| Yoshimi, S | 1 |
| Murakami, E | 1 |
| Ohya, T | 1 |
| Yabusaki, H | 3 |
| Nakagawa, S | 1 |
| Tsuchiya, Y | 2 |
| Otsuo, T | 1 |
| Noda, K | 1 |
| Umekita, N | 2 |
| Nasu, K | 1 |
| Inoue, S | 2 |
| Matsumura, H | 1 |
| Iwasaki, Y | 3 |
| Iwanaga, T | 4 |
| Nakano, D | 3 |
| Ami, K | 2 |
| Nagahama, T | 2 |
| Ohara, T | 1 |
| Ganno, H | 2 |
| Hataji, K | 2 |
| Kurokawa, T | 2 |
| Fukuda, A | 2 |
| Andou, M | 1 |
| Tei, S | 1 |
| Arai, K | 2 |
| Shimizu, J | 3 |
| Hayashi, S | 6 |
| Yasumoto, T | 1 |
| Zenitani, M | 1 |
| Watanabe, N | 1 |
| Takamoto, K | 1 |
| Kawanishi, K | 1 |
| Fujita, J | 2 |
| Kitada, M | 1 |
| Shimano, T | 1 |
| Kubo, H | 2 |
| Kijima, T | 1 |
| Kitahara, M | 1 |
| Tada, K | 2 |
| Miyahara, M | 1 |
| Hasegawa, H | 1 |
| Kitano, Y | 1 |
| Hatabe, S | 1 |
| Inoue, K | 2 |
| Funai, S | 1 |
| Tanaka, A | 1 |
| Kawaguchi, M | 1 |
| Asada, Y | 1 |
| Terada, T | 1 |
| Takehara, A | 1 |
| Fujisawa, K | 1 |
| Mitsui, T | 1 |
| Miura, S | 1 |
| Sudo, Y | 1 |
| Hirai, K | 4 |
| Takeyoshi, I | 2 |
| Kawate, S | 2 |
| Sunose, Y | 2 |
| Yoshinari, D | 2 |
| Totsuka, O | 2 |
| Nakanishi, H | 2 |
| Yamamura, Y | 1 |
| Kinoshita, K | 3 |
| Kondo, K | 2 |
| Kakisaka, T | 1 |
| Aiki, F | 1 |
| Matsuhisa, T | 1 |
| Hattori, A | 1 |
| Kazui, K | 1 |
| Iijimal, S | 1 |
| Handa, R | 3 |
| Ooshima, S | 1 |
| Miyake, Y | 2 |
| Hoshi, M | 2 |
| Doi, T | 5 |
| Kurokawa, E | 3 |
| Kikkawa, N | 3 |
| Terakura, M | 2 |
| Ikebe, T | 1 |
| Nishioka, T | 1 |
| Horiike, M | 1 |
| Kaneko, M | 1 |
| Aoki, Y | 1 |
| Kameda, A | 2 |
| Miyahara, E | 2 |
| Funakoshi, M | 1 |
| Hirai, T | 1 |
| Shinto, O | 1 |
| Yashiro, M | 2 |
| Kawajiri, H | 1 |
| Miwa, A | 1 |
| Hijioka, S | 1 |
| Seto, Y | 1 |
| Hatake, K | 1 |
| Kunieda, K | 2 |
| Nagao, N | 2 |
| Matsuhashi, N | 2 |
| Sasaki, Y | 4 |
| Yamada, A | 4 |
| Kanematsu, M | 2 |
| Imai, T | 4 |
| Sakuratani, T | 2 |
| Tajima, JY | 2 |
| Yanagawa, K | 1 |
| Matsunaga, N | 1 |
| Noda, S | 1 |
| Taku, K | 1 |
| Matsushita, S | 2 |
| Kawai, K | 2 |
| Mera, K | 3 |
| Ibusuki, A | 1 |
| Yoshii, N | 1 |
| Kanekura, T | 2 |
| Arai, T | 1 |
| Fukunaga, M | 2 |
| Ohsato, H | 1 |
| Sohta, Y | 1 |
| Kaze, C | 1 |
| Akazawa, N | 1 |
| Taguchi, K | 1 |
| Imai, A | 1 |
| Minato, M | 1 |
| Iwaki, H | 1 |
| Sugishita, H | 1 |
| Ishida, N | 1 |
| Sato, K | 4 |
| Tanishima, H | 1 |
| Horiuchi, T | 1 |
| Tamagawa, K | 1 |
| Tsujimoto, T | 1 |
| Miyagawa, Y | 1 |
| Ishida, K | 1 |
| Uemura, R | 1 |
| Hama, T | 1 |
| Sakaguchi, S | 1 |
| Shono, Y | 1 |
| Tsubakihara, H | 1 |
| Tabuse, K | 1 |
| Akaza, H | 1 |
| Ikemoto, I | 1 |
| Namiki, M | 1 |
| Usami, M | 2 |
| Fujimoto, H | 2 |
| Tsukamoto, T | 1 |
| Naito, S | 1 |
| Ayata, S | 1 |
| Maruyama, Y | 1 |
| Tsukada, Y | 1 |
| Ishii, S | 2 |
| Ueda, T | 1 |
| Higuchi, M | 1 |
| Mima, T | 1 |
| Yakushiji, N | 1 |
| Kao, PS | 1 |
| Chang, SC | 1 |
| Wang, LW | 1 |
| Lee, RC | 1 |
| Liang, WY | 1 |
| Lin, TC | 1 |
| Chen, WS | 1 |
| Jiang, JK | 1 |
| Wang, HS | 1 |
| Lin, JK | 1 |
| Nishikawa, A | 1 |
| Ohnishi, M | 1 |
| Tanahashi, S | 1 |
| Murai, M | 1 |
| Suzuki, E | 2 |
| Furuse, J | 2 |
| Ishii, H | 4 |
| Okusaka, T | 3 |
| Nakachi, K | 2 |
| Mitsunaga, S | 1 |
| Morizane, C | 2 |
| Yamamoto, D | 1 |
| Kanematsu, S | 1 |
| Ah, K | 1 |
| Furuichi, N | 2 |
| Yanagawa, S | 1 |
| Takakura, N | 2 |
| Aoki, H | 2 |
| Ohno, S | 2 |
| Nishizaki, M | 1 |
| Endo, W | 1 |
| Fujie, Y | 2 |
| Toyoda, Y | 1 |
| Yoshioka, S | 2 |
| Hojou, S | 1 |
| Maeura, Y | 1 |
| Irino, T | 1 |
| Okamura, A | 1 |
| Inaba, Y | 2 |
| Danno, K | 2 |
| Kagara, N | 1 |
| Kanoh, T | 2 |
| Ohnishi, T | 2 |
| Tohno, T | 1 |
| Kagawa, K | 3 |
| Monden, T | 2 |
| Imaoka, S | 3 |
| Watayo, Y | 1 |
| Amagasa, H | 1 |
| Kawasaki, N | 1 |
| Ohhinata, R | 1 |
| Maeda, Y | 2 |
| Sasaki, E | 1 |
| Hirose, H | 2 |
| Miyoshi, N | 2 |
| Kim, HM | 2 |
| Yamashita, S | 2 |
| Shingai, T | 2 |
| Kano, S | 1 |
| Gotoh, K | 1 |
| Motoori, M | 2 |
| Takahashi, H | 4 |
| Miyashiro, I | 2 |
| Ohigashi, H | 2 |
| Yano, M | 2 |
| Ishikawa, O | 2 |
| Okubo, K | 1 |
| Asukai, K | 1 |
| Maekawa, T | 1 |
| Kashiwazaki, M | 2 |
| Yano, K | 1 |
| Fujimoto, T | 2 |
| Kusumoto, M | 1 |
| Toyoda, S | 1 |
| Ishikawa, N | 2 |
| Kusumoto, C | 1 |
| Doi, F | 1 |
| Hara, F | 1 |
| Kiyoto, S | 1 |
| Takabatake, D | 1 |
| Aogi, K | 1 |
| Ohsumi, S | 1 |
| Shimane, T | 1 |
| Akiyama, R | 1 |
| Uzuki, A | 1 |
| Sugimoto, A | 1 |
| Ikenoya, Y | 1 |
| Egawa, S | 1 |
| Sanbe, T | 1 |
| Suzaki, H | 1 |
| Iwase, H | 5 |
| Shimada, M | 3 |
| Tsuzuki, T | 2 |
| Sugihara, M | 2 |
| Haruta, J | 1 |
| Shinoda, M | 2 |
| Kumada, T | 1 |
| Chiba, F | 1 |
| Shuto, C | 1 |
| Yamada, S | 2 |
| Konishi, F | 1 |
| Yasumura, S | 1 |
| Shojaku, H | 1 |
| Takakura, H | 1 |
| Fujisaka, M | 1 |
| Tsubota, M | 1 |
| Naruse, A | 1 |
| Tachino, H | 1 |
| Satoh, M | 2 |
| Nakano, O | 1 |
| Kuwahara, M | 1 |
| Ito, A | 2 |
| Arai, Y | 2 |
| Takita, M | 1 |
| Iwasaki, E | 1 |
| Hatogai, K | 1 |
| Kishino, R | 1 |
| Seki, E | 1 |
| Izumiya, M | 1 |
| Maeda, N | 1 |
| Nakazawa, A | 1 |
| Mizuki, A | 1 |
| Handa, K | 2 |
| Shimoyama, Y | 2 |
| Mukai, K | 2 |
| Higuchi, H | 1 |
| Takaishi, H | 1 |
| Hibi, T | 2 |
| Tsukada, N | 1 |
| Horie, A | 1 |
| Nomura, T | 1 |
| Iketani, S | 1 |
| Kanai, I | 1 |
| Nakatani, Y | 1 |
| Hamada, Y | 1 |
| Toriumi, F | 2 |
| Ei, S | 1 |
| Okada, R | 1 |
| Masai, K | 1 |
| Mito, M | 1 |
| Ishimaru, N | 1 |
| Mizuno, K | 1 |
| Yamanashi, T | 1 |
| Koshida, Y | 2 |
| Motegi, K | 2 |
| Tajima, T | 2 |
| Takase, Y | 1 |
| Takahashi, N | 1 |
| Toya, H | 1 |
| Hirano, T | 2 |
| Goto, T | 1 |
| Nemoto, H | 1 |
| Yokomizo, K | 1 |
| Kitamura, Y | 1 |
| Sakuraba, K | 1 |
| Soda, H | 1 |
| Matsubara, T | 2 |
| Ishibashi, K | 1 |
| Kigawa, G | 1 |
| Hibi, K | 1 |
| Dan, N | 1 |
| Tendo, M | 1 |
| Hori, T | 1 |
| Takiguchi, S | 1 |
| Miyata, H | 1 |
| Yonekura, K | 1 |
| Miyaki, A | 1 |
| Katsube, T | 2 |
| Kuhara, K | 1 |
| Usuda, A | 1 |
| Isohata, N | 1 |
| Asaka, S | 1 |
| Murayama, M | 2 |
| Naritaka, Y | 2 |
| Makino, I | 1 |
| Nakagawara, H | 1 |
| Fujita, H | 1 |
| Kitagawa, H | 1 |
| Tani, T | 1 |
| Uchida, K | 3 |
| Nakashima, A | 2 |
| Nitori, N | 1 |
| Kato, A | 1 |
| Okada, A | 1 |
| Kuroda, J | 1 |
| Kadomura, T | 1 |
| Kubota, K | 1 |
| Origuchi, N | 1 |
| Fujisaki, M | 2 |
| Kitajima, M | 3 |
| Mikayama, Y | 2 |
| Toyokawa, H | 1 |
| Yanagimoto, H | 1 |
| Kamata, M | 1 |
| Ohe, C | 1 |
| Sakaida, N | 1 |
| Kitade, H | 1 |
| Matsui, Y | 1 |
| Kwon, AH | 1 |
| Kawachi, Y | 1 |
| Kuwabara, S | 1 |
| Musha, N | 1 |
| Wakabayashi, M | 1 |
| Nakamura, H | 1 |
| Katsuta, E | 1 |
| Kaneko, J | 1 |
| Iwata, N | 1 |
| Aoyagi, H | 1 |
| Takahata, T | 2 |
| Hasegawa, K | 1 |
| Maejima, S | 1 |
| Yoneda, M | 1 |
| Komatsu, S | 1 |
| Kametaka, H | 1 |
| Koyama, T | 1 |
| Seike, K | 1 |
| Mitomo, S | 1 |
| Koeda, K | 2 |
| Chiba, T | 1 |
| Uesugi, N | 1 |
| Sugai, T | 1 |
| Wakabayashi, G | 1 |
| Minamoto, K | 1 |
| Yuasa, I | 1 |
| Inoue, T | 2 |
| Yachida, S | 2 |
| Usuki, H | 2 |
| Kimura, T | 2 |
| Hagiike, M | 2 |
| Okano, K | 2 |
| Mori, Y | 2 |
| Tamamori, Y | 1 |
| Kawakami, Y | 1 |
| Honda, Y | 1 |
| Nakahara, T | 1 |
| Naeshiro, N | 1 |
| Miyaki, D | 1 |
| Nagaoki, Y | 1 |
| Kawaoka, T | 1 |
| Takaki, S | 1 |
| Hiramatsu, A | 1 |
| Waki, K | 1 |
| Hyogo, H | 1 |
| Aikata, H | 1 |
| Arihiro, K | 1 |
| Sanetou, H | 1 |
| Chayama, K | 1 |
| Ukon, K | 1 |
| Itagaki, T | 1 |
| Teramoto, S | 1 |
| Hirata, Y | 1 |
| Sakaguchi, K | 2 |
| Takahashi, Y | 5 |
| Suito, T | 1 |
| Kameyama, Y | 1 |
| Nakayama, S | 2 |
| Hirayama, M | 1 |
| Kuroiwa, G | 1 |
| Kawano, Y | 1 |
| Takada, K | 1 |
| Miyanishi, K | 1 |
| Takimoto, R | 1 |
| Kobune, M | 1 |
| Kato, J | 1 |
| Tono, T | 1 |
| Kawabata, R | 1 |
| Fujii, C | 1 |
| Izeki, C | 1 |
| Oohinata, R | 1 |
| Oohashi, M | 1 |
| Wang, ML | 1 |
| Zhou, LY | 1 |
| Lu, XY | 1 |
| Yang, JF | 1 |
| Yu, HG | 1 |
| Maruyama, K | 2 |
| Furukawa, J | 2 |
| Maruyama, N | 2 |
| Tanaka, J | 2 |
| Katsumoto, Y | 2 |
| Nakaguchi, K | 2 |
| Sue, F | 2 |
| Yoshihara, W | 2 |
| Hara, A | 3 |
| Harada, T | 3 |
| Tsunematu, I | 1 |
| Izumi, N | 2 |
| Iwamoto, S | 2 |
| Satake, K | 2 |
| Miyazaki, H | 1 |
| Shiomi, T | 2 |
| Yano, T | 3 |
| Ono, H | 1 |
| Sato, M | 2 |
| Ohchi, T | 1 |
| Kudo, S | 1 |
| Ogata, K | 1 |
| Koga, Y | 1 |
| Ishiodori, H | 1 |
| Ishihara, A | 1 |
| Hoshi, S | 1 |
| Ohyama, C | 1 |
| Namiki, S | 1 |
| Hagisawa, S | 1 |
| Saito, S | 2 |
| Shirasaka, T | 2 |
| Iyo, T | 2 |
| Nakarai, K | 3 |
| Kaida, S | 3 |
| Indo, T | 2 |
| Okeya, M | 2 |
| Kusugami, K | 2 |
| Yang, TS | 1 |
| Hsu, KC | 1 |
| Chen, JS | 1 |
| Imamura, Y | 1 |
| Baba, Y | 2 |
| Tahara, K | 1 |
| Kubozono, O | 1 |
| Ogura, Y | 1 |
| Maenohara, S | 1 |
| Moriya, H | 1 |
| Uchida, Y | 1 |
| Denno, R | 1 |
| Kanai, M | 1 |
| Takabayashi, A | 1 |
| Sadahiro, S | 2 |
| Saguchi, T | 1 |
| Yasuda, S | 2 |
| Makuuchi, H | 2 |
| Murayama, C | 1 |
| Shimizu, C | 1 |
| Ohta, K | 2 |
| Ohyama, S | 1 |
| Itoh, H | 1 |
| Ii, T | 1 |
| Takegawa, S | 2 |
| Kiriyama, M | 1 |
| Dohba, S | 1 |
| Kojima, Y | 2 |
| Sunami, K | 1 |
| Takayama, M | 1 |
| Niki, T | 1 |
| Inoue, H | 1 |
| Hamano, K | 1 |
| Okutani, T | 1 |
| Hirohata, S | 1 |
| Nakashima, T | 1 |
| Yasutake, K | 1 |
| Sashikata, T | 1 |
| Tsukahara, A | 3 |
| Nikkuni, K | 1 |
| Kokai, H | 1 |
| Iwabuchi, M | 1 |
| Imai, G | 1 |
| Yokoyama, H | 1 |
| Mochida, A | 1 |
| Shiina, M | 1 |
| Yamada, K | 1 |
| Ishibashi, J | 1 |
| Chida, N | 1 |
| Tadokoro, K | 1 |
| Inaba, S | 1 |
| Matsushita, Y | 1 |
| Araki, Y | 1 |
| Ogino, A | 1 |
| Yamada, E | 1 |
| Matsuyama, T | 1 |
| Koyama, M | 1 |
| Watabe, S | 1 |
| Tsuge, T | 1 |
| Kamio, Y | 1 |
| Chiba, M | 1 |
| Matsuyama, S | 1 |
| Takei, M | 1 |
| Kido, S | 1 |
| Magata, S | 1 |
| Motoyama, K | 1 |
| Kitahara, K | 1 |
| Takahashi, I | 1 |
| Kakeji, Y | 1 |
| Emi, Y | 1 |
| Sakurai, M | 1 |
| Yonemura, Y | 4 |
| Endo, K | 1 |
| Ikeda, Y | 2 |
| Toh, Y | 1 |
| Kohnoe, S | 1 |
| Okamura, T | 3 |
| Kawai, H | 1 |
| Ohtsu, A | 2 |
| Hamamoto, Y | 1 |
| Nagashima, F | 1 |
| Muto, M | 2 |
| Sano, Y | 2 |
| Kobayashi, O | 2 |
| Sairenji, M | 3 |
| Motohashi, H | 1 |
| Imada, T | 2 |
| Ishimura, K | 1 |
| Izuishi, K | 1 |
| Karasawa, Y | 1 |
| Goda, F | 1 |
| Maeta, H | 1 |
| Kaibara, N | 2 |
| Takagane, A | 2 |
| Abe, K | 1 |
| Irinoda, T | 3 |
| Nakaya, T | 1 |
| Yonezawa, H | 1 |
| Saito, K | 3 |
| Kanzaki, N | 1 |
| Ohtani, S | 1 |
| Nemoto, T | 1 |
| Hoshino, Y | 2 |
| Kogure, M | 2 |
| Miyagawa, K | 1 |
| Mitachi, Y | 2 |
| Masuda, T | 2 |
| Oogoshi, T | 1 |
| Sakai, W | 1 |
| Imazu, H | 1 |
| Yoshida, I | 1 |
| Tonomura, S | 1 |
| Nozoe, Y | 2 |
| Sakurai, Y | 1 |
| Ochiai, M | 1 |
| Morifuji, M | 2 |
| Kanehiro, T | 1 |
| Sasaki, M | 2 |
| Meguro, E | 2 |
| Kaizuka, H | 1 |
| Inaba, T | 1 |
| Hayakawa, Y | 2 |
| Okada, S | 2 |
| Wakabayashi, J | 1 |
| Kuramochi, H | 2 |
| Tenma, N | 1 |
| Kawami, H | 1 |
| Shigematsu, H | 1 |
| Fujimoto, Y | 1 |
| Nomura, K | 3 |
| Oota, H | 1 |
| Kamimura, T | 1 |
| Masuda, H | 1 |
| Karube, H | 1 |
| Ookame, H | 1 |
| Sakamoto, N | 1 |
| Koizumi, Y | 1 |
| Tomita, M | 2 |
| Obata, H | 1 |
| Nakajo, S | 1 |
| Tanaka, O | 2 |
| Nabeshima, K | 1 |
| Soeda, J | 1 |
| Kondo, Y | 1 |
| Ogoshi, K | 1 |
| Akaiwa, J | 1 |
| Nakao, K | 3 |
| Koishi, K | 1 |
| Nishizaki, K | 1 |
| Ooiwa, N | 1 |
| Yamamura, T | 2 |
| Esumi, K | 1 |
| Masuda, N | 2 |
| Ishida, H | 2 |
| Masutani, S | 1 |
| Tatsuta, M | 1 |
| Kawasaki, T | 1 |
| Iijima, S | 3 |
| Naoi, Y | 1 |
| Ohshima, S | 1 |
| Yoshihara, T | 1 |
| Fujita, T | 2 |
| Nishi, H | 1 |
| Takao, T | 1 |
| Mano, M | 1 |
| Komatsubara, S | 1 |
| Konishi, N | 1 |
| Ohmori, Y | 1 |
| Mohri, Y | 1 |
| Tonouchi, H | 1 |
| Akiba, Y | 1 |
| Otani, Y | 4 |
| Kumai, K | 2 |
| Akagi, Y | 3 |
| Ito, K | 2 |
| Hino, S | 1 |
| Nonaka, T | 1 |
| Hara, S | 2 |
| Hamakawa, H | 1 |
| Kajikawa, H | 1 |
| Nario, K | 1 |
| Miyahara, H | 1 |
| Rubio Suárez, A | 1 |
| Teigeiro Núñez, V | 1 |
| Gallo Terán, J | 1 |
| Señaris González, B | 1 |
| Mesuro Domínguez, N | 1 |
| Watanabe, O | 1 |
| Okabe, T | 1 |
| Haga, S | 1 |
| Doi, R | 1 |
| Tokuhara, T | 1 |
| Michigami, S | 1 |
| Yada, K | 1 |
| Hibuse, Y | 1 |
| Ogawa, Y | 2 |
| Takashima, T | 4 |
| Kashiwagi, K | 1 |
| Inoue, D | 1 |
| Shibuya, H | 1 |
| Hirata, K | 2 |
| Yajima, T | 1 |
| Furukawa, Y | 1 |
| Hattori, Y | 1 |
| Yamaoka, Y | 1 |
| Fujihara, M | 1 |
| Kuniki, H | 1 |
| Hoshimoto, S | 1 |
| Hagiuda, J | 1 |
| Igarashi, N | 1 |
| Matsui, H | 2 |
| Koyama, Y | 2 |
| Miyakita, M | 1 |
| Takanosu, S | 1 |
| Tatsuzawa, Y | 2 |
| Kawaura, Y | 2 |
| Yasutomo, N | 1 |
| Kawabata, M | 1 |
| Katsura, H | 1 |
| Sakao, J | 2 |
| Yokotani, H | 1 |
| Souda, S | 2 |
| Yajima, H | 1 |
| Kusuyama, A | 1 |
| Nagayama, A | 1 |
| Anazawa, S | 1 |
| Yanaga, K | 2 |
| Aoyagi, K | 1 |
| Koufuji, K | 1 |
| Miyagi, M | 1 |
| Imaizumi, T | 1 |
| Takeda, J | 1 |
| Mishima, H | 1 |
| Ikenaga, M | 2 |
| Sawamura, T | 1 |
| Takiyama, W | 1 |
| Mukaida, H | 1 |
| Konno, S | 1 |
| Obu, M | 1 |
| Hamaguchi, K | 1 |
| Shimakawa, T | 1 |
| Yagawa, Y | 1 |
| Aiba, M | 1 |
| Kaneko, K | 2 |
| Watanabe, A | 4 |
| Ishikawa, H | 5 |
| Ohyama, T | 2 |
| Niimi, Y | 1 |
| Woo, IS | 1 |
| Moon, DH | 1 |
| Shim, BY | 1 |
| Lee, MA | 1 |
| Byun, JH | 1 |
| Kim, KW | 1 |
| Kang, JH | 1 |
| Chung, IS | 1 |
| Hong, YS | 1 |
| Park, SY | 1 |
| Lee, KS | 1 |
| Yunotani, S | 2 |
| Noguchi, R | 1 |
| Shinozaki, Y | 1 |
| Tani, H | 1 |
| Sakai, M | 2 |
| Ishimitsu, T | 1 |
| Tabuchi, M | 1 |
| Hihara, J | 1 |
| Hamai, Y | 1 |
| Taomoto, J | 1 |
| Toge, T | 3 |
| Deguchi, Y | 1 |
| Shioya, M | 1 |
| Takenaka, K | 1 |
| Doi, H | 1 |
| Komai, Y | 1 |
| Higuchi, A | 1 |
| Abe, N | 1 |
| Sugiyama, M | 1 |
| Atomi, Y | 1 |
| Muneoka, K | 2 |
| Shirai, Y | 3 |
| Yokoyama, N | 2 |
| Okumura, S | 3 |
| Hatakeyama, K | 2 |
| Ogino, H | 1 |
| Misawa, T | 1 |
| Nasu, T | 1 |
| Ihara, Y | 1 |
| Kubo, S | 1 |
| Sadamoto, Y | 1 |
| Mizuno, I | 1 |
| Mohri, N | 1 |
| Fukaya, S | 1 |
| Shinagawa, N | 1 |
| Manabe, T | 2 |
| Mitomi, T | 1 |
| Noto, T | 1 |
| Kumada, K | 1 |
| Hiki, Y | 1 |
| Yamakawa, T | 1 |
| Amano, T | 1 |
| Oki, S | 1 |
| Oka, H | 1 |
| Takemiya, S | 1 |
| Nishiyama, K | 1 |
| Ogawa, N | 1 |
| Nakata, B | 3 |
| Sawada, T | 1 |
| Mizukami, Y | 1 |
| Suzuki, M | 1 |
| Niimi, K | 1 |
| Nagashima, T | 1 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Hotokezaka, M | 1 |
| Iwamura, T | 1 |
| Chijiiwa, K | 1 |
| Seo, S | 1 |
| Miki, A | 1 |
| Kitai, T | 1 |
| Ino, K | 1 |
| Higashiyama, H | 1 |
| Ukikusa, M | 1 |
| Waseda, R | 1 |
| Ohtake, Y | 1 |
| Ogata, Y | 2 |
| Matono, K | 2 |
| Sasatomi, T | 2 |
| Ishibashi, N | 1 |
| Ohkita, A | 1 |
| Mizobe, T | 1 |
| Ogo, S | 1 |
| Ikeda, S | 2 |
| Nakamura, R | 1 |
| Akatsu, Y | 1 |
| Shioiri, T | 1 |
| Kusano, T | 1 |
| Kitamura, M | 1 |
| Warabi, M | 1 |
| Mitsuhashi, M | 1 |
| Aratake, K | 1 |
| Ogawa, S | 1 |
| Itabashi, M | 1 |
| Shirotani, N | 1 |
| Kameoka, S | 1 |
| Ishihara, C | 1 |
| Shotsu, M | 1 |
| Ishiwa, N | 1 |
| Takeda, A | 1 |
| Ogoshi, T | 1 |
| Ishiguro, A | 3 |
| Munakata, M | 4 |
| Sakata, Y | 4 |
| Mizuno, Y | 1 |
| Naito, H | 1 |
| Mino, K | 1 |
| Shibazaki, W | 1 |
| Minagawa, N | 1 |
| Orimo, T | 1 |
| Ichimura, W | 1 |
| Murakami, N | 1 |
| Bandou, H | 1 |
| Morita, K | 2 |
| Koizumi, H | 1 |
| Yoshino, H | 1 |
| Tawaraya, K | 1 |
| Ishiguro, K | 1 |
| Tanemura, H | 1 |
| Oshita, H | 1 |
| Kanno, A | 1 |
| Kusakabe, M | 1 |
| Hatoh, T | 1 |
| Yamada, M | 1 |
| Adachi, T | 1 |
| Tomita, E | 1 |
| Sugiyama, A | 3 |
| Ishigami, S | 2 |
| Aridome, K | 2 |
| Nakajo, A | 1 |
| Okumura, H | 1 |
| Hokita, S | 2 |
| Natsugoe, S | 2 |
| Aikou, T | 2 |
| Ikawa, S | 1 |
| Kubota, D | 1 |
| Katsuragi, K | 1 |
| Ohba, K | 1 |
| I, S | 1 |
| Matsuyama, M | 1 |
| Jingu, K | 1 |
| Sasagawa, K | 1 |
| Kagaya, A | 1 |
| Itoh, K | 1 |
| Minami, H | 2 |
| Ito, N | 1 |
| Matsui, W | 1 |
| Inagaki, J | 1 |
| Miki, H | 1 |
| Kittaka, N | 1 |
| Aihara, T | 1 |
| Sugimoto, K | 1 |
| Takatsuka, Y | 1 |
| Nakanome, A | 1 |
| Shiga, K | 1 |
| Sagai, S | 1 |
| Kameyama, S | 1 |
| Murayama, R | 1 |
| Miyazato, K | 1 |
| Kurashita, K | 1 |
| Ishimine, T | 1 |
| Nagamine, Y | 1 |
| Kohakura, F | 1 |
| Shinzato, S | 1 |
| Tomimori, K | 1 |
| Kugai, Y | 1 |
| Uchima, H | 1 |
| Ohnuma, M | 1 |
| Uchiyama, T | 1 |
| Kamiyama, Y | 1 |
| Ise, H | 1 |
| Aranda, E | 1 |
| Abad, A | 1 |
| Carrato, A | 1 |
| Cervantes, A | 1 |
| Tabernero, J | 1 |
| Díaz-Rubio, E | 1 |
| Uyama, R | 1 |
| Yoshizawa, Y | 1 |
| Tajiri, T | 4 |
| Endo, Y | 1 |
| Mitsuya, T | 1 |
| Sanada, Y | 1 |
| Tsunezuka, Y | 1 |
| Oda, M | 1 |
| Moriyama, H | 1 |
| Nagata, N | 1 |
| Oba, K | 1 |
| Sugiyama, Y | 1 |
| Hayashidani, Y | 1 |
| Sudo, A | 1 |
| Shirakawa, T | 1 |
| Yokoi, K | 2 |
| Seya, T | 1 |
| Horiba, K | 1 |
| Kanazawa, Y | 1 |
| Okawa, K | 1 |
| Yoshioka, M | 1 |
| Oaki, Y | 1 |
| Tokunaga, A | 2 |
| Ishizuka, T | 1 |
| Yoshiyasu, M | 1 |
| Yanagi, K | 1 |
| Bando, K | 1 |
| Sunagozaka, H | 1 |
| Yamashita, T | 1 |
| Kagaya, T | 1 |
| Kaneko, S | 2 |
| Kurita, H | 1 |
| Koike, T | 1 |
| Miyazawa, H | 1 |
| Kurashina, K | 1 |
| Anegawa, G | 1 |
| Ohta, R | 1 |
| Kai, T | 1 |
| Anai, H | 1 |
| Yokoyama, S | 1 |
| Tsunoda, A | 1 |
| Kamiyama, G | 1 |
| Narita, K | 1 |
| Suzuki, N | 1 |
| Oonaka, T | 1 |
| Kusano, M | 1 |
| Kamisawa, H | 1 |
| Sasaki, S | 1 |
| Hayashi, Y | 1 |
| Kohri, K | 1 |
| Yamada, R | 1 |
| Hatori, S | 1 |
| Makino, T | 1 |
| Yamazaki, Y | 1 |
| Takanashi, Y | 1 |
| Kawasaki, K | 1 |
| Kamigaki, T | 1 |
| Takase, S | 1 |
| Shirasaka, D | 1 |
| Shinoda, H | 1 |
| Kuroda, D | 2 |
| Kuroda, Y | 1 |
| Wakakuwa, R | 1 |
| Nakajima, H | 1 |
| Mizuta, N | 1 |
| Mizuta, M | 1 |
| Nakatsukasa, K | 1 |
| Hachimine, Y | 1 |
| Fujiwara, I | 1 |
| Sawai, K | 1 |
| Kawamura, S | 1 |
| Yamagishi, D | 1 |
| Sumi, Y | 1 |
| Shimada, E | 1 |
| Sumida, Y | 1 |
| Kondou, M | 1 |
| Hashizume, S | 1 |
| Tokunaga, T | 1 |
| Kamohara, R | 1 |
| Matsutani, T | 1 |
| Egami, K | 1 |
| Sasajima, K | 1 |
| Maruyama, H | 1 |
| Miyamoto, M | 1 |
| Maruta, F | 1 |
| Koide, N | 1 |
| Miyagawa, S | 1 |
| Sakai, K | 2 |
| Oka, T | 1 |
| Ozawa, K | 1 |
| Saito, Y | 3 |
| Senoo, T | 2 |
| Taguchi, T | 5 |
| Terasawa, T | 3 |
| Mori, T | 1 |
| Oshima, A | 1 |
| Kasai, M | 1 |
| Funakoshi, A | 2 |
| Senju, T | 1 |
| Sumii, T | 2 |
| Jeung, HC | 1 |
| Rha, SY | 1 |
| Cho, BC | 1 |
| Yoo, NC | 1 |
| Roh, JK | 1 |
| Roh, WJ | 1 |
| Chung, HC | 1 |
| Ahn, JB | 1 |
| Obuchi, T | 1 |
| Sugimura, Y | 1 |
| Hatakeyama, G | 1 |
| Hosoi, Y | 1 |
| Seshimo, I | 1 |
| Ezumi, K | 1 |
| Takayama, O | 1 |
| Hirota, S | 1 |
| Monden, M | 1 |
| Nishiura, H | 1 |
| Ishii, K | 1 |
| Nonami, M | 1 |
| Shigemori, M | 1 |
| Katsurada, A | 1 |
| Azechi, H | 1 |
| Kondo, M | 2 |
| Tojo, M | 1 |
| Asagoe, K | 1 |
| Inoue, F | 1 |
| Suwa, H | 2 |
| Saiga, T | 1 |
| Kitano, M | 2 |
| Doi, M | 2 |
| Shimizu, M | 2 |
| Yoshii, H | 2 |
| Tambo, Y | 1 |
| Kasahara, K | 1 |
| Fujimura, M | 1 |
| Tamori, S | 1 |
| Araya, T | 1 |
| Sone, T | 1 |
| Nakao, S | 1 |
| Noda, Y | 3 |
| Matsumoto, Y | 1 |
| Hioki, J | 1 |
| Chinen, T | 1 |
| Nakachi, N | 1 |
| Nakamoto, M | 2 |
| Uchima, N | 1 |
| Hirata, T | 1 |
| Hokama, A | 2 |
| Kinjo, N | 1 |
| Kinjo, F | 1 |
| Nakatani, K | 1 |
| Nishimura, K | 2 |
| Shimoda, T | 1 |
| Azuma, M | 2 |
| Katada, C | 1 |
| Higuchi, K | 1 |
| Saigenji, K | 1 |
| Idelevich, E | 1 |
| Karminsky, N | 1 |
| Dinerman, M | 1 |
| Katsenelson, RL | 1 |
| Zvi, NB | 1 |
| Baruch, NB | 1 |
| Biran, H | 1 |
| Man, S | 1 |
| Shani, A | 1 |
| Nakajima, G | 1 |
| Harada, K | 1 |
| Kawashima, Y | 3 |
| Uchida, D | 1 |
| Koga, M | 1 |
| Kamitani, T | 1 |
| Futami, K | 3 |
| Arima, S | 4 |
| Sakamoto, C | 1 |
| Karimata, H | 1 |
| Nagahama, M | 1 |
| Akamatsu, M | 1 |
| Teruya, J | 1 |
| Takaesu, H | 1 |
| Itoh, J | 2 |
| Aoki, M | 1 |
| Munakata, A | 1 |
| Murayama, T | 1 |
| Toeda, H | 1 |
| Imazu, Y | 1 |
| Ooyama, R | 1 |
| Seike, J | 1 |
| Honda, J | 1 |
| Miyoshi, T | 2 |
| Umemoto, A | 1 |
| Tangoku, A | 1 |
| Mimatsu, K | 1 |
| Kawasaki, A | 1 |
| Oida, T | 1 |
| Aramaki, O | 1 |
| Kuboi, Y | 1 |
| Kano, H | 1 |
| Ogura, M | 1 |
| Hoshi, K | 1 |
| Kanbara, T | 1 |
| Kawasaki, Y | 1 |
| Namima, T | 1 |
| Ohnuma, T | 1 |
| Sou, K | 1 |
| Saze, Z | 1 |
| Otani, S | 1 |
| Soeta, N | 1 |
| Kashimura, S | 1 |
| Osuka, F | 1 |
| Odashima, Y | 1 |
| Tokita, H | 1 |
| Kato, F | 1 |
| Ohta, H | 1 |
| Okuda, T | 2 |
| Fujimi, A | 1 |
| Kanisawa, Y | 1 |
| Izumi, K | 1 |
| Kitahara, T | 2 |
| Matsuya, H | 1 |
| Kawasaki, H | 1 |
| Shibata, S | 1 |
| Miyamoto, K | 1 |
| Kijima, H | 1 |
| Yoshino, M | 1 |
| Kinoshita, T | 1 |
| Fujiya, T | 1 |
| Inada, T | 1 |
| Mizutani, S | 1 |
| Uchikoshi, F | 1 |
| Yoshidome, K | 1 |
| Tori, M | 1 |
| Ueshima, S | 1 |
| Yamagami, Y | 1 |
| Nakahara, M | 1 |
| Teraishi, F | 1 |
| Chikuba, A | 1 |
| Nezu, M | 1 |
| Shimamura, H | 1 |
| Takiue, T | 1 |
| Chikuba, H | 1 |
| Tazawa, K | 1 |
| Matsui, K | 1 |
| Shinbo, M | 1 |
| Yamagishi, F | 1 |
| Tsukada, K | 1 |
| Choi, YJ | 1 |
| Chung, JS | 1 |
| Shin, HJ | 1 |
| Cho, GJ | 1 |
| Wang, SG | 1 |
| Lee, BJ | 1 |
| Cho, BM | 1 |
| Joo, YD | 1 |
| Sohn, CH | 1 |
| Sawaki, A | 1 |
| Mizuno, N | 1 |
| Hoki, N | 1 |
| Takagi, T | 1 |
| Yamao, K | 1 |
| Saji, S | 1 |
| Sekine, K | 1 |
| Ogino, T | 2 |
| Seki, Y | 1 |
| Goto, K | 1 |
| Eguchi, H | 1 |
| Tomita, H | 2 |
| Oshima, S | 1 |
| Narahara, H | 1 |
| Shimokawa, T | 1 |
| Tsuji, Y | 1 |
| Abe, S | 1 |
| Tamura, F | 1 |
| Nagashima, H | 1 |
| Oura, K | 1 |
| Kukitsu, T | 1 |
| Yoshizaki, N | 1 |
| Edsmyr, F | 1 |
| Andersson, L | 1 |
| Esposti, PL | 1 |
| Machida, T | 1 |
| Ikeuchi, H | 1 |
| Miura, Y | 1 |
| Akiyama, J | 1 |
| Sagara, Y | 1 |
| Tajiri, H | 2 |
| Yoshimori, M | 1 |
| Hijikata, A | 1 |
| Ozaki, H | 1 |
| Itoh, S | 1 |
| Konishi, Y | 1 |
| Harauchi, D | 1 |
| Shinoto, M | 1 |
| Ueki, M | 1 |
| Takagi, K | 1 |
| Kuno, K | 1 |
| Kajitani, T | 2 |
| Inokuchi, K | 2 |
| Kodama, Y | 1 |
| Kano, T | 2 |
| Tamada, R | 2 |
| Kumashiro, R | 1 |
| Suemasu, K | 1 |
| Nomoto, C | 1 |
| Moriyama, A | 1 |
| Murata, I | 2 |
| Kuroda, T | 1 |
| Yoshikawa, I | 1 |
| Tabaru, A | 1 |
| Ogami, Y | 1 |
| Otsuki, M | 1 |
| Koja, S | 2 |
| Itokazu, T | 2 |
| Maeshiro, N | 2 |
| Matsumura, J | 1 |
| Kochi, A | 1 |
| Kunii, Y | 2 |
| Kikuchi, K | 3 |
| Kurebayashi, J | 2 |
| Morise, K | 2 |
| Kaneko, H | 1 |
| Horiuchi, Y | 1 |
| Kuroiwa, A | 1 |
| Suga, S | 1 |
| Oka, Y | 1 |
| Yoshida, Y | 1 |
| Matsuda, R | 1 |
| Takatsuki, H | 1 |
| Shimahara, Y | 1 |
| Kobayashi, N | 2 |
| Hayakawa, M | 1 |
| Morooka, Y | 1 |
| Hattori, T | 2 |
| Kusama, M | 1 |
| Koyanagi, Y | 1 |
| Ebihara, Y | 1 |
| Arima, M | 1 |
| Matsunaga, T | 1 |
| Kamiya, S | 1 |
| Yamauchi, M | 1 |
| Esu, H | 1 |
| Simoji, Y | 1 |
| Kanazawa, T | 1 |
| Kawahara, H | 1 |
| Ashikaga, K | 1 |
| Kimura, C | 1 |
| Kuroda, H | 1 |
| Ono, M | 1 |
| Abe, R | 2 |
| Tsuchiya, A | 1 |
| Koie, H | 1 |
| Abo, S | 1 |
| Tsukamoto, M | 1 |
| Kotoh, T | 1 |
| Haraguchi, M | 1 |
| Tsuboi, S | 1 |
| Fukano, M | 1 |
| Eguchi, A | 1 |
| Iwao, Y | 1 |
| Furuta, T | 1 |
| Tadaoka, N | 1 |
| Sekine, C | 1 |
| Fujimori, T | 1 |
| Nimura, H | 1 |
| Tsutsumi, J | 1 |
| Kashimura, H | 1 |
| Itaya, S | 1 |
| Tsuge, I | 1 |
| Matsuda, T | 1 |
| Motai, H | 1 |
| Shimada, J | 1 |
| Baba, S | 1 |
| Tenma, K | 1 |
| Masaoka, T | 1 |
| Kato, M | 2 |
| Sawa, T | 3 |
| Yoshimitsu, S | 1 |
| Tomita, F | 1 |
| Takano, Y | 2 |
| Miyazaki, I | 3 |
| Kajanti, MJ | 1 |
| Pyrhönen, SO | 1 |
| Maiche, AG | 1 |
| Somekawa, Y | 1 |
| Asano, K | 1 |
| Taira, A | 2 |
| Imai, R | 1 |
| Ohkuwa, M | 1 |
| Kusada, O | 1 |
| Ueda, N | 1 |
| Yoshimitsu, Y | 1 |
| Ohta, N | 1 |
| Kadoya, N | 1 |
| Hirosawa, H | 1 |
| Konishi, I | 2 |
| Izumi, R | 1 |
| Hirono, T | 1 |
| Kogure, A | 1 |
| Kakefuda, T | 1 |
| Aiura, K | 1 |
| Arisawa, Y | 1 |
| Shirasugi, N | 1 |
| Noga, K | 1 |
| Watanabe, S | 1 |
| Fujita, Y | 3 |
| Mitsuishi, K | 1 |
| Umeno, T | 1 |
| Fuchino, Y | 1 |
| Tomita, A | 1 |
| Tsukagoshi, S | 1 |
| Motomura, K | 1 |
| Noguchi, S | 1 |
| Muramoto, M | 1 |
| Matsugaki, K | 1 |
| Ogino, K | 1 |
| Inukai, A | 1 |
| Akao, M | 1 |
| Kudo, T | 1 |
| Ebuchi, M | 1 |
| Inuyama, Y | 2 |
| Kida, A | 2 |
| Tsukuda, M | 2 |
| Satake, B | 2 |
| Nakagawachi, T | 1 |
| Samejima, R | 1 |
| Yonemitsu, N | 1 |
| Eguchi, T | 1 |
| Nukatsuka, M | 1 |
| Fujioka, A | 1 |
| Takeda, S | 1 |
| Unemi, N | 1 |
| Fukumori, H | 1 |
| Kurosumi, M | 1 |
| Dickson, RB | 1 |
| Naito, Y | 1 |
| Yoshizawa, M | 1 |
| Ohtake, K | 1 |
| Saku, T | 1 |
| Futagami, F | 1 |
| Iguchi, C | 1 |
| Nio, Y | 1 |
| Watanabe, H | 1 |
| Ohishi, T | 1 |
| Abe, M | 1 |
| Sumi, S | 1 |
| Takai, S | 1 |
| Taki, S | 1 |
| Fujino, R | 1 |
| Oshita, M | 1 |
| Otsuka, T | 1 |
| Hirose, Y | 1 |
| Sumitomo, M | 1 |
| Hayashi, N | 1 |
| Nagano, T | 1 |
| Matsumura, M | 1 |
| Horinaga, M | 1 |
| Kosugi, M | 1 |
| Ikeuchi, K | 1 |
| Palangié, T | 1 |
| Pierga, JY | 1 |
| Pouillart, P | 1 |
| Ohsawa, H | 1 |
| Aiba, K | 1 |
| Sugiyama, K | 1 |
| Mizunuma, N | 1 |
| Horikoshi, N | 1 |
| Takemura, T | 1 |
| Sadou, S | 1 |
| Nishinuma, T | 1 |
| Tsurui, H | 1 |
| Nakano, H | 1 |
| Matsusaka, T | 1 |
| Wakasugi, K | 1 |
| Yamamura, S | 1 |
| Sonoda, K | 1 |
| Kume, K | 1 |
| Tamura, H | 1 |
| Ando, J | 1 |
| Oka, S | 1 |
| Imoto, S | 1 |
| Tokunaga, Y | 1 |
| Kitaoka, A | 1 |
| Yagi, T | 1 |
| Ohsumi, K | 1 |
| Ogisawa, K | 1 |
| Nagatsuka, I | 1 |
| Matsumura, Y | 1 |
| Onoda, N | 1 |
| Miyagawa, T | 1 |
| Toyoda, H | 1 |
| Uesato, K | 1 |
| Asanuma, F | 1 |
| Ohsaku, M | 1 |
| Kaneo, K | 1 |
| Yasuda, K | 1 |
| Yamamori, T | 1 |
| Misawa, K | 1 |
| Ohashi, H | 1 |
| Nonomura, N | 1 |
| Ono, Y | 1 |
| Nozawa, M | 1 |
| Fukui, T | 1 |
| Imazu, T | 1 |
| Takaha, N | 1 |
| Sugao, H | 2 |
| Miki, T | 1 |
| Okuyama, A | 1 |
| Onoda, T | 1 |
| Miyagi, Y | 2 |
| Tsutsumi, S | 1 |
| Kuwano, H | 1 |
| Morinaga, N | 1 |
| Shimura, T | 1 |
| Asao, T | 1 |
| Hiraiwa, A | 1 |
| Morishita, M | 1 |
| Yagi, S | 1 |
| Yoriki, R | 1 |
| Sado, S | 1 |
| Kusumoto, Y | 1 |
| Tamaki, H | 1 |
| Hongo, S | 1 |
| Ishikura, H | 1 |
| Kinoshita, H | 1 |
| Fujino, H | 1 |
| Monden, Y | 1 |
| Yokota, M | 1 |
| Ouchi, J | 1 |
| Matsuo, S | 1 |
| Uchimura, K | 1 |
| Shimoda, S | 1 |
| Takeda, N | 1 |
| Koyama, S | 1 |
| Tsuchiya, K | 1 |
| Takemura, N | 1 |
| Osaka, Y | 1 |
| Sako, H | 1 |
| Ioka, Z | 1 |
| Nakane, Y | 1 |
| Morikawa, A | 1 |
| Okabe, R | 1 |
| Miyazawa, K | 1 |
| Ozaki, K | 1 |
| Kuriyama, H | 1 |
| Liu, J | 1 |
| Ikeguchi, M | 1 |
| Nakamura, S | 1 |
| Yamasaki, K | 1 |
| Morikawa, S | 1 |
| Ohnita, K | 1 |
| Taura, K | 1 |
| Isomoto, H | 1 |
| Mizuta, Y | 1 |
| Murase, K | 1 |
| Kohno, S | 1 |
| Takemura, M | 1 |
| Ohta, Y | 1 |
| Shuto, T | 1 |
| Takemura, S | 1 |
| Kitade, F | 1 |
| Sekimoto, T | 1 |
| Yagi, A | 1 |
| Sakuramoto, K | 2 |
| Osawa, N | 1 |
| Okajima, K | 3 |
| Onda, M | 1 |
| Teramoto, T | 1 |
| Fujita, I | 1 |
| Mizutani, T | 1 |
| Kiyama, T | 1 |
| Nishi, K | 1 |
| Okazaki, S | 1 |
| Muraoka, K | 1 |
| Nakai, M | 1 |
| Tsugawa, K | 1 |
| Segawa, M | 1 |
| Hamabe, Y | 1 |
| Ikuta, H | 1 |
| Osawa, M | 1 |
| Katoh, M | 1 |
| Saitoh, Y | 2 |
| Takiguchi, N | 2 |
| Fujii, T | 1 |
| Yokomori, T | 1 |
| Hisatsugu, T | 1 |
| Ohkuma, R | 1 |
| Ohsato, K | 1 |
| Fukuyama, N | 1 |
| Yamanouchi, A | 1 |
| Hasegawa, Y | 1 |
| Honnma, S | 1 |
| Takanashi, K | 1 |
| Nakagoe, T | 1 |
| Eida, K | 1 |
| Tobinaga, K | 1 |
| Kotake, Y | 1 |
| Nogawa, T | 1 |
| Sarashina, H | 1 |
| Nunomura, M | 1 |
| Oda, N | 1 |
| Omori, T | 1 |
| Okui, K | 1 |
| Adachi, M | 1 |
| Kobori, O | 1 |
| Ota, J | 1 |
| Sugimoto, T | 1 |
| Ooi, A | 1 |
| Mai, M | 1 |
| Deguchi, S | 1 |
| Kurihara, K | 1 |
| Muto, Y | 1 |
| Sagawa, M | 1 |
| Nagamoto, N | 1 |
| Usuda, K | 1 |
| Ohta, S | 1 |
| Kanma, K | 1 |
| Namba, M | 1 |
| Muto, K | 1 |
| Ikeguchi, S | 1 |
| Shida, S | 1 |
| Nakano, E | 1 |
| Iwasaki, A | 1 |
| Seguchi, T | 1 |
| Yoshioka, T | 1 |
| Tada, Y | 1 |
| Matsuda, M | 1 |
| Sonoda, T | 1 |
| Korenaga, D | 1 |
| Saito, A | 1 |
| Sugimachi, K | 1 |
| Sinmyo, K | 1 |
| Hosoi, H | 1 |
| Kitagawa, M | 1 |
| Susaki, H | 1 |
| Yoshimura, S | 1 |
| Shimura, H | 1 |
| Iga, C | 1 |
| Kousaki, G | 1 |
| Iwasa, Z | 1 |
| Utsunomiya, J | 1 |
| Okamoto, E | 1 |
| Kawahara, T | 1 |
| Sugawa, T | 1 |
| Nomoto, K | 1 |
| Tsuru, S | 1 |
| Awane, Y | 1 |
| Kamei, H | 1 |
| Ishibiki, H | 1 |
| Sekiguchi, M | 1 |
| Piccinini, L | 1 |
| Corradini, R | 1 |
| Vandelli, C | 1 |
| Luppi, G | 1 |
| Di Marco, G | 1 |
| Hojo, K | 1 |
| Aota, M | 1 |
| Yokomise, H | 1 |
| Jinno, K | 1 |
| Daitoh, N | 1 |
| Nagamatsu, Y | 1 |
| Nakarai, I | 1 |
| Matsuo, T | 1 |
| Kawahara, M | 1 |
| Shinoda, A | 1 |
| Yoshinaka, K | 1 |
| Takagami, S | 1 |
| Saeki, T | 1 |
| Nishiyama, M | 1 |
| Niimoto, M | 1 |
| Yamane, T | 1 |
| Nishioka, B | 1 |
| Matsuki, N | 1 |
| Sakuma, H | 1 |
| Yagi, M | 1 |
| Hagino, S | 1 |
| Katayama, K | 2 |
| Note, M | 1 |
| Uogishi, M | 1 |
| Ueno, K | 1 |
| Sawazaki, K | 1 |
| Ohyanagi, H | 1 |
| Tagashira, Y | 1 |
| Kurogoh, F | 1 |
| Shiromizu, K | 1 |
| Matsuzawa, M | 1 |
| Ishihara, O | 1 |
| Kinami, Y | 1 |
| Peek, U | 1 |
| Miyata, R | 1 |
| Kamata, T | 1 |
| Shiba, E | 1 |
| Wada, A | 1 |
| Higashino, Y | 1 |
| Asano, E | 1 |
| Akimoto, R | 1 |
| Uchida, H | 1 |
| Mukawa, A | 1 |
| Nagakawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer[NCT00392899] | Phase 3 | 2,025 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| The Effect of Postoperative Supplemental Parenteral Nutrition (SPN) in Gastric Cancer Patients Who Underwent Gastrectomy: A Multicenter Prospective Randomized Controlled Trial[NCT04607057] | Phase 4 | 224 participants (Anticipated) | Interventional | 2020-12-22 | Recruiting | ||
| Docetaxel, Oxaliplatin, Fluorouracil (FLOT Regimen) Combined With Teriprizumab (PD-1) in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis: an Open, One-arm, Exploratory Study[NCT04886193] | 20 participants (Anticipated) | Interventional | 2021-04-16 | Recruiting | |||
| The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446] | Phase 2 | 20 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
| 1922GCCC: PHASE 2 STUDY OF PEMBROLIZUMAB AND BAVITUXIMAB FOR PROGRESSIVE RECURRENT/METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK[NCT04150900] | Phase 2 | 7 participants (Actual) | Interventional | 2020-01-13 | Active, not recruiting | ||
| Apatinib Plus XELOX Regime as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Patients With Lymph Node Metastasis[NCT03229096] | Phase 2 | 35 participants (Anticipated) | Interventional | 2017-02-01 | Recruiting | ||
| Phase III Trial of 3-weekly vs. 5-weekly Schedule of S-1 Plus Cisplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer.[NCT00915382] | Phase 3 | 625 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| A Multi-center, II Phase，Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Gemcitabine Plus Capecitabine Standard Adjuvant Therapy for Stage II/III Pancreatic Cancer[NCT03959150] | Phase 2/Phase 3 | 231 participants (Anticipated) | Interventional | 2020-01-05 | Recruiting | ||
| Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study[NCT04737551] | 400 participants (Anticipated) | Observational [Patient Registry] | 2020-01-01 | Recruiting | |||
| Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552] | Phase 3 | 870 participants (Anticipated) | Interventional | 2013-08-19 | Recruiting | ||
| Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320] | Phase 2 | 200 participants (Actual) | Interventional | 2015-10-05 | Active, not recruiting | ||
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-risk Women With Axillary Node-negative Breast Cancer (NSAS-BC)[NCT00152191] | Phase 3 | 1,300 participants (Anticipated) | Interventional | 1996-10-31 | Completed | ||
| The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)[NCT00152178] | Phase 3 | 680 participants (Anticipated) | Interventional | 1996-07-31 | Completed | ||
| A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Sintilimab in Gastric Cancer With Peritoneal Metastasis[NCT05648487] | Phase 2 | 46 participants (Anticipated) | Interventional | 2023-01-01 | Not yet recruiting | ||
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| A Phase II Study Assessing Efficacy and Safety of TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated Metastatic Colorectal Cancer[NCT03517618] | Phase 2 | 41 participants (Actual) | Interventional | 2014-07-05 | Completed | ||
| A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of UFT Compared With Surgery Alone for Serosa-negative Advanced Gastric Cancer (NSAS-GC)[NCT00152243] | Phase 3 | 500 participants (Anticipated) | Interventional | 1997-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
31 reviews available for tegafur and Lymph Node Metastasis
| Article | Year |
|---|---|
Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Topics: Allografts; Biopsy; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Drug Combi | 2020 |
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
[A Case of Remnant Gastric Cancer That Completely Responded to Neoadjuvant S-1 and Cisplatin Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2017 |
[A case of gastric cancer with virchow and para-aortic node metastasis treated successfully by neo-adjuvant chemotherapy with S-1/CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Combinations; Female; Humans; | 2013 |
[Urgent gastrectomy in a patient who developed perforated gastric cancer during preoperative chemotherapy with S-1 plus cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combin | 2014 |
[A case of advanced sigmoid colon cancer with metastases in the liver and the paraaortic lymph nodes successfully treated with 5-FU/l-LV and FOLFOX4 followed by S-1 leading to long-term complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Human | 2014 |
[Gastrectomy for a patient with advanced gastric cancer with spleen metastases following induction chemotherapy with S-1 plus cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female | 2014 |
[A case of para-aortic lymph node metastasis from colon cancer with complete response to uracil/tegafur plus leucovorin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Colonic Neoplasms; Humans; Leucovorin; | 2014 |
Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality | 2015 |
[A case of advanced gastric cancer responding to S-1/CDDP neoadjuvant chemotherapy, leading to a pathological complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Lymphati | 2015 |
[Curative resection for Stage IV advanced gastric cancer that responded to combination chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dru | 2014 |
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian | 2015 |
[A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastre | 2015 |
[A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; | 2016 |
[An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphati | 2016 |
[A Case of Gastric Cancer Responding to Neoadjuvant Chemotherapy Leading to Histological Change to Grade 3].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2016 |
[A Case of Simultaneous Multiple Gastric Cancers Showing Differences of Response after Neoadjuvant Chemotherapy with Docetaxel, CDDP, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2016 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; | 2010 |
[Pathological complete response in advanced gastric carcinoma by S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2011 |
[Recent advance in adjuvant therapy for breast cancer].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2002 |
[Progress in postoperative adjuvant chemotherapy in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Drug Administrat | 2002 |
[Advanced gastric cancer successfully treated by TS-1--case report].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta, Abdominal; Combined Modality Therapy; | 2004 |
[Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Chem | 2004 |
[Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell | 2004 |
[Recurrence of esophageal cancer treated by combination TS-1/CDDP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2005 |
[Recent important insights into treatment of pancreatic cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2005 |
[A patient with esophageal cancer recurrence responding to S-1 combined with cisplatin (CDDP)].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2007 |
[Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast N | 1997 |
[Benefits of adjuvant chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; | 1997 |
[A case of urothelial carcinoma associated with penile metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Lymphati | 1999 |
[A complete response persisting for twelve months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Drug Combinations; Female; Gastrectomy; Humans; Lymph | 2001 |
85 trials available for tegafur and Lymph Node Metastasis
| Article | Year |
|---|---|
A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704).
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Protocols; Docetaxe | 2020 |
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09).
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Cho | 2020 |
The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Topics: Aged; Disease-Free Survival; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; M | 2017 |
Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Com | 2018 |
S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Dr | 2018 |
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2018 |
Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonoscopy; | 2019 |
Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2019 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2019 |
Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Drug Combinations; Female; Humans; Japan; Lymph Node E | 2014 |
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; | 2014 |
Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Combinations; Female; Humans; Lymphatic Metastas | 2017 |
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2014 |
Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 2014 |
Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docet | 2014 |
A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis.
Topics: Adenocarcinoma; Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; A | 2015 |
Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysi | 2015 |
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease- | 2015 |
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2015 |
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JC
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2015 |
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F | 2016 |
A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dise | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptot | 2009 |
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy | 2009 |
Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema | 2009 |
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Combination | 2009 |
Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 2009 |
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Follow-Up St | 2010 |
Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; D | 2010 |
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2010 |
Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study.
Topics: Adult; Aged; Alanine Transaminase; Androgen Antagonists; Anorexia; Antimetabolites, Antineoplastic; | 2010 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carci | 2011 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviva | 2011 |
Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2012 |
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplasti | 2012 |
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cisplati | 2012 |
Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, | 2013 |
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combin | 2013 |
Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2003 |
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch | 2003 |
[Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule | 2003 |
[Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study].
Topics: Adult; Aged; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous C | 2003 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; | 2004 |
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Prot | 2005 |
[Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronothe | 2005 |
[Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Pr | 2005 |
[Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal | 2006 |
[S-1 monotherapy for pancreatic cancer].
Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2006 |
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set
Topics: Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Ne | 2006 |
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dru | 2006 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplat | 2007 |
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; | 2007 |
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Femal | 2007 |
A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Topics: Administration, Oral; Adult; Aged; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Combi | 2007 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free | 2008 |
[Clinical trial of UFT against disseminated breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 1984 |
Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluo | 1984 |
[High tissue concentration of 5-FU reduced local recurrence after administration of tegafur suppositories].
Topics: Chemotherapy, Adjuvant; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplas | 1995 |
[Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Admi | 1995 |
[Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Admi | 1995 |
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; | 1994 |
[The usefulness of pre- and immediately postoperative chemotherapy in colorectal cancer].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 1994 |
A cooperative randomized controlled study of adjuvant chemoendocrine therapy for breast cancer in Japan.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan | 1994 |
Oral tegafur in the treatment of metastatic breast cancer: a phase II study.
Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Bone Neoplasms; Breast Neoplasms; Female; Human | 1993 |
[Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 1996 |
[Preoperative adjuvant chemotherapy with oral anticancer agents for stomach cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, | 1997 |
[Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy | 1997 |
[Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Carcinoma, Squamous Ce | 1998 |
Dose-intense salvage therapy after neoadjuvant chemotherapy: feasibility and preliminary results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, | 1999 |
[Randomized comparative study of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) and UFT-tamoxifen regimens as adjuvant chemotherapy after surgery for breast cancer: Tochigi Prefectural Study Group for Post-Breast Cancer Adjuvant Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyc | 2000 |
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic | 2001 |
[Late phase II study of S-1 in patients with advanced head and neck cancer].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug A | 2001 |
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; | 2002 |
[Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Admi | 1991 |
[Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1990 |
[Cooperative study of postoperative long-term adjuvant therapy of breast cancer. First study of a series--comparative study between postoperative tegafur administration and no adjuvant chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltr | 1988 |
[Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy].
Topics: Female; Humans; Lymphatic Metastasis; Lymphocyte Activation; Male; Middle Aged; Mitomycin; Mitomycin | 1986 |
[Adjuvant chemotherapy of colorectal cancer--results of prospective randomized trials].
Topics: Administration, Rectal; Adult; Aged; Colonic Neoplasms; Drug Administration Schedule; Female; Humans | 1986 |
[Prospective randomized controlled study of bestatin in gastric cancer surgery].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucin | 1988 |
[Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku].
Topics: Administration, Oral; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Hu | 1988 |
456 other studies available for tegafur and Lymph Node Metastasis
| Article | Year |
|---|---|
[A Case of Advanced Gastric Cancer with Distant Lymph Nodes Metastasis Showing a Complete Response to Six-Courses Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2021 |
N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur-uracil/leucovorin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans | 2023 |
Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; D | 2019 |
[A Case of Successful Surgical Treatment for Paraaortic Lymph Nodes Recurrence of Gallbladder Cancer].
Topics: Aged; Drug Combinations; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic | 2019 |
[A Case of Advanced Gastric Cancer with Right Gastroepiploic Vein Tumor Thrombus Treated by Preoperative S-1 plus CDDP That Resulted in Pathological Complete Response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2019 |
[A Case of Long-Term Survival with Far Advanced Gastric Cancer after Multidisciplinary Treatments, including Conversion Surgery].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphatic Metastasis; Mal | 2020 |
[Case of Gastric Cancer with Para-Aortic Lymph Node Metastases Successfully Treated with S-1/Docetaxel Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymph No | 2020 |
[Long-Term Survival for a Patient with StageⅣ Gastric Cancer with Multiple Liver Metastases for Ten Years Who Was Treated with Only S-1Chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; | 2020 |
[A Case of Histological Response of Grade 3 Achieved by Preoperative Chemotherapy with S-1/Oxaliplatin(SOX)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lympha | 2021 |
[A Case of Advanced Gastric Cancer with Extensive Lymph Node Metastasis That Showed pCR to Preoperative Chemotherapy Containing SP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2020 |
[A Case of Gastric Cancer with Extensive Lymph Node Metastasis Causing Stenosis Symptoms in the Primary pCR after Preoperative Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Drug Combinations; G | 2021 |
Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreati | 2021 |
Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biomarkers; Cape | 2022 |
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplati | 2017 |
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Topics: Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Ant | 2018 |
[A Case of Conversion Surgery for a Patient with Initially Unresectable Pancreatic Cancer with a Pathological Complete Response to S-1 Chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Lymphatic Metastasis; Neoa | 2017 |
[Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; | 2017 |
[A Curatively Resected Case of Lateral Lymph Node Metastasis Five-Years after Initial Surgery for Rectal Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Lymph Node Excision; Lymph | 2017 |
[A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenum; Female; Gastrecto | 2017 |
[A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy].
Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Drug Co | 2017 |
[A Successful Treatment for Stage III c Gastric Cancer with Low Cardiac Function Using S-1 plus Oxaliplatin(SOX)as a Neoadjuvant Chemotherapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastre | 2017 |
Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biomarkers, Tumor; Cell N | 2018 |
Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherap | 2018 |
The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chem | 2018 |
Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Feasibility Stud | 2018 |
[A Case of Long-Term Survival in a Patient with Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Who Responded to Combined Modality Therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; Drug Co | 2018 |
[A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Lymph Node Excision; Lymp | 2018 |
[A Case of cStage Ⅲ Esophagogastric Junction Adenocarcinoma That Showed pCR to Preoperative Chemotherapy Containing SOX].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Esophagogas | 2018 |
[Gastric Neuroendocrine Carcinoma(NEC)Treated with CDDP plus CPT-11 Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Drug Com | 2019 |
[A Case of Gastric Small Cell Carcinoma with Rapid Regrowth after Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Combinations; | 2019 |
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Gastrectom | 2019 |
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer.
Topics: Aged; Chemotherapy, Adjuvant; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Logisti | 2019 |
[Long-Term Survival of a Patient with Inoperable Gastric Cancer with Distant Lymph Node Metastasis-A Case Report].
Topics: Aged; Drug Combinations; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Oxonic Acid; Stomach Neo | 2019 |
Intramucosal gastric cancer with fifteen metastatic lymph nodes: report of a case.
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2012 |
The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Ant | 2013 |
Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2013 |
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations | 2014 |
Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; | 2013 |
[A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2013 |
[A case of advanced gastric cancer with bulky lymph node metastases responding to S-1/CDDP neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; L | 2013 |
Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; | 2013 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemo | 2013 |
[A case of recurrent pancreatic cancer effectively responding to S-1 combined irinotecan third-line chemotherapy with PSK].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Female; Human | 2013 |
[A case of advanced gastric cancer with regional lymph node metastasis showing pathological complete response after preoperative chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2013 |
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cel | 2013 |
[A case of effective multidisciplinary treatment for advanced gallbladder carcinoma with distant lymph node metastases].
Topics: Antineoplastic Agents; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female; Gallblad | 2013 |
[A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinati | 2013 |
[A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Drug Combinations; Gastrectomy; | 2013 |
[A case of locally advanced residual gastric cancer treated with combined resection of multiple adjacent organs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2013 |
[Pathological complete response in advanced gastric carcinoma with lymph node metastasis treated with combination neoadjuvant chemotherapy comprising S-1 and cisplatin-a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; L | 2013 |
[A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy | 2013 |
[A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug C | 2013 |
[A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combina | 2013 |
[Long-term survival after surgical resection of a cancer of unknown primary site-a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combination | 2013 |
CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Chemoradiotherapy; | 2014 |
Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Biliary Tr | 2013 |
Repeat hepatectomy for intrahepatic recurrence of cholangiolocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2013 |
[A case of complete response(CR)to S-1 and paclitaxel(PTX)combination therapy in a patient with unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Lymphatic M | 2014 |
[A case of advanced gastric cancer treated with curative resection after preoperative combined chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2014 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamid | 2014 |
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.
Topics: Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Ad | 2016 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Transport System ASC; Amino Acid Transport System y+; Ant | 2014 |
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2015 |
Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 2014 |
[A case of advanced gastric cancer with para-aortic lymph node metastases responding to S-1/CDDP chemotherapy that leads to a pathological complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; D | 2014 |
Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; H | 2014 |
S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Chemo | 2014 |
[A case of a patient with gastric cancer and peritoneal dissemination who survived for more than 10 years after successful treatment with S-1].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Female; Gastrectomy; | 2014 |
[A case of squamous cell carcinoma of the nipple skin successfully treated with S-1 alone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Squamous Cell; | 2014 |
[A case of gastric cancer with N2 lymph node metastasis and pancreatic invasion effectively treated with docetax-el/S-1 as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphati | 2014 |
[A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Is pancreatic fistula associated with worse overall survival in patients with pancreatic carcinoma?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemother | 2015 |
Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2014 |
Hepatobiliary and pancreatic: sigmoidal mesenterial lymph node metastasis from pancreatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon, | 2014 |
Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 2014 |
Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2015 |
[A case of recurrent gastric cancer successfully treated with S-1 oral administration].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Femal | 2015 |
[A case of liver and para-aortic lymph node metastasis of colorectal cancer responding to S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Colonic Neoplasms; Drug Combinations; Female; Humans; | 2015 |
[A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2014 |
[A case of pathological complete response to lt. Lateral lymph node metastasis from lower rectal cancer by S-1 combined neoadjuvant chemoradiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Combinations | 2014 |
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case report of advanced gastric cancer with bulky lymph node metastases successfully treated with induction chemotherapy followed by curative resection].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Induction Che | 2014 |
[A case of advanced gastric cancer successfully treated with second-line chemotherapy followed by curative conversion gastrectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug | 2014 |
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Ad | 2014 |
[A case of recurrent gastric cancer successfully treated with TS-1+CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2014 |
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biom | 2015 |
Number of Lymph Nodes in Rectal Cancer is Correlated with Response to Preoperative Chemoradiotherapy but is not Associated with Patient Survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease Progression; D | 2014 |
[Locally Advanced Gastric Cancer Treated with Curative Gastrectomy and Showing Pathological Complete Response after Chemotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; | 2015 |
Successful treatment of bilateral multiple lymph node metastases in extramammary Paget's disease with surgery and sequential chemotherapy of S-1 and docetaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Com | 2015 |
[A Study of Preoperative Chemotherapy with S-1 plus Cisplatin for Advanced Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2015 |
[A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Female | 2015 |
[Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2015 |
[Four Cases of Primary Small Intestinal Cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Duodenal Neoplasms; Fem | 2015 |
[A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2015 |
[Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2015 |
[A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans | 2015 |
[A Case of Resected Advanced Gastric Cancer Exhibiting Pathological Complete Response after Neoadjuvant Che-motherapy(DTX/CDDP/S-1:DCS)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Human | 2015 |
[A Case of Advanced Gastric Cancer Responding to Neoadjuvant Docetaxel/CDDP/S-1 Therapy with Metallic Stent Placement, Leading to Curative Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy | 2015 |
[A Case of Advanced Gastric Cancer with Long-Term Survival after Chemotherapy with Combined S-1 and CPT-11].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Humans; Irinotecan; | 2015 |
[A Case of Ascending Colon Cancer with Extra Iliac Lymph Node Metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon, Ascending; Colonic Ne | 2015 |
[A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gallbladder Neoplasms | 2016 |
Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Combi | 2016 |
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cape | 2016 |
[A Case of Virchow's Lymph Node Recurrence of Gastric Cancer Who Had Underwent Gastrectomy, and Treated with S-1 Monotherapy Leading to Complete Response (CR)].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; | 2016 |
Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradioth | 2016 |
[Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxy | 2016 |
[A Case of Long-Term Survival after Combination Therapy for Gastric Cancer with Synchronous Multiple Liver Metastasis].
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Hepatectomy | 2016 |
Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Squ | 2016 |
Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2017 |
[A Case of Successful Multidisciplinary Therapy for Advanced Esophagogastric Junction Cancer with Multiple Lymph Node Metastase].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Esoph | 2016 |
[A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Combinations; Female; Humans; | 2016 |
[Long-Term Complete Response by S-1 Chemotherapy for Gastric Cancer with Para-Aortic Lymph Node Metastases].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Drug Combinations; Gastrectomy; Humans; Lymph Node Exc | 2016 |
[A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lymphatic Me | 2016 |
[A Case of Pathological Complete Response after SOX Chemotherapy in Advanced Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2016 |
[A Case of Lymph Node Metastasis of Intrahepatic Bile Duct Cancer Successfully Treated Using Multidisciplinary Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2016 |
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; | 2008 |
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2008 |
[Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Ci | 2008 |
[A case of complete response to combination therapy of S-1 and CDDP for Stage IV gastric cancer with Virchow's lymph node and para-aorta lymph node metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Carcinoembryonic Antigen; Cisplatin; | 2008 |
Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic | 2008 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Camptothecin; Drug Combinations; Female | 2008 |
[A case of advanced gastric cancer with giant lymph node metastasis responding to S-1/CDDP neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2008 |
[Two cases of giant metastatic cervical lymphnode from oral cancer responding to concurrent chemoradiotherapy with S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug C | 2008 |
[Marked response to combination chemotherapy using S-1, CPT-11 for lymph node metastasis of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Drug Combinat | 2008 |
[A successful case of advanced nasal adenocarcinoma treated with tumor dormancy therapy with S -1 alone].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dis | 2008 |
[A case of multiple lymph node metastases from transverse colon cancer successfully treated with oral tegafur/uracil (UFT)/Leucovorin (LV)].
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colon, Tran | 2008 |
Adenosquamous carcinoma of maxillary sinus: case showing complete response to S-1.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ad | 2009 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2009 |
[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Drug Co | 2009 |
[Noticeable clinical response to S-1/CDDP combination therapy for Virchow node recurrence after surgery for advanced gastric carcinoma with marked involvement of the esophagus - report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2009 |
[A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2009 |
The usefulness of perfusion-weighted magnetic resonance imaging in advanced pancreatic cancer.
Topics: Aged; Antineoplastic Agents; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Kaplan-M | 2009 |
[Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Age Factors; Aged; Antineoplastic Combined Chemothe | 2009 |
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
Topics: AC133 Antigen; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2009 |
[S-1/CDDP combined neoadjuvant chemotherapy and surgical resection for advanced gastric cancer. Analysis of 12 patients with lymph node metastasis in Saitama Red Cross Hospital].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case of advanced colon cancer treated with preoperative chemotherapy (IRIS) leading to clinical complete response].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Chemotherapy | 2009 |
S-1 mediates the inhibition of lymph node metastasis in oral cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tu | 2009 |
[A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[A case report of primary duodenal adenocarcinoma with marked lymph node metastases responding to chemotherapy with S-1 plus CDDP combination].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 2009 |
Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Comb | 2009 |
[A case of advanced gastric cancer that a medical therapy effect was provided grade 3 by a histopathological diagnosis after long-term chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C | 2009 |
[A case of advanced rectal cancer that responded to S-1 with an extended complete response].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Combina | 2009 |
[A case of effective treatment with UFT/LV chemotherapy for para-aortic lymph node metastasis from colonic cancer 8 years after colectomy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2009 |
[A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma].
Topics: Administration, Oral; Aged; Anal Canal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anti | 2009 |
Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2009 |
[A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, | 2009 |
[A case of advanced gastric cancer with paraaortic lymph node recurrence reaching a long-term survival by S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Aorta, Abdominal; Chemotherapy, Adjuvant; Drug Combinations; Humans | 2009 |
[A case of recurrence gastric cancer patient who was post operated and multi drug chemotherapy was effective for administration of S-1 and docetaxel combination therapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2009 |
[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neo | 2009 |
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
[S-1 + CPT-11 combination therapy with continuing 30-month CR in a recurrent gastric cancer with para-aortic lymph node metastasis in adjuvant chemotherapy with S-1--a case report].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2010 |
[A case of gastric cancer with Virchow and para-aortic node metastases treated successfully using S-1].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Lymph Node Excision | 2010 |
[A case of advanced gastric cancer with distant lymph node metastases in cervical, supraclavicular and superior mediastinum successfully treated with S-1/Cisplatin (CDDP)/Lentinan combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrosc | 2010 |
[A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Lung Neoplasms; Lym | 2010 |
[A 14-month surviving patient on advanced esophageal cancer with big lymph node metastasis to cardia responding to S-1 plus cisplatin (CDDP) therapy at home].
Topics: Aged; Antineoplastic Agents; Cardia; Cisplatin; Drug Combinations; Esophageal Neoplasms; Esophagosco | 2008 |
[A case of advanced gastric cancer responding to neoadjuvant chemotherapy with S-1 and CDDP combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrosc | 2010 |
[A patient with small intestinal cancer and extensive lymph node metastasis who responded to S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Drug Combinations; Endosc | 2010 |
Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Drug C | 2010 |
Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Topics: Activin Receptors, Type I; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2010 |
Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery.
Topics: Aged; Antimetabolites, Antineoplastic; Disease-Free Survival; Drug Combinations; Humans; Lymphatic M | 2010 |
[Three cases of gastric cancer with para-aortic lymph node metastases succesfully treated by S-1/CDDP combination therapy followed by curative resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; D | 2010 |
[A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Combined Modality Therapy; Drug | 2010 |
Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis | 2010 |
[A case of luminal B recurrent breast cancer with liver and lymph node metastases successfully treated with combination therapy of S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2010 |
[A case of advanced gastric cancer responding to S-1/paclitaxel/lentinan as neoadjuvant chemoimmunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lentin | 2010 |
[A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2010 |
A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
Topics: Adult; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colostomy; Drug Combinations; Female | 2010 |
[Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Deoxycytidine; Drug Combination | 2010 |
[Combination chemotherapy of S-1, docetaxel and CDDP produces a remarkable response in a patient with metastases of supraclavicular lymph nodes and gingival carcinoma of the mandible].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clavicle; Docetaxel; Drug Combinations; F | 2010 |
The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2010 |
[Complete histological response in advanced gastric cancer with Virchow's node metastasis after chemotherapy including S-1/CDDP--report of a case].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2010 |
Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 2011 |
[A case of multi-drug resistant breast cancer with liver metastasis treated effectively by S-1 monotherapy].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Combinations; Dru | 2010 |
[A case of advanced colon cancer with metastases to both supraclavicular and para-aortic lymph nodes effectively treated by radiation and S-1 therapy].
Topics: Administration, Oral; Colonic Neoplasms; Combined Modality Therapy; Drug Combinations; Female; Human | 2010 |
[A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy].
Topics: Combined Modality Therapy; Deoxycytidine; Drug Combinations; Fatal Outcome; Gemcitabine; Humans; Lym | 2010 |
[A clinical case of lymph node recurrence after resection of gastric cancer successfully treated by combination chemotherapy with irinotecan and cisplatin].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2010 |
[Highly advanced gastric cancer that responded to neoadjuvant combination chemotherapy with docetaxel/CDDP/S-1 (DCS)].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2010 |
[A case of advanced gastric cancer successfully treated with chemoradiotherapy targeting for recurrent lymph node metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2010 |
[Report of two cases successfully treated by chemo-radiation against lymph node metastasis after gastric cancer surgery].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2010 |
[A case of gastric endocrine cell carcinoma with liver metastases treated with S-1/CDDP].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ant | 2010 |
[A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic A | 2010 |
[A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, | 2010 |
[A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2010 |
[A case report of primary adenocarcinoma of small intestine].
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
[A case of multiple para-aortic lymph node metastases from squamous cell carcinoma of an unknown primary responding completely to chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Squamous Cell; Cisplatin; Drug Com | 2011 |
Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2011 |
[Efficacy of concurrent chemoradiotherapy in cases with cervical lymph node metastasis from oropharyngeal or hypopharyngeal cancer].
Topics: Adult; Aged; Aminohydrolases; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Ther | 2011 |
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Ne | 2011 |
[Effect of S-1 in a patient with metastatic eyelid sebaceous carcinoma].
Topics: Aged; Drug Combinations; Eyelid Neoplasms; Female; Humans; Lymphatic Metastasis; Oxonic Acid; Positr | 2011 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 2011 |
A case of gastric cancer accompanied with massive splenic invasion by metastatic lymph nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Endoscopy, Digestive S | 2011 |
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2011 |
Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2012 |
[An elderly gastric cancer patient with multiple-node metastases treated successfully using S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Combined Modality Therapy; Drug Combinations; Humans; | 2011 |
[Complete response to S-1/CDDP combination in a patient with obstructive jaundice secondary to lymph node metastasis by gastric cancer - a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Jaundi | 2011 |
Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients.
Topics: AC133 Antigen; Adult; Aged; Aged, 80 and over; Antigens, CD; Antimetabolites, Antineoplastic; Biomar | 2011 |
[A case of breast cancer with postoperative metastasis to the supraclavicular lymph nodes-recurrence-free survival achieved by surgical excision following chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy, Needle; Breast Neoplasms; Clavicle; Combine | 2011 |
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Ther | 2012 |
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Combinations; | 2011 |
[Evaluation of pre-operative chemotherapy with S-1 plus CDDP against advanced gastric cancer with paraaortic lymph node metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; D | 2011 |
Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doce | 2012 |
Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Ch | 2012 |
Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biom | 2012 |
Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Cisplatin; Drug C | 2011 |
Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Co | 2012 |
Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemoradiotherapy; | 2012 |
[A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal].
Topics: Aged; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; | 2011 |
[Prognosis and clinical course of gastric cancer with para-aortic lymph node metastasis after curative D2 gastrectomy and adjuvant chemotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Combined Modality Therapy; Drug Combinations; Female; | 2011 |
[A case of locally advanced gastric cancer responding to preoperative S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2011 |
[A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1].
Topics: Aged; Ambulatory Care Facilities; Antineoplastic Agents; Chemoradiotherapy; Docetaxel; Drug Combinat | 2011 |
[A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Drug Combinati | 2011 |
[A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Humans | 2012 |
[A case of S-1-resistant resected advanced gastric cancer with para-aortic lymph node recurrence responding to bi-weekly CPT-11 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Camptothecin; Cisplatin; Drug Comb | 2012 |
Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anorexia; Antimetabolites, Antineoplastic; Chemoradiotherap | 2012 |
[Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2012 |
[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Hepatocellular; Combined Modalit | 2012 |
[A case of advanced gastric cancer with recurrence-free long survival showing disappearance of distant lymph node metastases by S-1/docetaxel therapy followed by curative resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphati | 2012 |
[Two cases of long-term response treated by S-1 with concurrent radiotherapy followed by S-1 treatment for non-small cell lung cancer patients].
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Comb | 2012 |
Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug | 2013 |
[A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy].
Topics: Antimetabolites, Antineoplastic; Aorta; Chemoradiotherapy; Drug Combinations; Humans; Lymphatic Meta | 2012 |
[A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent].
Topics: Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cisplatin; Drug Combinations; Ei | 2012 |
[A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemoradiotherapy; Drug Combinations; Esophagogastr | 2012 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP as neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Administratio | 2002 |
[A case of gastric carcinoma with metastasis in a paraaortic lymph node that responded to TS-1/CDDP combination therapy, in which the patient was able to undergo extirpation with grade B curability].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Administration Schedule; Drug | 2002 |
[Complete response in a case of recurrent gastric cancer treated with TS-1].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Sch | 2002 |
[A case of advanced gastric cancer with invasion of pancreas effectively treated by combined chemotherapy of TS-1 and paclitaxel (TXL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule | 2002 |
[Low-dose cisplatin and UFT for hormone refractory prostate cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Com | 2002 |
[Complete response in a case of advanced scirrhous type 3 gastric cancer of with bulky N2 para-aorta lymph node metastases treated by combined chemotherapy of TS-1 and CDDP].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Ad | 2002 |
[TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedul | 2002 |
Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; D | 2002 |
[A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2002 |
[A case of recurrent advanced gastric cancer suggesting the efficacy of TS-1 and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Chemotherapy, | 2002 |
[Two patients with recurrent colon cancer who underwent surgery following a combination of irinotecan and UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptoth | 2002 |
[A case of stage IV gastric carcinoma with lymph nodes metastases of the paraaorta responding markedly to TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cispl | 2002 |
[A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality | 2003 |
[A case of advanced gastric adenocarcinoma with mild elevation of serum SCC that responded remarkably to adjuvant chemotherapy of ADM, CDDP, ETP and 5-FU (ACVF)].
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chemothera | 2003 |
[A case of advanced gastric cancer treated with paclitaxel and TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Gas | 2003 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Proto | 2003 |
[A case report--TS-1/CDDP combined chemotherapy found effective for metastatic recurrence after operation for colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colon, Sigmoid; Combined Modality T | 2003 |
[A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2003 |
[A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Ducts, Extrahepatic; Cholecystectomy; Drug Adminis | 2003 |
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2003 |
Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Drug Evaluation; Fe | 2003 |
Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; D | 2003 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehyd | 2003 |
[A case of gastric cancer with metastasis to cervical lymph nodes and pulmonary lymphangitis carcinomatosa responding to neoadjuvant chemotherapy with TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Combinations; Gastrectomy | 2003 |
[Sustained NC status for a long period after combined chemotherapy of TS-1 and CDDP for residual lesions following gastrectomy for gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2003 |
[A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Cisplatin; Drug Ad | 2003 |
[A case of advanced gastric cancer which became operable after chemotherapy with combination of TS-1/CDDP and in which complete disappearance of liver metastasis was histopathologically confirmed].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2003 |
[A case of advanced gallbladder cancer with biliary tract stenosis which responded to TS-1 chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Cisplatin; Constriction, Pat | 2003 |
[A case of advanced gastric carcinoma successfully treated with TS-1/CDDP as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; | 2003 |
[A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; | 2003 |
[Remarkable response of simultaneous advanced esophageal and gastric cancer to combined chemotherapy with weekday-on/Weekend-off TS-1 plus biweekly cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Carcinoma, Squamo | 2003 |
[A case of advanced gastric cancer attaining histological CR of paraaortic lymph node after TS-1/CDDP neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cisplatin; Drug Admin | 2003 |
[A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; D | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2003 |
[A case of distant metastasis from advanced gastric cancer treated with TS-1, which maintained NC (no change) for 9 months].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
[A case of lymph node recurrence after curative operation of type 4 gastric cancer, successfully treated with TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
[Long-term survival after neck lymph node metastases from sigmoid colon cancer--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Combined Modalit | 2003 |
[A case of lymph node metastasis after total laryngectomy successfully treated with chemoradiotherapy with TS-1].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Humans; Laryngeal Neoplasms; Laryngectomy; Lymph | 2003 |
[A case of effective response to TS-1 of inoperable gastric cancer, in the course of chemotherapy for malignant lymphoma].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
Modified pharmacokinetic modulating chemotherapy using 5-fluorouracil, UFT, and taxotere (docetaxel) for advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Fluorouracil; Humans; Infusion | 2003 |
Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2003 |
[Concurrent chemoradiation experience of recurrent gastric cancers resistant to TS-1].
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Administration Schedule; Drug Combinatio | 2003 |
[A case of advanced maxillary carcinoma with cervical lymph node metastases showing a complete response to the combination therapy of CDDP, TS-1 and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2004 |
[A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combin | 2004 |
[A case of metastatic esophageal cancer responding remarkably to combination chemotherapy of TS-1 and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administra | 2004 |
[A case of heterochronous liver metastasis of gastric cancer favorably responding to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Adminis | 2004 |
[A case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Sche | 2004 |
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Ad | 2004 |
[A case of advanced gastric cancer with a tumor embolus in the portal vein successfully treated with TS-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2004 |
[A case of paraaortic lymph nodes metastases responding to TS-1 following surgery for gastric cancer].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aorta; Combined Modality Therapy; Drug Administrati | 2004 |
[A complete response using TS-1 in a patient with paramesenteric lymph node recurrence of gastric cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Administratio | 2004 |
[A case of recurrent gastric cancer tolerant to TS-1 therapy successfully treated by TS-1 combined with docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Administrati | 2004 |
[A case of gastric cancer with abdominal paraaortic lymph node metastases responding to TS-1 plus CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Cisplatin; Drug Ad | 2004 |
[Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Topics: Administration, Oral; Adult; Aged; Agmatine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2004 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP combination therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality | 2004 |
[A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration | 2004 |
[Clinical efficacy of TS-1 combined with cisplatin for advanced cardiac gastric cancer with multiple liver metastases--two case reports].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Drug Admini | 2004 |
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Adm | 2005 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Sched | 2005 |
[A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2005 |
[Successfully resected advanced gastric carcinoma after combined chemotherapy of TS-1 plus CDDP--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 2005 |
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen].
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; | 2005 |
[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2005 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A case of gastric cancer with abdominal para-aortic lymph node metastases responding to TS-1 + CDDP neoadjuvant chemotherapy].
Topics: Aorta, Abdominal; Cisplatin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Lymphatic | 2005 |
[A case of transverse colon cancer with left supraclavicular lymph node metastasis and paraaortic lymph node metastases responding to TS-1].
Topics: Antimetabolites, Antineoplastic; Aorta; Biomarkers, Tumor; CA-19-9 Antigen; Clavicle; Colectomy; Col | 2005 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemo | 2006 |
[Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Drug Administrat | 2005 |
[A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dru | 2005 |
[A case of advanced gastric cancer with paraaortic lymph node metastasis reaching long-term survival by TS-1 treatment].
Topics: Antimetabolites, Antineoplastic; Aorta; Colectomy; Combined Modality Therapy; Disease-Free Survival; | 2005 |
[Prediction and treatment of peritoneal dissemination in gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combination | 2005 |
[Two cases of advanced gastric cancer, successfully treated with TS-1/CDDP combination chemotherapy--case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2005 |
[A case of advanced gastric cancer with obstructive jaundice that responded to TS-1/CPT-11 combination therapy after percutaneous transhepatic cholangio drainage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract; Camptothecin; Combined Modality Thera | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combi | 2005 |
[A case of primary small intestinal cancer accompanied by virchow lymph node metastasis undergoing TS-1 treatment].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2005 |
[Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[Radiation therapy leading to complete response of residual lymph node metastasis in advanced gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Gastrectomy; Hu | 2005 |
[A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2005 |
[A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chemothera | 2005 |
[Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2005 |
[A case of gastric adenosquamous carcinoma with abdominal paraaortic lymph node metastases successfully treated by TS-1 plus CDDP neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Carcinoma, Adenosquamous; Chemothe | 2006 |
[Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2006 |
[Two cases of gastric cancer with peritoneal dissemination that responded to TS-1 without progression or recurrence for over 3 years].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Schedule; Drug | 2006 |
[A case report of cancer of the lip--complete response by a neo-adjuvant chemotherapy using a novel method of TS-1 administration].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Administrati | 2006 |
[A case of scirrhous gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 2006 |
[A case of advanced colon cancer with metastases to both para-aortic lymph nodes and cervical vertebrae effectively treated by TS-1 therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta; Cecal Neoplasms; Cervical Vertebrae; C | 2006 |
Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy).
Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic C | 2006 |
[Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Topics: Aged; Antineoplastic Agents; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; | 2006 |
[A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2006 |
A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinatio | 2006 |
[Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronotherapy; Co | 2006 |
[A case of recurrent esophageal cancer responding to second-line chemotherapy of TS-1/docetaxel combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2006 |
[A case of advanced gastric cancer successfully treated by TS-1 and CDDP after jejunostomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2006 |
[A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Co | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Co | 2006 |
Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2006 |
[A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinoma, Smal | 2006 |
Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; | 2006 |
[Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration | 2006 |
[A case of unknown primary cancer responding to TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2006 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
[A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2006 |
[A case of non-curatively resected gastric cancer successfully treated over 17 months with TS-1 and irinotecan combination therapy].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; D | 2006 |
[A case of N3 gastric cancer successfully treated by TS-1 followed by curative resection].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combi | 2006 |
[A case of non-curatively resected colon cancer with liver and lymph node metastases treated by TS-1/CPT-11 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic | 2006 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |
[A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combin | 2006 |
[Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Anemia; Antimetabolites, Antineoplastic; Drug Administra | 2006 |
[Three cases of successfully resectable advanced gastric cancer responding to TS-1 plus CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2006 |
Complete response of highly advanced colon cancer with multiple lymph node metastases to irinotecan combined with UFT: report of a case.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Col | 2006 |
[A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2006 |
[A partial response to combined TS-1 and docetaxel chemotherapy enabling a curative resection after the failure of combined TS-1 and CDDP chemotherapy in a patient with unresectable gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Gastrectomy; Humans; Lymphatic | 2006 |
[A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Cisplatin; Deoxy | 2007 |
[A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2007 |
[Recurrent esophageal cancer with complete response to TS-1 chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Ther | 2007 |
A case of suspected S-1 induced interstitial pneumonia.
Topics: Adult; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Combinations; Dyspnea; Female; | 2007 |
Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cisplatin; Drug C | 2007 |
Combination therapy of S-1 and CDDP for patients with colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp | 2007 |
[A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Adm | 2007 |
[A case of ascending colon cancer with enlarged metastatic lymph nodes around superior mesenteric arterial root that responded dramatically to S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colon, Ascending; Colonic N | 2007 |
[A case of multiple bone metastases from gastric cancer treated with combination chemotherapy of S-1 and CDDP].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Admi | 2007 |
[A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Adminis | 2007 |
[A case of unresectable advanced pancreatic cancer treated by S-1 with concurrent radiotherapy].
Topics: Adenocarcinoma; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Camptothecin; Drug Administr | 2007 |
[A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel].
Topics: Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combin | 2007 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cispl | 2007 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine | 2007 |
[A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Biomarker | 2007 |
[An elderly case of advanced cervical esophageal cancer successfully treated with UFT after chemoradiotherapy with docetaxel/5-FU/CDDP].
Topics: Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combi | 2007 |
[A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Chemothera | 2007 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Adm | 2007 |
[A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2007 |
[A case of recurrence after resection of stage IV advanced bile duct cancer responding well to S-1/cisplatin combination chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2007 |
[A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female | 2007 |
[A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Humans; | 2007 |
[A case of advanced gastric cancer with peritoneal dissemination responding to S-1/CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2007 |
[Marked response to S-1 chemotherapy for para-aortic lymph node metastasis arising from gastric cancer].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta; Drug Administration Schedule; Drug Com | 2007 |
[A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Constriction, Pathologic; Drug Administ | 2007 |
Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2008 |
[Effect of S-1 in a patient with post-operative recurrence of carcinoma of the ampulla of Vater].
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Drug Combinations; Fe | 2007 |
[An elderly patient with recurrent rectal cancer successfully responded to S-1 combined with CPT-11].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonoscopy; Drug C | 2007 |
[A long-term survival case of advanced sigmoid colon cancer with massive metastases to the para-aortic lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Biomarkers, Tumor; Humans; Lymphatic Metastas | 2007 |
[Three successful cases with CPT-11 + CDDP chemotherapy where S-1 failed to respond to recurrent gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cisplatin; Dr | 2007 |
The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Combinations; Endo | 2007 |
[A case of metastatic gastric endocrine cell carcinoma which could be curably resected after chemotherapy with S-1/CDDP].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Ce | 2008 |
Chemotherapy in advanced urinary bladder cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1984 |
[Effect of extended chemotherapy using tegafur following surgery of stage III stomach cancer].
Topics: Aged; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle | 1983 |
[Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Tra | 1984 |
[An autopsy report of pancreatic carcinoma following the achievement of significant prolongation of survival, despite the lack of a definitive diagnosis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphatic Metastasis | 1984 |
[A statistical study of management based on prognostic factors after surgical treatment for cervical carcinoma].
Topics: Adenocarcinoma; Administration, Oral; Adult; Age Factors; Carcinoma, Squamous Cell; Combined Modalit | 1984 |
Prolonged survival of gastric cancer patients on a specific adjuvant chemotherapy.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; D | 1984 |
Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Human | 1982 |
[Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combin | 1982 |
Pericardiac metastasis from advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorouracil; Heart Neoplasms; Human | 1995 |
[Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Humans; Ly | 1995 |
[A case of bilateral multiple lung metastases from breast cancer successfully treated with carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Femal | 1995 |
[A case of peritoneal metastasis of breast cancer successfully treated by multidisciplinary therapy with hyperthermia therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1994 |
[Tissue concentration of tegafur suppository in patients with head and neck cancer--concentration of 5-FU in cancer tissue].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorouracil; Head and Neck Neopla | 1994 |
[A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Gallbladder Neopl | 1994 |
[A case of early gastric cancer with Virchow's node metastasis, effectively treated by high dose of UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymph Nodes; Lymphatic Metas | 1993 |
[CDDP.UFT therapy for advanced or metastatic gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 1993 |
[Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Head and Neck Neo | 1993 |
[A case report of adenosquamous cell carcinoma of the stomach responding well to combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 1993 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseas | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 1996 |
[A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug C | 1997 |
[A case of advanced gastric cancer successfully treated by UFT and CDDP followed by surgical resection proving cancer cell disappearance in the stomach].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration | 1998 |
[Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone].
Topics: Administration, Oral; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colonic Neopl | 1998 |
[A case of advanced gastric carcinoma with disappearance of cancer cells by neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cispla | 1998 |
Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.
Topics: Animals; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; | 1997 |
Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 1998 |
[A case of rectal cancer with lymph node metastasis (N4) successfully treated with low-dose cisplatin and UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplati | 1999 |
[A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
Topics: Administration, Oral; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Combi | 1999 |
[Case of stage IVb gastric cancer in which favorable anti-tumor effect and good QOL were observed due to UFTP therapy after low-dose CDDP-tegafur therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administratio | 1999 |
[Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 1999 |
[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Len | 2000 |
[A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 2000 |
[Efficacy of UFT in the treatment of para-aortic lymph node metastasis following gastric cancer surgery: case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; | 2000 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Sc | 2000 |
[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplas | 2000 |
[A complete response persisting for seven months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Administration Schedule; Drug Comb | 2000 |
[A case report of TS-1 in a patient with advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combination | 2000 |
[A case of recurrent gastric cancer successfully treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Huma | 2001 |
[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitum | 2001 |
Animal model of para-aortic lymph node metastasis.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Squamous | 2001 |
[Complete response in a case of advanced gastric cancer with liver and intra-abdominal lymph node metastases treated by combined chemotherapy of TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combin | 2001 |
[A case of postoperative gastric cancer responding to adjuvant chemotherapy with TS-1--a novel oral formation of 5-fluorouracil].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Co | 2001 |
Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Ne | 2001 |
[A case of advanced gastric cancer successfully treated with TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Lymph Nodes; Lymphatic M | 2002 |
[Dormant chemotherapy by low-dose FP and low-dose UFT-E in recurrent gastric cancer with long-term survival--a case report].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administr | 2002 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to preoperative chemotherapy and surviving 4 years and 4 months after total gastrectomy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; D | 2002 |
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha Catenin; Antineoplastic Combined Chemotherapy | 2002 |
[A case report of advanced gastric cancer responding to TS-1, a novel oral fluorouracil derivative].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Carcinoembryonic Antig | 2002 |
[A case of unresectable gastric cancer complicated by a serious hepatic disorder and Virchow lymph node metastasis in which FP therapy and TS-1 administration were effective].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2002 |
[A clinicopathological study on preoperative anticancer chemotherapy for gastric cancer (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Synergism; Drug Therapy, Combination; Female; F | 1978 |
[A comparative study on the preoperative administration of 5-FU DS and FD-1 against gastric cancer--with special reference to histological findings (author's transl)].
Topics: Adult; Aged; Female; Fluorouracil; Furans; Humans; Lymphatic Metastasis; Male; Middle Aged; Preopera | 1979 |
[Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembr | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; | 1992 |
[A case of complete remission of lymph nodes metastasis from esophageal cancer with combination treatment of UFT and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 1992 |
[Histopathological findings in rectal carcinomas undergoing preoperative irradiation combined with chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; | 1992 |
[A clinical study of vitamin A concerning auxiliary chemotherapies after operation of gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gastrectomy; Humans; Lymphatic | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
[The usefulness of UFT administration in colorectal cancer with emphasis on postoperative administration (Part 3)].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combine | 1991 |
[Clinicopathological study on rectal cancer after sphincter-saving operation in conjunction with preoperative radiation therapy].
Topics: Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurre | 1991 |
[An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrecto | 1990 |
[Evaluation of subselective intraarterial infusion chemotherapy in advanced gastric cancer and recurrence case-evaluated on factors other than direct effects].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 1990 |
The effect of UFTM therapy on primary and metastatic colon cancer from the same human xenotransplanted into nude mice.
Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colo | 1990 |
[A case of local recurrent breast cancer with complete response to combination of systemic chemotherapy and topical use of adriamycin ointment].
Topics: Administration, Topical; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin | 1990 |
[Adjuvant therapy in resectable non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Combined | 1986 |
[Plasma and tissue concentration of tegafur by a new soft capsule type suppository in colorectal carcinoma].
Topics: Aged; Aged, 80 and over; Capsules; Colorectal Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; | 1989 |
[Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional | 1989 |
Postoperative adjuvant chemotherapy inhibits early recurrence of early gastric carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Drug Evaluation; Gastrectomy; Humans; Lymphatic Metastasis; Mi | 1989 |
[Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Biotransformation; Colonic Neop | 1989 |
Distributions of tegafur in tissues of gastric adenocarcinoma patients: tissue uptakes and concentrations in plasma after oral and rectal administrations.
Topics: Adenocarcinoma; Administration, Oral; Administration, Rectal; Adult; Aged; Female; Fluorouracil; Hum | 1989 |
[A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modali | 1989 |
[Differing progress patterns in cancer of the uterine cervix and variant effects of adjuvant chemotherapy based on histological type].
Topics: Adenocarcinoma; Azirines; Carbazilquinone; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Lymp | 1986 |
Tegafur chemotherapy for the treatment of gut and liver cancer.
Topics: Adult; Aged; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lymphatic Metastasis; Male | 1986 |
[Serum and tissue concentrations of UFT in patients with lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymph No | 1986 |
[A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Humans; Liver | 1986 |
[The problems of postoperative adjuvant chemotherapy in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Lymphatic Metastasis; Mitomycin | 1987 |
[Clinical results of UFT fine granule therapy by cooperative study. Osaka UFT Granulation Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capsules; Drug Admini | 1987 |
[A case of recurrent sigmoid colon cancer successfully treated with 5-FU and UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Lympha | 1988 |
[Effect of PMU therapy (CDDP, MMC and UFT) against terminal gastric carcinoma. Hokuriku Cisplatin Round-table Conference].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule | 1988 |
[Clinical study on the effect of chemotherapy in the treatment of pancreatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Lymphatic Metastasis; | 1988 |
Is postoperative radiotherapy or maintenance chemotherapy necessary for carcinoma of the uterine cervix?
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Middle Ag | 1988 |
[Inflammatory breast carcinoma--possibilities and results of surgical treatment and adjuvant chemotherapy, especially when done preoperatively].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Doxor | 1988 |
[A case of gastric cancer successfully treated with hyperthermo-chemo-radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; H | 1985 |
[A case of long-term survival of liver metastasis of breast cancer successfully treated with chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cy | 1985 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1985 |
[Effect of immunochemotherapy with levamisole on gastric cancer patients--three-year survival rates].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gast | 1985 |